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Abstract 
	  
Red sandalwood has been admired for centuries for its beautiful color, hardness and 
durability, especially in Asian countries. The chemical nature of its colorants, 
however, has long been a mystery. Almost 160 years after Pelletier’s pioneering 
studies, the structures of the major pigments santalin A/B and santarubin A/B were 
elucidated by Arnone et al in 1975.[1] The following work is dealing with the 
synthesis of flavonoids and, in particular, with the members of the santalin family. 
The assembly of these complex natural products has been achieved in a longest linear 
sequence of 7 steps starting from commercially available starting material (Scheme	  
1). 
 
 
	  
Scheme 1 – Efficient synthesis of santalin A from commercially available starting material. 
 
In general, the research project focuses on the development of a biomimetic synthesis 
of santalin A & B and santarubin A & B as well as on the complex, racemic 
oxafenestrane santalin Y.[2] Especially fascinating is the biosynthetic connection of 
these fundamentally different structures, which are believed to arise from two simple, 
achiral building blocks. In this work the limits of biomimetic synthesis were tested 
and it was tried to find out whether this natural products could be assembled along 
biosynthetic lines, without the necessity of enzymatic catalysis.[3] A formal 4+2 
cycloaddition and oxidiation cascade was assumed to give rise of benzoxanthenone 
natural products (santalin A/B and santarubin A/B), while a formal 3+2 cycloaddition 
followed by Friedel-Crafts cyclization was envisioned for the formation of santalin Y. 
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For a unified synthesis of these family members, a robust and scalable route to the 
common precursor, namely anhydrobase was necessary. This was achieved by novel 
methods using a zinc-base mediated Negishi cross–coupling developed by the group 
of Prof. Knochel.[4] Preparation of benzylstyrenes, could be achieved by using novel 
allylation strategies, including a π-allyl Suzuki coupling,[5] Friedel-Crafts allylation[6] 
and olefin cross-metathesis.[7] The tested biomimetic conditions were successful in the 
synthesis of santalin AC, santalin A and B and santarubin A and B. However the 
conditions applied have not resulted in santalin Y. In the course of overcoming 
selectivity problems, deeper insight in the reactivity of anhydrobase and 
benzylstyrenes has been gained and could serve to unravel new reactivities and 
methods in flavonoid chemistry. 
	   iii	  
Acknowledgements 
 
First of all, I want to thank Prof. Dr. Dirk Trauner for his supervision of my work 
over the last 4 years. I cannot thank enough for giving me an intellectual challenging 
project, the freedom to test myself in the field of total synthesis, the trust in my work 
as well as the freedom to explore new ideas and solve problems at hand. 
 
I am very thankful to Prof. Dr. Paul Knochel for agreeing to be the second reviewer of 
this thesis as well as Prof. Dr. K. Karaghiosoff, Prof. Dr. F. Bracher, Prof. Dr. A. 
Hoffmann-Röder and Prof. Dr. em. W. Steglich for accepting to be co-reviewers. 
 
Especially, I am very grateful to Desiree Stichnoth, Julien Lefranc, Filip Bihelovic 
and Giulio Volpin for careful proofreading of this work. 
 
I want to thank all past and present members of the green lab Philipp Stawski, Daniel 
Hog, Matthias Schönberger, Timm Fehrentz (chronologically) for the excellent lab 
atmosphere and intellectual support. 
 
I am very thankful to my students Jakob Franke, Hinnerk Saathoff, Robin Meier, 
Jessica Steinbacher, Jonathan Wieser, Martin Maier and Antonio Fernandez Vargas 
for their hard work and input. 
 
Furthermore, I want to thank for support provided by the Trauner group staff Petra 
Böhrer, Heike Traub, Dr. Martin Sumser, Tobias Kauer, Carrie Louis, Luis de la Osa 
de la Rosa for their help in organizing my chemical life, and as well as the analytical 
team of the LMU for their invaluable help. 
 
I want to thank all past and present Trauner group members, which I had the pleasure 
to meet during my time at the LMU. 
 
Finally, I am deeply thankful to Desiree Stichnoth and my family for their never-
ending support. 
	   iv	  
Table of Abbreviations 
	  
 
Å   Ångström (10-10 m) 
Ac   acetyl 
aq.   aqueous 
ATR   attenuated total reflection 
br   broad 
Bn   benzyl 
Bu   butyl 
c   concentration 
CAN   ceric ammonium nitrate 
CCDC   Cambridge crystallographic data center 
CoA   Coenzyme A 
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MS    mass spectrometry 
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I. Flavonoids and the Major Constituents of Red Sandalwood 
 
Flavonoidic structures stem biosynthetically from the shikimic acid and the 
polyketide pathway.[8] Structures derived from this combined biosynthetic origin are 
widely distributed in plants and present polyphenolic systems. While in general 
phenolic structures are believed to be rather simple, this class shows a huge diversity 
by means of complexity, varying states of oxidation and biological function (Figure	  
1).[9] 
 
 
	  
Figure 1 – Structural diversity of polyphenolic structures. 
 
The polyphenolic structures shown in Figure	  1 give an impression of the diversity in 
this class, starting from rather simple stilbene structures such as resveratrol (1)[10] to 
flavones, for example quercitin (3), to dimers (4) and trimers (5) of flavone units. 
Biosynthetically, the oligomeric structures can be made by oxidative couplings. This 
is possible because of the presence of easily oxidizable catechol and pyrogallol 
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units.[9c] More diverse functionalization is observed in presence of an amino function, 
for example in colchicine (2).[11] 
 
As mentioned before, the flavonoidic structures can be drawn back biosynthetically to 
shikimic acid (6) (Scheme	   2), which, upon linking of a unit of enol pyruvate (7), 
finally leads to chorismic acid (8). An enzyme-catalyzed Claisen rearrangement 
results in prephenic acid (9), the precursor of aryl pyruvic acids. Further 
functionalization by pyridoxal phosphate dependent transaminases (PPT) finally 
yields the amino acids phenylalanine and tyrosine. The transformation from amino 
acids to coumaric acid (10) has been shown to be an elimination of ammonia to 
generate the phenylpropanoid. Coumaric acid is the precursor for a wide range of 
natural products produced in plants.[8] 
 
 
	  
Scheme 2 – Plant phenols stem from shikimic acid. 
 
Coumaric acid itself reacts further in two distinct pathways. One is the oxidative 
modification of its core resulting in phenylpropanoid structures, for example, lignans, 
lignines or coumarins. Another possibility for functionalisation is the integration of 
coumaric acid into the polyketide synthase pathways. This elongation of a 
phenylpropanoid starter unit by C2 units, derived from malonyl-CoA can react further 
by reduction and dehydratisation processes into the class of stilbenes and flavonoids 
(Scheme	  3). Enzyme catalyzed folding domains facilitate the formation of polyketide 
structures (11) to chalcone 12 similar to a Claisen reaction. In presence of ortho-
hydroxy groups, an intramolecular Michael attack and reoxidation can lead to the 
flavonoids, which are found in a huge diversity throughout the plant kingdom. 
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Scheme 3 – Chalcones and flavones can be made along the shikimic acid and the polyketide 
pathway. 
 
While these structures follow a linear pathway towards complexity, isoflavones show 
a skipped phenyl ring on the adjacent carbon atom. The mechanism of this 
rearrangement has not been completely elucidated, but it is believed that starting for 
example from naringenin 14 a NADPH and oxygen codependent radical mechanism 
via 15 is responsible for the migration of the phenyl ring to yield isoflavone 16 after 
oxidation (Scheme	  4).  
 
 
	   	  
Scheme 4 – Interconversion of flavones to isoflavones using a radical mechanism. 
 
As isoflavonoidic structures are widely spread in plants, the function of these natural 
products is not fully understood. Due to the presence of easily oxidizable aromatic 
hydroxy groups, the main purpose is believed to be protection from highly reactive 
radicals formed by oxygen.[9c] This is seen in the fact that most of the so far isolated 
polyphenolic structures show antioxidative activity, which protect living organisms 
from oxidative stress. Oxidative stress is believed to cause a variety of age dependent 
diseases like Alzheimer, Parkinson, amytrophic lateral sclerosis (ALS) and more.[12] 
Therefore, a deep understanding of antioxidative substances is essential in 
understanding, preventing, and treating these diseases. 
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Due to the presence of large conjugated π -systems, polyphenolic structures tend to 
show strong and bright colors. Some of these colorants have been used for centuries 
as dyes in the field of textiles and furniture. An example for these very colorful plants 
is the hardwood of red sandalwood. This unique colored wood has fascinated and 
influenced many people in different cultural historical contexts. In Asian countries, 
where this remarkable tree is cultivated, red sandalwood was used in religious 
contexts or as highly valued furniture in imperial households. These applications 
show the desire of humans for beautiful and appealing colors. Objects carved from the 
red hardwood (Figure	  2) were reserved only for a few people. 
 
 
	  
Figure 2 – Objects carved from the red hardwood of sandalwood. 
 
In 1814 Pelletier’s pioneering studies tried to shine light into the structural details of 
these coloring matters.[13] Due to the complex mixtures of different grades of 
oxidation and different methylation patterns, the structures of the main colorants 
could not be elucidated for more than one century. In the 1970’s, studies towards the 
elucidation of these natural products became again more prominent as a structure was 
proposed for santalin A and B.[14] This proposal could be corrected later by a series of 
studies carried out by the group of Arnone in 1975.[1, 15] 
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Figure 3 – The core of the santalins and santarubins. 
 
While the elucidated structures of santalin A,B (17, 18) and santarubin A,B (19, 20) 
share the same core, the substitution pattern, including the oxidation state and 
methylation, varies. The core of the red colorants shows a unique 
9H-benzo[a]xanthenone structure (Figure	   3), which centers a highly substituted 
naphthalene core. They differ in the substitution of their phenyl substituent at C5, 
which can either bear a resorcinol pattern (santalins) or a catechol pattern 
(santarubins). The opposite is true for the benzyl substituent in position 6 as shown in 
Figure 4.  
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Figure 4	  – The major colorants of red sandalwood. 
 
 
In 1995 the group of Kinjo reexamined the red hardwood of Pterocarpus santalinus 
and isolated two minor colorants besides the already known santalins A & B and 
santarubins A & B.[2] Santalin AC (21), a coumarin, and santalin Y (22), a rather 
complex natural product could be obtained. Santalin Y occurs as a racemate and has 
five stereogenic centers, a highly functionalized oxafenestrane as well as phenyl and 
benzyl substitutents directly attached to this core. The proposed structure could be 
verified by a crystal structure shown in Figure	  5. It impressively depicts the bend, 
convex structure of santalin Y. 
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Figure 5 – Crystal structure of santalin Y. 
 
The isolation of santalin AC and santalin Y from red sandalwood lead to a 
biosynthetic proposal for the class of santalins and santarubins, focusing on one 
precursor for the formation of all members.[2] 
 
The proposed structure can be traced back to isoflavylium cation 24, which can react 
further through a vinylogous attack of a benzylstyrene 23 to the most electrophilic site 
of the benzopyrylium cation. The resulting reactive quinone methide 25 can be 
attacked by the neighboring electron rich pyrogallol unit. The formed tetracyclic core 
structure 26 shows very labile C-H bonds in positions 5, 6 and 6a and a labile 
phenolic H bond, which are supposed to be oxidized instantly after the cycloaddition 
(Scheme	  5).  
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Scheme 5 – Biosynthetic proposal for the formation of santalin A. 
 
The same is true for the formation of santalin Y. A benzylstyrene isomeric to 23, with 
respect to the double bond position, attacks in the same manner as for santalin A, but 
the formed quinone methide 28 is nucleophilically attacked by the catechol unit of the 
formed benzopyran unit resulting in dearomatized structure 29. It is believed that this 
strained system reacts further through a Friedel-Crafts cyclization after 
tautomerisation of the hydroxyketone, leading to santalin Y (22) in a concerted 
fashion (Scheme	  6). 
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Scheme 6 – Biosynthetic proposal for the formation of santalin Y. 
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II. Synthetic Studies towards Santalin Y & Ayamenin E and 
Synthesis of Santalin AC 
 
 
	  
Scheme 7 – Retrosynthetic analysis for santalin Y. 
 
The elaboration of a biosynthetic proposal, based on the presence of benzoxanthenone 
dyes and racemic santalin Y, prompted us to investigate a synthesis of this class along 
this biosynthetic assembly line (retrosynthesis is shown in Scheme	  7).[2] 
 
Therefore, a robust synthetic route for isoflavylium cation 24, as well as for the 
benzylstyrene building block 27 was needed. In this chapter, the different strategies 
towards the formation of isoflavylium unit 24 are described. A subchapter describes 
the preparation of benzylstyrene 27 by means of olefin cross-metathesis from two 
rather simple building blocks. With this proposed precursor in hand the biosynthetic 
proposal has been tested and will be presented in the final subchapter. 
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II.	  1. Preparation of Anhydrobase 30 
 
II. 1. 1. Friedel-Crafts cyclization approach 
 
Studies towards the family members of red sandalwood started with investigations for 
a robust preparation of isoflavylium 24 or anhydrobase 30, respectively. Literature 
precedence has raised hope to enter this class of compounds by a four step sequence 
starting from pyrogallol, attaching a functional handle at the C4 position (Scheme	  8). 
These functionalized phenols are known to react further with symmetric phenols in an 
intermolecular Friedel-Crafts arylation under strong acidic conditions providing a 
benzopyrylium 24 in one step (Scheme	  8).[16] 
 
 
	  
Scheme 8 – Retrosynthesis for the formation of isoflavylium salt from malonyldialdehyde 32. 
 
II.	  1.	  1.	  1. Approach to aryl malonyldialdehyde 32 via Willgerodt-Kindler & 
studies towards Ayamenin E 
 
The first entry started with functionalization of pyrogallol 33 by a Friedel-Crafts 
acylation using acetic anhydride.[17] This reaction yielded acetopyrogallol 34 in 
acceptable yields with concomitant protection of the phenol. The only observed side-
product was acetylated pyrogallol, which suggests, that the phenolic group is 
protected first, directing the Friedel-Crafts acylation strongly in the favored C4 
position (shown in Scheme	  9). 
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Scheme 9 – Friedel-Crafts acylation gives entry to acetophenol. 
 
The following step was an oxidative transposition of the carbonyl group to form aryl 
acetic acid 35 in one step under Willgerodt-Kindler conditions (Scheme	  10).[18] The 
mechanism of this reaction is still in debate, but it is believed that the formed 
thiocarbonyl amide is hydrolyzed under basic conditions, which in this case 
deprotects the acetylated phenol in the same step. Aryl acetic acid 35 was obtained in 
moderate yield. 
 
 
	  
Scheme 10 – Willgerodt-Kindler Reaction transposes the carbonyl function. 
 
Next, treatment of phenyl acetic acids with an excess of in situ generated Vilsmeier’s 
chloroiminium reagent formylates the benzylic position twice, which upon heating 
would decarboxylate. The presence of either a hydroxy or methoxy group in ortho-
position to the benzylic position seems to hamper the reaction, which has been proven 
to work smoothly with the simpler phenyl model system (Scheme	  11).[19] 
 
 
	  
Scheme 11 – Decarboxylative formylation under Vilsmeier-Haack conditions failed. 
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The presence of an ortho-hydroxy group facilitated the formation of substituted 
benzofuran systems, either simple 36 or chlorinated 37 as a mixture. It is believed that 
during the formylation under acidic conditions (POCl3) an interruption takes place, 
which forms an instable oxonium ion 38 at the methoxy group, which is deprotected 
to form the furan ring. Chlorination may result from chloride substitution from a 
generated benzolactone 39 (Scheme	  12). 
 
 
	  
Scheme 12 – Vilsmeier-Haack conditions give rise of benzofuran aldehydes 36 and 37 and 
their proposed intermediates 38 and 39. 
 
While milder variants of this method were tested, it became clear that under no 
conditions the aryl malonyldialdehyde could be formed, always favoring the 
formation of the previously mentioned benzofurans in different ratio. 
 
Providing the highly functionalized chlorobenzofuran aldehyde 37 in a short step 
sequence, it was realized that this can give a fast entry to the isoflavone derived 
natural product ayamenin E (40)[20]. Benzofuran 37 displays two electrophilic 
positions, which could be potentially attacked by phloroglucinol 41 to assemble the 
reduced form of ayamenin E with respect to the benzylic alcohol. In Figure	  6 the two 
building blocks are shown, which could be fused by a formal 3 + 3 cycloaddition. 
This could happen via attack of the chlorinated Michael-system by the phenolic 
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function of phloroglucinol. A Friedel-Crafts cyclization could close the ring to form 
the tetracyclic system. 
 
 
	  
Figure 6 – Ayamenin E (benzofuran precursor in bold). 
 
A reaction took place in presence of a weak base (NEt3) at elevated temperatures. 
Formation of benzylic alcohol 42 was proposed and tested in the subsequent oxidation 
step (Scheme	  13). 
 
 
	  
Scheme 13 – 3 + 3 cycloaddition gives rise of the proposed structure 42. 
 
Final oxidation of the benzylic alcohol has been shown to be more complex than 
anticipated and failed under various oxidation conditions (Table	  1). 
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Entry Reagent Solvent Equivalents Conclusion 
1 MnO2 CH2Cl2 50 c.m. 
2 TPAP/NMO MeCN 1.5 c.m. 
3 IBX EtOAc 2 c.m. 
4 DMP EtOAc 3 c.m. 
5 PCC CH2Cl2 1 c.m. 
c.m. = complex mixture. 
Table 1 – Conditions tested for the oxidation of benzylic alcohols. 
 
One of the reasons for the formation of complex mixtures could be addressed to the 
strong intercalation of the phenolic proton and presence of free phenolic groups, 
making this group less prone to oxidation.  
 
 
II.	  1.	  1.	  2. Approach to aryl malonyldialdehyde 43 via DMF acetal 
 
As shown previously, formation of malonyldialdehyde under acidic conditions 
resulted in side reactions, which could not be overcome. This lead to the insight that 
formylation of aryl acetaldehyde under milder, neutral conditions could give 
compound 43. This strategy starts from pyrogallol unit 33, as the reduction of aryl 
acetic acid 35 to aldehyde 44 failed, resulting only in a complex mixture (Scheme	  
14).  
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Scheme 14 – Retrosynthesis of alternative ways to yield aryl malonyldialdehyde. 
 
Pyrogallol 33 afforded benzyl ether and subsequent Vilsmeier-Haack formylation 
resulted in benzaldehyde 45 in moderate yield over two steps (Scheme	  15). [21] 
 
 
	  
Scheme 15 – Benzaldehyde was formed via Vilsmeier-Haack formylation. 
 
Homologation of benzaldehyde 45 was achieved under Wittig conditions using 46 in 
very good yields.[22] Subsequent deprotection had to be carried out at low 
temperatures to avoid aldol side reactions. Aryl acetaldehyde 44 was obtained in good 
yields (Scheme	  16). 
 
 
	  
Scheme 16 – Homologation using Wittig-Kluge reaction. 
 
Dimethylamino acrolein 49 could be formed using dimethyformamide dimethyl acetal 
 (48) in DMF at room temperature. This reagent is known to formylate α-carbonyl 
groups under mild conditions.[23] Hydrolysis of the dimethylamino function using 
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strong basic conditions afforded aryl malonyldialdehyde 43 in good yields. It is 
noteworthy, that these products can act as bidentate ligands with coordinating metals 
forming complexes (Mg2+, Ca2+), thus decreasing the yield of this reaction (Scheme	  
17).  
 
 
	  
Scheme 17 – Formation of aryl malonyldialdehyde under mild conditions. 
 
With malonyldialdehyde 43 in hand, the stage was set to investigate the Friedel-Crafts 
type formation of isoflavylium salt.[16a] While literature describes formation of 
benzopyrylium salts with symmetric phenols (e.g. phloroglucinol), these results show 
that unsymmetrical catechol phenol coupling partners 50 are not suitable for the 
reaction. The catechol moiety seems to be a weak directing group for this aromatic 
substitution reaction. A wide survey of different substitution at the phenol groups as 
well as various strong and non-nucleophilic acids showed either decomposition or 
formation of complex mixtures (Table	  2). 
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Entry Acid Solvent R1 Conclusion 
1 HClO4 AcOH H decomp. 
2 HCl Et2O H c.m. 
3 HBF4 AcOH H decomp. 
4 HPF6 AcOH H decomp. 
5 HClO4 AcOH Ac decomp. 
6 HBF4 AcOH Ac decomp. 
7 HPF6 AcOH Ac decomp. 
decomp. = decomposition; c.m. = complex mixture. 
Table 2 – Attempts for the formation of isoflavylium salt 51. 
 
After this result, the strategy had to be changed to form the benzopyrylium salt from a 
preformed isoflavonoidic structure. 
 
II. 1. 2. Knoevenagel approach 
 
An alternative route to benzopyrylium salts can be achieved by reducing either 
coumarins or flavones to the corresponding lactol or benzylic alcohol by subsequent 
treatment with acidic agents. Synthesis of coumarin 52 by Knoevenagel conditions 
lead to two building blocks, benzaldehyde 53 and phenyl acetic acid 54, which can be 
seen in Scheme	   18. Preliminary attempts using available pyrogallol acetic acid 35 
and commercially available free hydroxy benzaldehyde lead with the reported 
conditions to the desired coumarin in poor yields.[24] 
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Scheme 18 – Retrosynthesis for the formation of isoflavylium cation from coumarin 52 by 
Knoevenagel approach. 
 
The synthesis commenced with the preparation of phenyl acetic acid starting from 
pyrogallol unit 53. Therefore two competing routes for the preparation the silylated 
benzaldehyde 55 were carried out. One approach focused on ortho directed metalation 
using methoxy as coordinating groups and as an alternative lithium-halogen exchange 
to yield benzaldehyde 55 was attempted.[25] 
 
Due to the shorter sequence ortho-directed metalation was investigated. The first 
synthesis started with TBS protection of pyrogallol unit 33 affording silyl ether 56 in 
very good yield. Trapping the metalated species with DMF resulted in benzaldehyde 
55 in poor yield. For optimization TMEDA, a salt breaking additive, was added to 
improve the yield (Scheme	  19). 
 
 
	  
Scheme 19 – Formylation using ortho-directed metalation. 
 
Alternatively, metalation from brominated phenol 57 was attempted.[26] Literature 
known compound 57 was protected with a TBS group and showed very good 
halogen-lithium exchange ability, resulting in benzaldehyde 55 after trapping the 
lithiated species with DMF and hydrolysing under acidic conditions (Scheme	  20). 
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Scheme 20 – Formylation using lithium-halogen exchange. 
 
In analogy to the previously described route, benzaldehyde 55 was homologated using 
Wittig-Kluge conditions and enol ether 57 was deprotected under acidic conditions at 
low temperatures resulting in aldehyde 58 (Scheme	  21).[22] 
 
 
	  
Scheme 21 – Homologation using Wittig-Kluge conditions. 
 
Pinnick oxidation of aldehyde 58 resulted in silylated aryl acetic acid 59 in good yield 
over 6 steps (Scheme	  22). 
 
 
	  
Scheme 22 – Oxidation using Pinnick conditions. 
 
The synthesis of ortho-hydroxy benzaldehyde 63 started with the protection of 
commercially available benzaldehyde 60 with TBS groups resulting in silyl ether 61. 
Bayer-Villiger oxidation of benzaldehyde 61 resulted in formyl ester 62 in 
quantitative yield, giving the substrate for a Fries-rearrangement and an ortho-
directed formylation (Scheme	  23).  
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Scheme 23 – Preparation of formylphenol 62 using mCPBA. 
 
Fries rearrangement worked after careful optimization with boron trichloride as 
catalyst in low yields.[27] Due to low yields of this reaction, we changed the strategy to 
introduce the formyl group stepwise (Table	  3). 
 
 
 
Entry Catalyst Solvent Yield 
1 EtAlCl2 CH2Cl2 5% 
2 AlCl3 CH2Cl2 decomp. 
3 Et2AlCl CH2Cl2 traces 
4 BCl3 C2H4Cl2 26% 
decomp. = decomposition. 
Table 3 – Optimization of Fries rearrangement using different catalysts. 
 
We therefore changed to the ortho-directed formylation by deprotection of phenyl 
formyl ester 62, resulting in a phenolic hydroxy group in 64. Following literature, 
introduction of a formyl group can be directed by an adjacent hydroxy group.[28] This 
method facilitates a Lewis-acid directed redox mechanism using phenolic hydroxy 
groups to direct and resulted in benzaldehyde 63 in good yield (Scheme	  24). 
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Scheme 24 – Stepwise approach to ortho hydroxy benzaldehyde 63. 
 
With the two building blocks in hand, the Knoevenagel coumarin synthesis was 
attempted. The harsh conditions of this method afforded always the peracetylated 
coumarin product 65. Best results were obtained by slow addition of arylacetic acid 
59 to benzaldehyde 53 in presence of potassium acetate in acetic anhydride (Table	  4). 
 
 
 
 
Entry Base Solvent Ratio 53:59 PG Yield 
1 KOAc Ac2O 2:1 H traces 
2 KOAc Ac2O 1:2 H 7 % 
3 NaOAc Ac2O/toluene 1:1 TBS 14 % 
4 KOAc Ac2O/toluene 1:1 TBS 15 % 
5 NaOAc Ac2O 1:1 TBS 22 % 
6 KOAc Ac2O 1:1 TBS	   24 % 
 
Table 4 – Optimization of Knoevenagel coumarin synthesis. 
	  
Unfortunately the unsatisfactory low yield made further investigation of this route 
impossible, due to the wasteful amounts of material needed for the preceding steps.  
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II. 1. 3. Suzuki coupling approach 
 
Instead of forming the oxygen containing coumarin ring system in one step, the 
coumarin fragment is assembled first and the pyrogallol unit is attached in a second 
step. It is known from literature that cross-coupling reactions using aryl boronic acids 
lead to coumarin structures (Scheme	  25).[29] 
 
 
	  
Scheme 25 – Retrosynthesis for the formation of the isoflavylium cation from coumarin via 
Suzuki approach. 
 
Following this strategy, the first step was the literature known preparation of esculetin 
71 using commercially available substances which gave the desired product in 
moderate yields (Scheme	   26).[30] Due to the cheap availability of the starting 
materials, large amounts of esculetin could be prepared in one operation (15 g scale). 
 
	  
Scheme 26 – Formation of esculetin using a decarboxylative oxidation mechanism. 
 
Bromination of esculetin 71 gives rise to bromocoumarin 72 in good yield and as a 
single regioisomer. Silyl protection of 72 was achieved under standard conditions 
giving the halogen-coupling partner 67 in good yield (Scheme	  27). 
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Scheme 27 – Formation of bromoesculetin. 
 
As an alternative to the bromo coupling partner, a method developed by the group of 
Prof. Knochel was used to yield iodocoumarin 74 from TBS protected esculetin 73 in 
very good yields.[4a] This method allows a diaminozinc base to regioselectively 
deprotonate coumarins in the α-position (Scheme	  28). 
 
 
	  
Scheme 28 – Formation of iodo esculetin facilitating directed metalation. 
 
The readily prepared aryl bromide 75 can be transformed to the boronic acid 76 in a 
single operation through halogen-lithium exchange, trapping of the anionic species 
with borate and hydrolysis of boronic ester to the corresponding acid using silica 
(Scheme	  29).[31] 
 
 
	  
Scheme 29 – Formation of boronic acid by lithium halogen exchange. 
 
With the two coupling partners in hand, the cross-coupling was tested under various 
conditions (Table	  5). 
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Entry Catalyst Ligand X Solvent Ratio 
67/74:76 
Conditions Yield 
1 Pd(PPh3)4 - Br benzene 1:1 21 h/ 70°C traces 
2 Pd(PPh3)4 - Br DMF/H2O 1:1 1 h/ 70°C deprot. 
3 Pd2dba3 SPhos Br toluene 1:1 50 h/ 70°Ca 46% 
4 Pd(OAc)2 RuPhos Br toluene 1:1 13 h/ 100°Ca 55% 
5 Pd(dppf)Cl2 - I toluene 1:1.5 16 h/ 110°Ca s.m. 
6 Pd2dba3 SPhos I DMF 1:1.5 3 h/ 105°Ca deprot. 
7 Pd(OAc)2 SPhos I toluene 1:2 1.5 h / 120°Ca 62% 
8 Pd(OAc)2 RuPhos I toluene 1:2 1.5 h / 120°Ca 85% 
s.m. = starting material; deprot. = deprotection; a = microwave irradiation. 
Table 5 – Optimization of the Suzuki cross-coupling. 
 
 
The best result was obtained using palladium(II) acetate and Buchwald’s RuPhos 
ligand[32] as catalyst system, in combination with toluene and dry potassium carbonate 
under microwave conditions at 120 °C.  
 
It is noteworthy to mention, that coupling under standard conditions using aqueous 
media or aqueous bases in polar solvents lead to deprotection of the TBS ethers. This 
is probably due to the labile TBS-phenol bond, which can be easily deprotected under 
basic as well as acidic aqueous conditions. Another important lesson taught by this 
system is the acceleration of the cross-coupling reaction by microwave irradiation. 
This is believed to happen due to thermal effects. Homogeneous heating of polarized 
solvents increase the rates of formation of products, especially in transition metal 
catalysis.[33] 
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II. 1. 4. Negishi coupling approach 
 
Suzuki cross-coupling approach worked well and gave access of TBS protected 
esculetin 73. To minimize the step number, it was believed that zincated TBS-
esculetin 77 could react further with aryl bromide 75 in a cross-coupling reaction 
using Negishi conditions (Scheme	  30). 
 
 
	  
Scheme 30 – Retrosynthesis for the formation of the isoflavylium salt from coumarin via 
Negishi approach. 
 
It is proven, that the TBS protected esculetin can be regioselectively metalated by 
zinc bases. Therefore the metalation by optimizing the system was tested with 
different literature known TMP-Zn derivatives (Table	  6). [4, 34] 
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Entry Base Catalyst Ligand Solvent Ratio 
73:75 
Conditions Yield 
1 78 Pd(PPh3)4 - THF/toluene 1:1 20 h/ 
100°C 
s.m. 
2 78 Pd(dppf)Cl2 - THF 1:1 20 h/ 
100°C 
s.m. 
3 78 PEPPSI-iPr - CH2Cl2 1:1 20 h/ 
100°C 
c.m. 
4 78 Pd(OAc)2 RuPhos toluene 1:1.4 6 h/ 70°C 51 % 
5 78 Pd(OAc)2 XPhos toluene 1:1 8 h/ 70°C 40 % 
6 78 Pd(OAc)2 SPhos toluene 1:1 5 h/ 60°C 64 % 
7 78 Pd(OAc)2 SPhos toluene 1.4:1 4 h/ 60°C 84 % 
8 79 Pd(PPh3)4 - toluene 1:1 20 h/100°C s.m. 
9 79 Pd(OAc)2 RuPhos toluene 1:1 7 h/80°C 45 % 
s.m. = starting material; c.m. = complex mixture. 
Table 6 – Optimization of the Negishi cross-coupling. 
 
 
As shown aryl coumarin 66 can be obtained in very good yields using palladium(II) 
acetate and Buchwald’s SPhos ligand[32] as the catalyst system and 
TMP2ZnMgCl22LiCl (78) as zinc base. TMPZnClLiCl (79) resulted in the same 
product, yet in lower yield, which might be due to the electronic reasons of the mono 
zincated species (Figure	  7). 
 
 
	  
Figure 7 – Different metalated coumarins. 
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It is noteworthy to mention that, despite the argument that one coumarin of the 
diorganozinc species might act as a “dummy” ligand, both coumarin units couple in 
this reaction to give cross-coupled products. One of the major issues was the 
generation of homocoupled products. Due to the electron rich aromatic bromide, 
literature known second transmetalation processes can occur giving rise of the 
homocoupled products.[35] Therefore, an excess of coumarin 73 was used to suppress 
homocoupling to small amounts. 
 
TBS deprotection resulted in the natural product santalin AC (21) (Scheme	  31).[2] 
 
 
	  
Scheme 31 – Desilylation yielded in santalin AC. 
 
En route to isoflavylium salt, coumarin 66 was reduced to lactol 82 using DIBAL-H 
(Scheme	  32). During the optimization studies it appeared that slow addition of the 
reducing agent as well as using on equivalent at very low temperature was crucial to 
avoid overeduction of the desired lactol, resulting in isoflavenes.  
 
 
	  
Scheme 32 – Reduction of coumarin to lactol 82. 
 
With lactol 66 in hand, the formation of isoflavylium salt 83 was attempted. A variety 
of strong acids that bear a non-nucleophilic counterion were tested making the salt 
isolable from acidic media (Table	  7).[16b] 
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Entry Brønstedt Acid Solvent Eq. (acid) Yield 
1 HCl Et2O 3 c.m. 
2 HBF4 AcOH 3 traces + c.m. 
3 HPF6 AcOH 3 traces + c.m. 
4 HClO4 AcOH 3 39 % 
5 HClO4 AcOH 5 76 % 
6 HClO4 AcOH 9 55 % 
c.m. = complex mixture. 
Table 7 – Optimization of the formation of isoflavylium salt. 
 
The best results for the formation of the isoflavylium salt could be achieved by 
treating lactol 82 with perchloric acid in acetic acid. In this step, a subsequent 
protonation, dehydration and final global deprotection lead to isoflavylium 
perchlorate in one operation. Problematic isolation could be overcome by 
precipitation from acetic acid, which finally afforded crystals suitable for X-ray 
(Figure	  8). 
 
	  
Figure 8 – Crystal structure of isoflavylium perchlorate 81. 
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This structure is the first report of an isoflavylium salt bearing free hydroxy groups, 
while the perchlorate is hovering over the positively charged oxygen of the pyrylium 
moiety. 
 
For the synthesis of further members of the santalin family it was important to 
deprotonate the rather acidic isoflavylium salt 81 to the corresponding anhydrobase 
30 as can be seen in Scheme	  33. Attempts with inorganic bases (e.g. NaOH, NaOAc, 
NaOMe, basic buffers) in aqueous media were unsuccessful. Finally the sterically 
demanding, non-nucleophilic base 2,6-bis-tert-butyl pyridine in acetonitrile gave 
anhydrobase, which could be isolated via precipitation. 
 
	  
Scheme 33 – Deprotonation resulted in anhydrobase 30. 
 
 
II. 1. 5. Summary 
 
In summary, this chapter describes the successful preparation of anhydrobase 30. 
Starting from classical approaches towards the anhydrobase synthetic surprises lead to 
an approach towards the natural product ayamenin E (40). A formal 3 + 3 
cycloaddition resulted benzylic alcohol 42, which so far could not be oxidized to 
ayamenin E (Scheme	  34). 
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Scheme 34 – Synthesis of the reduced form of ayamenin E. 
 
While this rapid protecting group free approach failed, different attempts were carried 
out, including a Knoevenagel coumarin synthesis and late stage functionalizations 
starting from protected esculetin using Suzuki and Negishi cross-couplings. A novel 
method developed by the group of Prof. Knochel lead to regioselective zincation and 
a subsequent Negishi cross-coupling resulted in coumarin 66 in only three steps 
(Scheme	  35). 
 
 
	  
Scheme 35 – Rapid assembly of coumarin 66 using zinc mediated Negishi coupling. 
 
Coumarin 66 is the branching point in the synthesis of all members of the santalin 
family. While deprotection lead to santalin AC (21), a reduction followed by 
dehydratisation and global deprotection and deprotonation resulted in anhydrobase 
30, the building block for all members of the santalin family (Scheme	  36). 
 
 
	  
Scheme 36 – Coumarin 66 acts as a branching point for santalin AC (21) and anhydrobase 
30. 
O OH
OMe
OH
MeO
OH
MeO O
O
OH
Cl
O
O
HO
MeO
OH
OH
HO
35 37 42
DMF
POCl3
HO OH
OH41
AcO
AcO
OAc HO O
OH
HOOC
3 steps
LLS
O OTBSO
TBSO
MeO
OTBS
OMe
69 70 66
O OTBSO
TBSO
MeO
OTBS
OMe
O OHO
HO
MeO
OH
OMe
OO
HO
MeO
OH
OMe
66santalin AC (21)
3 steps1 steps
30
	  32	  
 
	  33	  
II.	  2. Preparation of Benzylstyrene in the Synthesis of Santalin Y 
 
For the distinct synthesis of members of the santalin family, a robust and selective 
synthesis of trans-benzylstyrenes had to be developed.  
 
The attempts in this field were guided by literature precedence for the preparation of 
this neglected class of natural products using olefin cross-metathesis.[7b] 
Retrosynthetically, benzylstyrene 27 could be derived from allylphenol 84 and styrene 
85 (Scheme	  37). 
 
 
	  
Scheme 37 – Retrosynthetic analysis for the generation of benzylstyrene 27. 
 
Lewis-acid were shown to promote aromatic Claisen rearrangements for the exact 
system, giving a fast entry to allylphenolic portion 84.[36] The synthesis started with 
mono allyl protection of 86, which gave the product 87 in moderate yields due to 
competing bis-allylation of resorcinol 86. Selecting the appropriate protecting group 
for the remaining free phenol was crucial, due to its sterical influence in the 
regioselective outcome of the Claisen rearrangement (Scheme	  38). 
 
 
	  
Scheme 38 – Preparation of the Claisen rearrangement precursor. 
 
The TBDPS protecting group is superior to the smaller TBS protecting groups, 
leading to a 11:1 (TBDPS) and a 7:1 (TBS) mixture of regioisomers favoring 4- over 
2-allyl phenol (Table	   8). It is remarkable that Lewis–acids promote the reaction at 
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low temperatures, given the fact that at standard conditions aromatic Claisen 
rearrangements can be observed at very high temperatures.[36] 
 
 
 
 
Entry Catalyst Solvent Protecting group Yield 
1 BCl3 CH2Cl2 TBS 45 % 
2 EtAlCl2 CH2Cl2 TBDPS 43 % 
3 BCl3 CH2Cl2 TBDPS 60 % 
4 Et2AlCl CH2Cl2 TBS 59 % 
5 Et2AlCl CH2Cl2 TBDPS 64 % 
 
Table 8 – Optimization of the Claisen rearrangement. 
 
Methylation of the resulting phenolic group under mild conditions was carried out by 
treatment with Me3OBF4 in presence of proton sponge (Scheme	  39).[37] Traditional 
conditions using bases and methyl iodide resulted in complex mixtures of various 
methylated and silylated products, suggesting that these conditions in polar solvent 
desilylate allyl phenol 91 easily. Final deprotection using TBAF yielded allyl 
phenol 84. 
 
 
	  
Scheme 39 – Methylation and deprotection yielding allyl phenol 84. 
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Wittig olefination of before mentioned benzaldehyde 61 afforded styrenes 93 and 94 
in moderate yields (Scheme	  40). 
 
 
	  
Scheme 40 – Preparation of styrene coupling partners using Wittig olefination. 
 
Selectivity in cross-metathesis depends strongly on the olefinic coupling partners. 
Based on studies from Grubbs et al., [7a] one can predict tendencies for hetero- and 
homocoupling based on classification of the olefinic building blocks. Therefore a 
methyl styrene 93 and a simple styrene 94 were used as olefins for the cross-
metathesis to favor the formation of the desired hetero coupled product 95. 
 
The olefin cross-metathesis was attempted using either dichloromethane or toluene as 
solvent systems and ruthenium based metathesis catalysts (Table	  9).  
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Entry Catalyst Solvent R1 R2 Ratio 
93/94:92/84 
Yield 
1 G I CH2Cl2 Me H 1:1 13 % 
2 G II CH2Cl2 Me H 1:1 62 % 
3 HG I CH2Cl2 Me H 1:1.5 17 % 
4 HG II CH2Cl2 Me H 1:2 27 % 
5 G II toluene H H 1:1 56 % 
6 G II toluene Me TBDPS 1:1 n.i. 
n.i. = not possible to isolate. 
Table 9 – Optimization of olefin cross-metathesis. 
 
Olefin cross-metathesis reaction worked best with dichloromethane and Grubbs 2nd 
generation catalyst. The best results were achieved with free allyl phenol and this 
substrate had the advantage of easier purification. 
 
Final deprotection using TBAF resulted in benzylstyrene 27, which can be directly 
used in the synthesis of santalins in the next step (Scheme	  41). 
 
 
	  
Scheme 41 – Final deprotection using the fluoride source TBAF. 
 
In summary a short synthesis of benzylstyrene 27 has been accomplished in a longest 
linear sequence of 7 steps applying a Lewis–acid promoted aromatic Claisen reaction 
as well as an olefin cross-metathesis. 
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II.	  3. Studies towards Santalin Y 
	  
II. 3. 1. Thermal Coupling 
 
With isoflavylium, anhydrobase and benzylstyrene in hand, the intermolecular 
coupling leading to santalin Y was investigated. A thermal reaction was envisaged 
resulting in santalin Y from isoflavylium to precursor 29, which can react further to 
santalin Y in one step. When benzylstyrene 27 was reacted with isoflavylium 
perchlorate 83, decomposition of 27 was observed, at low and high temperatures 
(Scheme	   42). This is most likely attributed to the fact, that the isoflavylium 
perchlorate is very acidic due to the presence of perchloric acid. Strong acidic media 
might result in cationic polymerization of benzylstyrene 27 to polystyrenes. 
 
 
	  
Scheme 42 – Attempts towards santalin Y using isoflavylium perchlorate 83 were 
unsuccessful. 
 
Therefore, the moderately basic anhydrobase 30 was employed and reacted in 
presence of benzylstyrene 27 at elevated temperatures. Under thermal conditions, 
santalin Y could not be obtained but only formation of benzoxanthenone structure 97 
was observed. The main reason for selective generation of this structure is attributed 
to the electronrich and nucleophilic pyrogallol unit of the anhydrobase. The first step 
in this cascade is the nucleophilic attack of benzylstyrene 27 to anhydrobase 30 
generating para-quinone methide 28. This very electrophilic position is preferentially 
attacked by the less bulky and very nucleophilic pyrogallol unit instead of position 9 
that would have led to santalin Y (depicted by arrows in Scheme	  43). 
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Scheme 43 – Thermal coupling resulted in benzoxanthenone 97 and proposed transition 
state. 
 
All attempts using thermal conditions and applying different additives (Lewis acids, 
Brønstedt acids) afforded benzoxanthenone structure 97, called “santalin Y 
benzoxanthenone isomer”. A potential thermal 1,3 hydride shift of benzylstyrene 27 
leading to santalin A could be excluded, as the analytical data for isolated 
benzoxanthenone structure 97 did not match the reported data for the natural product 
(13C NMR shift for C16 in ppm: 26.6 (97); 33.0 (santalin A)).[2] Subsequently further 
approaches to the synthesis of santalin Y were considered. 
 
 
II. 3. 2. Photochemical Coupling 
 
As thermal coupling pathways only lead to formation of “santalin Y benzoxanthenone 
isomer”, optional biomimetic pathways leading to this complex natural product were 
investigated. Reaction pathways leading to reactive intermediates, facilitating a 
formal 1,3-dipolar cycloaddition were put focus on. 
 
It was reported that hydroxy groups in close proximity to the carbonyl function might 
facilitate an excited state intramolecular proton transfer (ESIPT).[38] A proton, 
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interchelated between a hydroxy and a keto group might be transferred onto the 
carbonyl function upon irradiation with light. This mechanism would generate the 
zwitterionic molecule 98 (Scheme	   44), which can be drawn in a tautomerized 
structure already displaying the electrophilic position next to the pyrylium oxygen and 
an in situ generated nucleophilic position in para-position to the phenolate 99. This 
dipolar structure can be also drawn as a carbonyl ylide 100, a well-known 
intermediate in 1,3-dipolar cycloadditions.  
 
 
	  
Scheme 44 – Proposed formation of 1,3 dipole by ESIPT. 
 
Hypothetically, this dipolar structure can react further with olefinic structures. In this 
case, this olefin is benzylstyrene 27, which could lead to structure 29 via the transition 
state depicted in Scheme	   45. While 1,3-dipolar cycloadditions are described as 
concerted mechanisms, a stepwise process in the formation of the santalin Y precursor 
29 might be more reasonable (Scheme	  45). 
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Scheme 45 – Proposed cycloaddition with transition state for the formation of 29. 
 
This hypothesis has been used synthetically by different research groups to facilitate 
intra- and intermolecular cycloadditions leading to cycloheptanes with an oxa-
bridge.[38a, 39] We investigated, whether this bioinspired plan could generate santalin Y 
using light and mild additives (Scheme	  46). In opposition to previous examples, we 
hoped this pathway might provide the intermediate reacting further without use of 
protecting groups. 
 
 
	  
Scheme 46 – Attempts for the formation of santalin Y (Table 10 with conditions in the 
experimental part). 
 
Major experimental difficulties were faced due to the insolubility of anhydrobase 30 
in most standard solvents used for photochemical reactions. It seemed that 
anhydrobase 30 is easily soluble in protic solvents, such as methanol, ethanol, and 
mixtures of organic solvents, e.g. acetone, acetonitrile, dichloromethane and 
chloroform with water. Anhydrobase could be dissolved in chloroform, but we were 
faced with solubility problems with benzylstyrene 27. Carrying out the reaction in 
polar solvent led to preferential formation of side products resulting from the attack of 
O
HO
O
HO
OH
MeO
HO OMe
MeO
OH
29
OHO
O
MeO
OH
OMe30
HO
HO
OMe
OH
27
OHO
O
OMe
HO
MeO
HO
HO
OH
OMe
101
HO
HO
OMe
OH
OO
HO
MeO
OH
OMe
O
HO
O
HO
OH
MeO
HO OMe
MeO
OH
Conditions
27
30
22
	  41	  
H2O or ROH into the most electrophilic position of anhydrobase, leading to lactol or 
ketal 102, respectively.  
 
Even after extensive screening (Table	   10) of different light sources the formal 1,3 
dipolar cycloaddition could result neither in intermediate structure 29 nor santalin Y 
(22). One possible reason might be the absorption of light due to the coloring 
properties of anhydrobase in solution, which is at an absorption maximum of λmax = 
441 nm. We therefore tested different concentrations and different reaction vessels to 
provide a larger surface of irradiation. Unfortunately, this did not result in products 29 
and 22, but into formation of traces of benzoxanthenone 97 and its reduced precursor 
103 (Figure	  9). Generation of benzoxanthenone 97 and its precursor 103 are probably 
due to the thermal pathway. After long reaction time, anhydrobase 30 is attacked by 
benzylstyrene 27, which can than be trapped by the electronrich and satirically less 
demanding pyrogallol unit. By exclusion of air, it was possible to isolate precursor 
103, which upon prolonged exposure to air oxidized to benzoxanthenone 97. 
 
 
	  
Figure 9 – Detectable side-products from photochemical attempts. 
 
 
II. 3. 3. Late stage introduction of aryl ring 
 
The very electron rich pyrogallol unit hampers the efforts towards the synthesis of 
santalin Y. So, it was decided to construct the oxafenestrane moiety first and 
introduce the aryl ring at a later stage, reacting bromoflavylium compound 105 with 
benzylstyrene 27 shown in Scheme	  47, the reaction might lead to the tetracyclic core 
of santalin Y. 
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Scheme 47 – Retrosynthetic analysis by late stage arylation. 
 
The synthesis started with the reduction of the previously prepared TBS bromo-
esculetin 67 to the corresponding lactol 106 (Scheme	  48). Using the same conditions 
as for lactol 106, the yield improved drastically as no side-products were detected. 
Protonation, dehydration and deprotection could be achieved, but with slightly lower 
yields than in the arylated congener 82. 
 
 
	  
Scheme 48 – Preparation of bromo flavylium perchlorate 105. 
 
With both coupling partners in hand, the investigation of thermal coupling by treating 
flavylium salt with base was started, in order to generate the anhydrobase in situ and 
adding benzylstyrene in one portion. Formation of oxafenestrane structure 104 could 
not be observed, but nucleophilic attack of the resorcinol moiety of benzylstyrene 27 
to anhydrobase generated flavene 107 (Scheme	  49). 
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Scheme 49 – Coupling resulted in flavene structure 107. 
 
From this result it is believed that an aryl substituent in C2 position is essential for 
favoring a vinyligous attack of benzylstyrene 27 to anhydrobase. In Figure	  10 the left 
drawing describes the attack of the styrene group of benzylstyrene 27 to the 
anhydrobase 30. This is favored over the attack of the resorcinol unit of benzylstyrene 
27 shown by the dashed arrow, due to the minimal sterical interaction of the smaller 
styrene group with the pyrogallol unit next to C1. The right drawing describes the 
attack of the resorcinol unit to brominated anhydrobase 108. This shows, that the 
resorcinol unit is the most nucleophilic position of the benzylstyrene if the sterical 
demanding pyrogallol unit is left out. 
 
	  
Figure 10 – Sterical hindrance favors the attack of the vinylogous attack. 
 
 
II. 3. 4. Carbene generated carbonyl ylide coupling 
 
Taking the previous results into account, we believed that generating the carbonyl 
ylide in presence of the pyrogallol unit is necessary in the synthesis of santalin Y. We 
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therefore came to the conclusion that by generating the reactive species 100 under 
thermal conditions santalin Y might be formed (Scheme	  50).[40] 
 
 
	  
Scheme 50 – Retrosynthetic analysis generating carbonyl ylide from carbene. 
 
Amino aziridine derivatives 110 and 111 (Figure	  11) investigated by A. Eschenmoser 
could fragment with subsequent extrusion of nitrogen to afford a reactive carbene 
under thermal conditions.[41] 
 
 
	  
Figure 11 – Amino aziridines investigated by A. Eschenmoser. 
 
Both known aminoaziridines 110 and 111 were prepared and the structure of 111 was 
confirmed by crystallographic analysis (Figure	  12). During their preparation it was 
found out that diphenyl amino aziridine 111 has a higher tendency to decompose than 
compound 110, probably due to the higher stability of stilbene 114 in comparison to 
the high ring tension of aziridines. 
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Figure 12 – Crystal structure of diphenyl amino aziridine 111. 
 
The synthesis started by treating the already prepared lactol 82 with amino aziridines 
110 and 111. That reaction should lead to phenol compound 112, which upon 
desilylative quinone oxidation would lead to para-quinone 113. Heating this 
compound would generate carbene 104 by extruding nitrogen and stilbene. Carbene 
could be nucleophilically attacked by quinone oxygen generating the carbonyl ylide 
100 (Scheme	  51). 
 
 
	  
Scheme 51 – Proposed formation of carbonyl ylide from carbene 109. 
 
During these studies it was found out that the coupling of amino aziridines 110 and 
111 with lactol led to decomposition, yielding either complex mixtures of 
OTBSO
O
MeO
OTBS
OMe
100
OH NTBSO
TBSO
MeO
OTBS
OMe
N
PhPh
O NTBSO
O
MeO
OTBS
OMe
N
PhPh
112 113
OTBSO
O
MeO
OTBS
OMe
109
	  46	  
isoflavylium salts or stilbene 114. The presence of acids or protic solvents increased 
the decomposition rate of amino aziridines 110 and 111 (Scheme	  52). 
 
 
	  
Scheme 52 – Unsuccessful attempts to couple amino aziridines to lactol 82 and observation 
of stilbene 114, the only detectable side-product. 
 
 
 
II. 3. 5. Summary 
 
In summary, this chapter describes the progress towards the synthesis of santalin Y. 
Thermal coupling of deprotected benzylstyrene 27 and anhydrobase 30 afforded 
exclusively benzoxanthenone structure 97. Attempts towards the oxafenestrane 
structure of santalin Y using “biomimetic conditions”, for example thermal and 
photochemical approaches, resulted in structure 97 and its reduced precursor when 
experiments were attempted with inert conditions. 
 
 
	  
Scheme 53 – Thermal coupling of benzylstyrene 27 and anhydrobase 30 resulting in the 
benzoxanthenone structure 97. 
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Coupling of a simplified benzopyrylium salt 105 and benzylstyrene 27 resulted in 
flavene structure 107. This gave the insight that an aryl ring in the C2 position is 
essential in the regioselective coupling of benzylstyrene 27 to anhydrobase 30 due to 
steric reasons (Scheme	  54). 
 
 
	  
Scheme 54 – Coupling of benzylstyrene 27 and anhydrobase 30 resulting in flavene 107. 
 
Future directions towards santalin Y may lead to two different approaches. The first 
approach includes blocking the nucleophilic pyrogallol unit by group R (115) (R = Br, 
TMS), thus favoring the nucleophilic attack of C8 to para-quinone methide 116. This 
plan could potentially lead to santalin Y (22) after attack via the dashed arrow and 
removal of the blocking group (Scheme	  55). 
 
 
	  
Scheme 55 – Future directions leading to santalin Y (R = blocking group). 
 
A second approach involves cooperative dual catalysis, having a Lewis acidic (LA) 
and a Brønstedt basic site (B) incorporated in one catalyst, which is depicted in 
Scheme	   56. The Lewis acidic moiety could potentially activate anhydrobase 30 
favoring the nucleophilic attack of benzylstyrene 27. The released basic portion could 
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then deprotonate the vicinal hydroxy group thus generating a nucleophilic position 
para to phenolate, which could attack para-quinone methide 117. Subsequent Friedel-
Crafts cyclization could be favored by the Lewis acid and generate santalin Y (22) in 
one step. 
 
 
	  
Scheme 56 – Future directions leading to santalin Y via dual catalysis. 
 
Cooperative dual catalysts may be either metalorganic catalysts or organocatalysts. 
Lanthanide metalorganic catalyst 118 developed in the group of Shibasaki[42] display 
a Lewis acidic site, which upon coordination release a Brønstedt basic site (depicted 
in Figure	  13). Thiourea based catalysts 119 developed from Takamoto[43] can activate 
carbonyls via H-bond donation and can subsequently deprotonate with an amine in 
close proximity. Due to the racemic nature of santalin Y an asymmetric induction by 
chiral ligands is irrelevant.  
 
	  
Figure 13 – Cooperative dual catalysts from Shibasaki 118 and Takamoto 119. 
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III. Total Synthesis of Santalin A/B and Santarubin A/B  
 
III.	  1. Synthesis of Santalin A and B 
III. 1. 1. Synthesis of benzylstyrenes by Lewis-acid catalyzed allylation 
 
The synthesis of benzylstyrenes was achieved using different strategies. A method 
described by the groups of Tamaru[44] and Chan[6], facilitating the formation of allylic 
cations from alcohols was examined, because these reactive intermediates can react 
further in a Friedel-Crafts type reaction to yield benzylstyrenes (Scheme	  57). This 
can be achieved using Lewis- or Brønstedt-acids. In this approach the use of 
Brønstedt acids was avoided due to the instability of phenolic TBS groups to acidic 
conditions. 
 
 
	  
Scheme 57 – Retrosynthesis of benzylstyrene 120 using Friedel-Crafts allylation. 
 
Synthesis of an allylic alcohol 121 started with monoprotection of resorcinol (86) to 
mono silyl ether 123.[45] The product was obtained in moderate yields due to mixtures 
of mono- and di-protected resorcinol along with starting material. Selective ortho- 
formylation to benzaldehyde 124 was carried out under literature known 
conditions.[28] Successive methylation of benzaldehyde 124 to methyl ether 125 could 
be achieved using MeI and an excess of silver(II) oxide (Scheme	  58). 
 
 
 
OH
OH
OMe
HO
OMe
PGO
OH
OPG
OPG
120 121 122
	  50	  
	  
Scheme 58 – Preparation of benzaldehyde 125. 
 
Addition of vinyl Grignard to benzaldehyde 125 resulted the desired 126 product in 
moderate yields (Scheme	  59). The moderate yield can be explained by the sterical 
demanding ortho-methoxy group. This group might push the formyl group out of 
conjugation, thus making it less reactive. 
 
 
	  
Scheme 59 – Formation of allylic alcohol using vinyl Grignard. 
 
With the allylic alcohol in hand, the Friedel-Crafts type reaction using different 
catalysts was tested. As depicted in Scheme	  60, TBS protected catechol and catechol 
(122) were tested as nucleophiles with a variety of Lewis- and Brønstedt-acids.[6] 
 
 
	  
Scheme 60 – Attempts of Friedel-Crafts allylation using catechol (PG = H, TBS). 
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Under various conditions the reaction did not provide the desired product 120. The 
nucleophilicity of catechol derivatives does not appear to be strong enough in this 
reaction. Consumption of allylic alcohol leads to a complex, polar mixture. Catechol 
nucleophiles remain untouched in the reaction mixture, suggesting an allylic 
polymerization with the resorcinol moiety. 
 
 
III. 1. 2. Synthesis of benzylstyrenes by Tsuji-Trost type allylation 
 
Weak nucleophilicity of catechol derivatives seemed to hamper the previously 
described Friedel-Crafts reaction. Therefore, this reaction was conducted with more 
nucleophilic metal catechol derivatives and using an allylic ester, which can easily 
form an allylic cation in the presence of transition metals (Scheme	  61).[44, 46]  
 
 
	  
Scheme 61 – Retrosynthesis of benzylstyrene using Tsuji-Trost allylation or allylic arylation. 
 
Therefore, the already prepared allylic alcohol 126 was converted into the 
corresponding allylic ester 130. This reaction transposed the allylic pattern to the 
terminal allylic position, as can be seen in Scheme	   62. The reason for this 
transposition might be the sterical demanding ortho-methoxy group. 
 
 
	  
Scheme 62 – Unexpected formation of allyl ester. 
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The prepared allylic ester 130 was used with a variety of different in situ generated 
metalated catechol species. The organometalic was generated using halogen-lithium-
exchange and transmetallated to more covalent magnesium, zinc and tin species. 
Reacting this species further in presence of allylic ester and palladium(0) did not 
result in the desired benzylstyrene 132. Dehalogenated catechol starting material was 
isolated, while the allylic ester 130 decomposed under these conditions (Scheme	  63). 
 
 
	  
Scheme 63 – Unsuccessful attempts of nucleophilic arylation. 
 
III. 1. 3. Synthesis of benzylstyrenes by π-allyl-Suzuki cross-coupling 
 
To test whether Tsuji-Trost type reactions work with organometals, the more stable, 
isolable organometalic species was used to prove their generation. Allylic alcohol 126 
was reacted with boronic acid derivatives. This reaction has the advantage that under 
these conditions the boronic acid could activate allylic alcohol in situ, forming the 
allyl cation in presence of palladium(0) and couple the most nucleophilic, activated 
carbon in the same step (Scheme	  64).[5] 
 
 
	  
Scheme 64 – Retrosynthesis of benzylstyrene using π-allyl Suzuki coupling. 
 
We planned to carry out this reaction for the benzylstyrenes, ultimately leading to 
santalin B, using guaiacol (134). Guaiacol 134 was selectively brominated in para-
position to the free hydroxy group. Subsequent TBS protection yielded bromo 
guaiacol 135 in good yield. Bromine-lithium exchange, trapping with B(OiPr)3 and 
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hydrolysis resulted in boronic acid 137 in moderate yield (Scheme	  65). The moderate 
yield is due to competing spontaneous phenol formation. 
 
 
	  
Scheme 65 – Preparation of boronic acid 137. 
 
With the two coupling partners in hand, the π-allyl Suzuki cross-coupling was leading 
to successful formation of benzylstyrene 138 (Scheme	  66).  
 
 
	  
	  
Scheme 66 – π-Allyl Suzuki coupling resulting in santalin B building block 138 and the 
intermediate borate 139 with the observed side-product 140. 
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oxygen nucleophile to the terminal position, giving allylic alcohol 140.[47] Even 
elevated temperatures and longer reaction time could not increase the yield. 
 
Benzylstyrene 138 was reacted with anhydrobase 30 to santalin B (18) after 
deprotection (reaction is described in chapter III.1.5). Due to a shifted signal in 1H 
NMR (position 30: 6.51 ppm (synthetic); 6.36 ppm (reported)) it was believed that 
bromination lead to the meta-bromination with respect to the TBS ether. Therefore the 
system was tested with boronic acid derived from a different brominated guaiacol as 
well. Preparation of boronic acid 144 started with selective bromination of acetoxy 
guaiacol 141 and subsequent saponification giving bromo guaiacol 142. 142 was 
converted to silylated species 143 and bromine-lithium exchange, trapping with 
B(OiPr)3 and hydrolysis yielded boronic acid 144 in moderate yield (Scheme	  67). 
 
 
	  
Scheme 67 – Preparation of boronic acid 144 for iso-santalin B benzylstyrene. 
 
Palladium catalyzed coupling lead to benzylstyrene 145, which is an isomer to 138 
with respect to the position of the O-methyl group on the catechol moiety. This 
became clear after checking the final product with NOESY, which showed strong 
coupling from the methoxy group to C3 depicted in Scheme	   68. Surprisingly, the 
yields were significantly higher owing to the increasing nucleophilicity of the carbon 
in para-position to the methoxy group. 
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Scheme 68 – π-Allyl Suzuki coupling resulting in iso-santalin B building block. 
 
In this case, the major side product appeared to be also transposed allylic alcohol 140, 
which could be isolated from the reaction mixture. 
 
With these encouraging results in hand, this reaction with the symmetric catechol unit 
leading to the santalin A benzylstyrene was attempted. The synthesis started with 
bromination of catechol (146) under acidic conditions followed by double TBS-
protection giving bromo catechol 147 in good overall yield (Scheme	  69). 
 
 
	  
Scheme 69 – Preparation of TBS bromo catechol 148 suitable for the synthesis of santalin A. 
 
Unfortunately, bromine-lithium exchange of 148 failed under various conditions only 
affording phenol 64 depicted in Scheme	  70. This might be due to contamination of 
HCl in the hydrolysis step of boronic esters. 
 
 
	  
Scheme 70 – Attempts towards boronic acid 149 and only observed product phenol 64. 
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Therefore, pinacol boronic ester was chosen as a substitute. This substrate should 
avoid side-reactions in the palladium catalyzed coupling step due to steric bulk, 
making the oxygen nucleophile less accessible. Indeed, pinacol boronic ester 150 
could be formed in very good yield from TBS bromo catechol 148 via bromine-
lithium exchange (Scheme	  71). 
 
 
	  
Scheme 71 – Preparation of pinacol boronic ester 150. 
 
Unfortunately, the subsequent coupling step to benzylstyrene 132 failed under various 
conditions using different palladium catalysts, solvents and microwave irradiation 
(Scheme	   72). This might be due to the lower nucleophilicity of pinacol boronic 
esters. 
 
 
	  
Scheme 72 – Coupling of pinacol boronic ester went uneventful. 
 
III. 1. 4. Synthesis of benzylstyrenes by Heck cross-coupling 
 
It appeared that the major problem in the synthesis of benzylstyrene 132 was the 
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palladium species could be overcome by literature known additives.[48] The 
retrosynthesis is shown in Scheme	  73. 
 
 
	  
Scheme 73 – Retrosynthesis of benzylstyrene using Heck cross-coupling. 
 
The synthesis started with the preparation of resorcinol halides. We therefore chose 
aryl iodides and aryl bromides due to their known reactivity in oxidative additions 
with palladium. 
 
For the selective introduction of bromide in methyl resorcinol, a literature known 
procedure to resorcinol bromide 156 was followed.[49] Thus bromination of resorcylic 
acid 153 with subsequent decarboxylation at elevated temperatures gave 154, which 
upon selective tosylation of resorcinol followed by methylation of the ortho-phenolic 
group resulted in protected aryl bromide 155. Deprotection of the tosyl group under 
basic conditions resulted in deprotected phenol 156, which could be silylated in 
moderate yield. This 4-step sequence gave selective entry to bromide coupling partner 
157 in good overall yield (Scheme	  74). 
 
 
	  
Scheme 74 – Formation of aryl bromide 157, precursor for the Heck reaction. 
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Selective iodination was accessible from commercially available mono methoxy 
resorcinol 158 by oxidative iodination to afford iodo resorcinol 159 in moderate yield 
(Scheme	  75). 
 
 
	  
Scheme 75 – Regioselective iodination of phenol 158. 
 
The allylic coupling partner 152 was prepared from commercially available eugenol 
(160) by oxidative demethylation via the ortho-quinone. Reduction with Na2S2O4 in 
the same operation yielded allyl catechol 161 (Scheme	  76). TBS protection resulted 
in the formation of allyl coupling partner 162 in good yields.[50] 
 
 
	  
Scheme 76 – Oxidative demethylation of eugenol resulted in allylcatechol 162. 
 
This reaction was tested under various conditions, applying different solvents, 
palladium sources and different coupling partners. Unfortunately, formation of 
benzylstyrene 163 could not be observed under any conditions (Scheme	  77). 
 
 
	  
Scheme 77 – Unsuccessful attempts of the Heck coupling (PG = H, TBS; X = Br, I). 
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Under the applied conditions, most of the time TBS deprotection could be observed, 
which was due to polar solvents like DMF or solvent mixtures with water. In two 
cases, the isomerization of the double bond of allylspecies 152 could be observed 
giving traces of styrene 164 (Figure	  14). 
 
	  
Figure 14 – Isomerized product from Heck coupling. 
 
III. 1. 5. Synthesis of benzylstyrenes by cross-metathesis and biomimetic 
synthesis of Santalin A/B 
 
The successful experience with olefin cross-metathesis in the synthesis of 
benzylstyrene 27 suitable for santalin Y prompted us to test the same reaction 
conditions with different allyl species 162 and benzylstyrene 165 (Scheme	  78).[7] 
 
 
	  
Scheme 78 – Retrosynthesis of santalin A benzylstyrene 132 using olefin-metathesis. 
 
Styrene coupling partner 165 was prepared from benzaldehyde 125 under Wittig 
conditions in good yields (Scheme	  79). 
 
	  
Scheme 79 – Styrene coupling partner 165 was prepared from benzaldehyde 125. 
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The olefin cross-metathesis resulted in benzylstyrene 132, which could not be 
characterized due to co-polar impurities. Deprotection with a fluoride source resulted 
in pure benzylstyrene 120 in moderate yield (Scheme	  80). 
 
 
	  
Scheme 80 – Olefin cross-metathesis to form benzylstyrene 120. 
 
With the two coupling partners in hand, conditions were applied which have been 
already investigated in the previous chapter. With slight modifications, e.g. using a 
solvent mixture of MeCN and MeOH, it was able to isolate santalin A in good yields 
(Scheme	   81), given the complexity of the proposed cascade. Best results were 
obtained with a solvent mixture of methanol and acetonitrile, under air atmosphere, at 
elevated temperatures. During the studies towards santalin A it was realized that an 
excess of anhydrobase 30 (2.5 eq.) was necessary for the full conversion. This arises 
the question whether 30 only plays a role as an electrophile or can act as an internal 
oxidant as well.  
 
 
	  
Scheme 81 – Biomimetic cascade resulting in santalin A. 
 
For the synthesis of santalin B, coupling partner 167 was prepared, also using olefin 
cross-metathesis. Commercially available eugenol (160) and styrene 165 were used in 
TBSO
TBSO
HO
HO
OMe
OH(48%)over 2 steps
1) 
    Grubbs II
    CH2Cl2
2) TBAF, THF
TBSO
OMe
162 120
165
HO
HO
OMe
OH
OO
HO
MeO
OH
OMe
120
30
(67%)
80 °C
MeOH/MeCN
O O
OH
MeO
OH
OMe
HO
MeO
OH
HO
santalin A (17)
	  61	  
the formation of benzylstyrene 166. Due to the difference in polarity, benzylstyrene 
could be separated from its homo-coupled side products by flash column 
chromatography. Deprotection of the TBS-ether using TBAF resulted in 
benzylstyrene 167 in moderate yields, resulting in coupling partner 167 in a longest 
linear sequence of six steps from commercially available material (Scheme	  82). 
 
 
	  
Scheme 82 – Olefin cross-metathesis resulted in desired santalin B benzylstyrene 167. 
 
Synthesis of santalin B was accomplished, applying the same conditions used for 
santalin A (Scheme	  83). While santalin A precipitated upon cooling in the solvent 
system, purification of santalin B appeared to be more complicated. While standard 
silica chromatography gave poor results due to aggregation to the stationary phase, 
sephadex size-excluding chromatography gave good results in this case.  
 
 
	  
Scheme 83 – Biomimetic cascade resulting in santalin B. 
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III. 1. 6. Summary 
 
Novel allylation methods for the synthesis of benzylstyrenes have been applied, 
yielding coupling partners for a biomimetic approach toward the benzoxanthenone 
members of the santalin family. Attempts via Friedel-Crafts allylation, Tsuji-Trost 
and Heck cross-coupling failed. A π-allyl Suzuki cross-coupling with aryl boronic 
acid 137 was successful (Scheme	  84). 
 
 
	  
Scheme 84 – Benzylstyrene 138 suitable for santalin B could be synthesis via π-allyl Suzuki 
coupling. 
 
The most versatile technique towards the synthesis of benzylstyrenes is olefin cross-
metathesis, coupling styrenes 165 with allylphenols 162. This very mild method has 
been shown to work with various substrates, even with unprotected acidic phenols 
(Scheme	  85). 
	  
Scheme 85 – Preparation of benzylstyrene 120 suitable for santalin A via olefin cross-
metathesis. 
 
The formation of santalin A and B has been observed using mild, bioinspired 
conditions. During these studies it became clear that an excess of anhydrobase 30 was 
necessary, which arises the question whether it only plays a role as an electrophile or 
can act as an internal oxidant as well (Scheme	  86).  
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Scheme 86 – Biomimetic assembly of anhydrobase 30 and benzylstyrene 120 to santalin A 
(17). 
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III.	  2. Synthesis of Santarubin A and B 
 
As the biomimetic cascade worked out reliably in the case of santalin A & B, the 
remaining members of the benzoxanthenone class, namely santarubin A & B, should 
be synthesized.  
 
 
	  
Scheme 87 – Retrosynthesis of the santarubin A benzylstyrene 168 using Friedel-Crafts 
allylation. 
 
The synthesis started with the benzylstyrene coupling partner of santarubin A. From 
previous experience we were confident that Friedel-Crafts allylation using O,O’-
dimethylresorcinol (170) with stabilized allylic cations derived from allylic alcohol 
169 would result in benzylstyrene 168 (Scheme	  87).[6] In order to minimize the step 
count Friedel-Crafts allylation was favored over olefin cross-metathesis. TBS 
protection of vanillin (171) and vinylation using vinyl Grignard afforded allylic 
alcohol 169 in very good overall yield (Scheme	  88). 
 
 
	  
Scheme 88 – Preparation of allylic alcohol 169 from vanillin. 
 
Treatment of allylic alcohol with catalytic amounts of copper(II) in the presence of an 
excess of O,O’-dimethylresorcinol at low temperatures gave benzylstyrene 173 in 
very good yield. Subsequent desilylation using standard conditions resulted in 
santarubin B precursor 168 (Scheme	  89). 
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Scheme 89 – Friedel-Crafts allylation resulted in desired benzylstyrene 168. 
 
With the precursors in hand the reaction cascade with the previously tested conditions 
was attempted. Santarubin A precipitated in the reaction medium and was isolated in 
very good yield (Scheme	  90). 
 
 
	  
Scheme 90 – Biomimetic cascade resulted in santarubin A. 
 
The better yields might be explained by the sterical less demanding environment of 
the santarubin biaryl axis in comparison to santalin A and B, which is depicted in 
Figure	  15. 
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Figure 15 – Comparison of the sterical hindrance in the biaryl axis of santalin A (17) and 
santarubin A (19). 
 
Friedel-Crafts type allylation with O,O’-dimethylresorcinol gave a fast entry to 
benzylstyrenes. Hence the same method for the synthesis of santarubin B 
benzylstyrene 176 was planned. Vinylation of already prepared TBS-benzaldehyde 
61, resulted in allylic alcohol 174 in good yields (Scheme	  91). 
 
 
	  
Scheme 91 – Preparation of allylic alcohol 174 using vinyl Grignard. 
 
Allylic alcohol 174 could be transformed to benzylstyrene 175 in the same fashion, 
applying the same conditions as for benzylstyrene 173. If the reaction was carried out 
at room temperature, double allylation of methoxy resorcinol could be observed. 
Desilylation resulted in benzylstyrene 176 in good yield and only four steps from 
commercially available starting material (Scheme	  92). 
 
 
O O
OH
MeO
OH
OMe
HO
OMe
santarubin A (19)
OMeHO
santalin A (17)
O O
OH
MeO
OH
OMe
HO
MeO
OH
HO
TBSO
TBSO
OHBrMg                  
THFTBSO
TBSO
O
(76%)
17461
H
	  67	  
	  
Scheme 92 – Friedel-Crafts allylation resulted in desired benzylstyrene 176. 
 
On mixing anhydrobase 30 and benzylstyrene 176 under the previously employed 
conditions, formation of santarubin B could be observed at elevated temperatures in 
very good yields (Scheme	  93). The desired benzoxanthenone dye could be isolated as 
a precipitate from the reaction mixture. 
 
 
	  
Scheme 93 – Biomimetic cascade resulting in santarubin B. 
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IV. Summary, Conclusion and Future Directions 
 
In summary, this work describes the progress towards the biomimetic synthesis of 
members of the santalin natural product family. Starting from classical approaches 
towards the anhydrobase, the presumable biosynthetic precursor, synthetic surprises 
lead to an approach towards the natural product ayamenin E (40). A formal 3+3 
cycloaddition resulted in benzyl alcohol 42, which so far could not be oxidized to 
ayamenin E (Scheme	  94). 
 
 
	  
Scheme 94 – Synthesis of the reduced form of ayamenin E. 
 
While this rapid approach failed, different attempts resulted in formation of the 
coumarin, including a Knoevenagel synthesis and late stage functionalizations using 
Suzuki and Negishi cross-couplings of protected esculetin. Use of a novel zinc base, 
developed by the group of P. Knochel, and a Negishi cross-coupling resulted in rapid 
formation of coumarin 66, which is the common precursor for all members of the 
santalin family (Scheme	  95). 
 
 
	  
Scheme 95 – Rapid assembly of coumarin 66 using zinc mediated Negishi coupling. 
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dehydration and global deprotection and deprotonation resulted in anhydrobase 30, a 
vinyligous para-quinone methide (Scheme	  96). 
 
 
	  
Scheme 96 – Coumarin 66 acts as a branching point for santalin AC (21) and anhydrobase 
30. 
 
Novel allylation methods applied for the synthesis of benzylstyrenes yielded coupling 
partners for a biomimetic approach toward the santalin members. Successful methods 
include a π-allyl Suzuki cross-coupling with aryl boronic acid 137 (Scheme	  97). 
 
 
	  
Scheme 97 – Benzylstyrene 138 suitable for santalin B could be synthesized via 
π-allyl Suzuki coupling. 
 
Friedel-Crafts allylation of easily ionizable allylic alcohols gave a fast entry to 
benzylstyrenes, even though it appeared that the substitution pattern of the 
nucleophilic aryl ring is important (Scheme	  98). 
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Scheme 98 – Synthesis of benzylstyrene 168 suitable for santarubin A via Friedel-Crafts 
allylation. 
 
The most versatile technique towards the synthesis of benzylstyrenes is olefin cross-
metathesis as shown in the coupling of styrene 165 with allylphenol 162. This very 
mild method has been shown to work with a wide range of substrates (Scheme	  99). 
 
 
	  
Scheme 99 – Preparation of benzylstyrene 120 suitable for santalin A via olefin cross-
metathesis. 
 
The formation of benzoxanthenone members of the santalin family has been observed 
using mild, bioinspired conditions. During these studies it became clear, that an 
excess of anhydrobase 30 was necessary, which arises the question, whether it only 
plays a role as an electrophile or can act as an co-oxidant as well (Scheme	  100).  
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Scheme 100 – Biomimetic assembly of anhydrobase 30 and benzylstyrene 120 to santalin A 
(17). 
 
With this unified method five members of the santalin family have been synthesized 
(Figure	   16). Synthetic progress towards the synthesis of santalin Y has been 
accomplished by coupling benzylstyrene 120 with anhydrobase 30. Due to the very 
nucleophilic nature of the pyrogallol unit, only the formation of benzoxanthenone and 
its reduced precursor was observed. Attempts to remove the pyrogallol unit and 
couple a simplified anhydrobase, revealed that an aryl ring next to the anhydrobase is 
necessary for shielding the electrophilic position. 
 
 
	  
Figure 16 – Prepared members of the santalin family. 
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group R (R = Br, TMS), thus favoring the nucleophilic attack of C8 to para-quinone 
methide. This plan could potentially lead to santalin Y (22) after attack via the dashed 
arrow and removing the blocking group (Scheme	  101). 
 
 
	  
Scheme 101 – Future directions leading to santalin Y (R = blocking group). 
 
A second approach involves dual catalysis, having a Lewis acidic (LA) and a 
Brønstedt basic site (B) incorporated in one catalyst. The Lewis acidic moiety could 
potentially activate anhydrobase 30 favoring the nucleophilic attack of benzylstyrene 
27. The released basic portion could then deprotonate the vicinal hydroxy group thus 
generating a nucleophilic position para to phenolate, which could attack para-
quinone methide 117. Subsequent Friedel-Crafts cyclization could be favored by the 
Lewis acid and generate santalin Y (22) in one step (Scheme	  102). 
 
 
	  
Scheme 102 – Future directions leading to santalin Y via dual catalysis. 
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V. Experimental Details 
V.	  1. General Experimental Details 
 
Unless stated otherwise, all reactions were performed in oven-dried glassware under a 
positive pressure of nitrogen. Tetrahydrofuran (THF) and diethyl ether (Et2O) were 
distilled from sodium benzophenone prior to use. Triethylamine was distilled over 
calcium hydride immediately prior to use. n-Butyllithium (n-BuLi) was titrated using 
iodine prior to use. All other solvents as well as starting materials and reagents were 
obtained from commercial sources and used without further purification or were 
prepared according to the cited procedures. Reactions were magnetically stirred and 
monitored by NMR spectroscopy or analytical thin-layer chromatography (TLC) 
using E. Merck 0.25 mm silica gel 60 F254 precoated glass plates. TLC plates were 
visualized by exposure to ultraviolet light (UV, 254 & 365 nm) and/or exposure to an 
aqueous solution of ceric ammoniummolybdate (CAM) followed by heating. Flash 
column chromatography was performed as described by Still et al.[51] employing 
silica gel (60 Å, 40–63 µm, Merck) and a forced flow of eluant at 1.3–1.5 bar 
pressure. Yields refer to chromatographically and spectroscopically (1H and 13C 
NMR) pure material.  
 
Instrumentation 
 
Proton nuclear magnetic resonance (1H NMR) spectra were recorded on Varian 
VNMRS 300, VNMRS 400, INOVA 400 or VNMRS 600 spectrometers. Proton 
chemical shifts are expressed in parts per million (δ scale) and are calibrated using 
residual undeuterated solvent as an internal reference (CDCl3: δ 7.26, d6-DMSO: δ 
2.50, d3-MeCN: δ 1.94, d6-acetone: δ 2.05). Data for 1H NMR spectra are reported as 
follows: chemical shift (δ ppm) (multiplicity, coupling constant (Hz), integration). 
Multiplicities are reported as follows: s = singlet, d = doublet, t = triplet, q = quartet, 
m = multiplet, br = broad or combinations thereof. Carbon nuclear magnetic 
resonance (13C NMR) spectra were recorded on Varian VNMRS 300, VNMRS 400, 
INOVA 400 or VNMRS 600 spectrometers. Carbon chemical shifts are expressed in 
parts per million (δ scale) and are referenced to the carbon resonances of the solvent 
(CDCl3: δ 77.0, d6-DMSO: δ 39.5, d3-MeCN: δ 118.3, 29.8, d6-acetone: δ 29.8). 
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Infrared (IR) spectra were recorded on a Perkin Elmer Spectrum BX II (FTIR 
System). IR data are reported in frequency of absorption (cm–1). Mass spectroscopy 
(MS) experiments were performed on a Thermo Finnigan MAT 95 (EI) or on a 
Thermo Finnigan LTQ FT (ESI) instrument. Melting points (mp) were determined 
with a Stanford Research Systems MPA120 apparatus and are uncorrected. UV-
spectra (UV) were obtained using a Varian Cary 50 Scan UV/Vis spectrometer and 
Helma SUPRASIL precision cuvettes (10 mm light path). 
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V.	  2. Experimental towards ayamenin E 
 
3-acetyl-2,6-dimethoxyphenyl acetate (34)[17] 
 
 
 
 
 
To a solution of 2,6-methoxyphenol (20.0 g, 130 mmol, 1 eq.) in Ac2O (37.0 mL, 392 
mmol, 3 eq.) was slowly added conc. H2SO4 (200 µL) at room temperature. The 
reaction mixture was heated to 140 °C for 28 h and was then allowed to cool room 
temperature. After addition of sat. aq. NH4Cl (100 mL), the mixture was extracted 
with EtOAc (3 × 180 mL). The combined organic extracts were washed with sat. aq. 
NaCl (120 mL) and dried (MgSO4). Flash column chromatography [Isohexane: 
EtOAc 8:1 → 6:1] afforded acetophenol 34 (21.9 g, 71%) as a white powder. 
 
Rf = 0.33 (Isohexane: EtOAc 7:3). 
 
mp (EtOAc): 107.2 – 108.5 °C. 
 
1H NMR (300 MHz, CDCl3): δ 7.69 (d, J = 9.0 Hz, 1H), 6.77 (d, J = 9.0 Hz, 1H), 
3.87 (s, 6H), 2.60 (s, 3H), 2.37 (s, 3H) ppm. 
 
13C NMR (75 MHz, CDCl3): δ 197.5, 168.5, 156.1, 153.5, 133.2, 128.5, 125.8, 107.3, 
62.1, 56.5, 30.8, 20.7 ppm. 
 
IR (ATR): ṽ = 2957, 1766, 1668, 1596, 1496, 1378, 1363, 866, 819 cm–1. 
 
HRMS (ESI):  calcd. for C12H14O5Na+ [M+Na]+:   261.0733, 
found:       261.0734. 
 
OAc
MeO OMe
O
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1-(3-hydroxy-2,4-dimethoxyphenyl)acetic acid (35) 
 
 
 
 
 
To a stirred solution of acetophenol 34 (21.9 g, 92.1 mmol, 1 eq.) in morpholine (48.0 
mL, 553 mmol, 6 eq.) were added p-toluenesulfonic acid (527 mg, 3.10 mmol, 3 mol-
%) and S8 (5.91 g, 184 mmol, 2 eq.). After refluxing for 2 h 30 min at 140 °C, aq. 
NaOH (20%, 240 mL) and tetrabutylammonium bromide (220 mg, 0.680 mmol) were 
added and the mixture was stirred additional 5 h 30 min at 110 °C. The reaction 
mixtures was diluted with HCl (conc., 90 mL) at 0 °C and extracted with EtOAc (4 × 
500 mL). The combined organic phases were washed with H2O (400 mL) and sat. aq. 
NaCl (400 mL) and dried (MgSO4). Flash column chromatography [CH2Cl2: MeOH 
96:4] afforded carboxylic acid 35 (8.16 g, 42 %) as a brownish solid. 
 
Rf = 0.44 (CH2Cl2: MeOH 9:1). 
 
mp (MeOH): 98.6 – 100.3 °C. 
 
1H NMR (300 MHz, CDCl3): δ 6.68 (d, J = 8.5 Hz, 1H), 6.59 (d, J = 8.5 Hz, 1H), 
3.86 (s, 3H), 3.81 (s, 3H), 3.57 (s, 2H) ppm. 
 
13C NMR (75 MHz, CDCl3): δ 220.6, 176.3, 147.7, 145.5, 138.8, 120.8, 106.6, 60.5, 
56.4, 36.0 ppm. 
 
IR (ATR): ṽ = 2981, 2941, 1695, 1498, 1339, 1219, 896, 808 cm–1. 
 
HRMS (ESI):  calcd. for C10H11O5– [M–H]–:   211.0612,  
found:       211.0614. 
OH
MeO OMe
O OH
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7-hydroxy-6-methoxybenzofuran-3-carbaldehyde (36) 
2-chloro-7-hydroxy-6-methoxybenzofuran-3-carbaldehyde (37) 
 
 
 
 
 
To POCl3 (2.61 mL, 17.0 mmol, 1.8 eq.) was added DMF (2.63 mL, 34.0 mmol, 3.6 
eq.) dropwise at 0 °C. After 20 min acetic acid 35 (2.00 g, 9.44 mmol, 1 eq.) was 
added and the resulting reaction mixture was heated up to 85 °C for 3 h. The mixture 
was allowed to cool to room temperature followed by the addition of ice (12 mL) and 
extraction with CH2Cl2 (3 × 200 mL). The combined organic phases were dried 
(MgSO4) and the solvent was removed in vacuo. The residue was dissolved in EtOH 
(14.3 mL), aq. NaOH solution (25% w/v, 18.8 mL) and heated to 85 °C for 45 min. 
The solvent was removed in vacuo followed by addition of ice (120 mL). The solution 
was adjusted to pH 2 with conc. HCl. Afterwards the aqueous solution was extracted 
with Et2O (3 × 200 mL). The combined organic extracts were washed with sat. aq. 
NaCl solution (160 mL) and dried (MgSO4). Flash column chromatography 
[Isohexane: EtOAc 4:1] afforded chlorobenzofuran 37 (140.0 mg, 7 %) as a yellow oil 
and benzofuran 36 (132 mg, 7%) as a pale yellow oil.  
 
 
2-chloro-7-hydroxy-6-methoxybenzofuran-3-carbaldehyde (37):  
 
Rf: 0.48 (Isohexane:EtOAc 7:3). 
 
1H NMR (300 MHz, CDCl3): δ 10.12 (s, 1H), 7.58 (d, J = 8.6 Hz, 1H), 6.98 (d, J = 
8.6 Hz, 1H), 5.79 (br, 1H), 3.96 (s, 3H) ppm.  
 
13C NMR (75 MHz, CDCl3): δ 184.5, 151.8, 145.4, 141.6, 130.9, 119.5, 116.6, 112.0, 
O
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110.0, 57.2 ppm. 
 
IR (ATR): ṽ = 3130 (m), 3083 (m), 3002 (w), 2873 (w), 1716 (w), 1653 (s), 1598 
(m), 1562 (m), 1507 (s), 1468 (s), 1440 (s), 1349 (s), 1268 (s), 1232 (s), 1119 (s), 
1077 (s), 978 (s), 782 (s) cm–1. 
 
HRMS (ESI):  calcd. for C10H6ClO4– [M–H]–:  224.9960, 
found:       224.9960. 
 
 
7-hydroxy-6-methoxybenzofuran-3-carbaldehyde (36):  
 
Rf: 0.33 (Isohexane: EtOAc 7:3). 
 
1H NMR (300 MHz, CDCl3): δ 10.13 (s, 1H), 8.21 (s, 1H), 7.64 (d, J = 8.6 Hz, 1H), 
7.02 (d, J = 8.6 Hz, 1H), 5.75 (br, 1H), 3.97 (s, 3H) ppm.  
 
13C NMR (75 MHz, CDCl3): δ 184.9, 155.7, 145.4, 144.1, 131.5, 124.0, 118.7, 112.7, 
109.9, 57.3 ppm.  
 
IR (ATR): ṽ = 3130 (m), 3083 (m), 3002 (w), 1655 (s), 1598 (m), 1562 (m), 1507 (s), 
1468 (s), 1441 (s), 1350 (s), 1269 (s), 1256 (s), 1198 (m) 1120 (s), 1078 (s), 979 (s), 
919 (s) 782 (s) cm–1. 
 
HRMS (ESI): calcd. for C10H7O4– [M–H]–:  191.0350, 
found:      191.0350. 
 
 
 
 
 
 
 
 
	  79	  
4’-methoxy-4H-benzofuro[2,3-b]chromene-3’,4,5,7-tetraol (42)  
 
 
 
 
 
To a stirred suspension of phloroglucinol (41) (24.5 mg, 0.19 mmol, 1.3 eq.) in Et2O 
(2 mL) was added chlorobenzofuran 37 (35.0 mg, 0.15 mmol, 1 eq.) at room 
temperature followed by the dropwise addition of NEt3 (8.00 µL, 580 µmol, 3.8 eq.). 
The resulting mixture was heated to 50 °C for 6 d. After 3 d and 5 d additional 
portions of phloroglucinol (5.67 mg, 0.05 mmol, 0.3 eq.; 3.78 mg, 0.03 mmol, 0.2 eq.) 
were added. After completion, aq. HCl solution (2.0 M, 10 mL) was added to the 
reaction mixture and was extracted with EtOAc (3 × 15 mL). The combined organic 
extracts were dried (MgSO4) and purified by flash column chromatography [CH2Cl2: 
MeOH 97:3] to afford alcohol 42 (33.0 mg, 0.10 mmol, 67%) as yellow foam. 
 
Rf: 0.32 (CH2Cl2: MeOH: AcOH: H2O 90:10:0.6:0.6). 
 
1H NMR (400 MHz, d6-acetone): δ 8.11 (s, 1H), 6.87 (d, J = 8.7 Hz, 1H), 6.58 (d, J = 
8.7 Hz, 1H), 6.41 (d, J = 2.1 Hz, 1H), 6.33 (d, J = 2.1 Hz, 1H), 5.62 (s, 1H), 3.85 (s, 
3H) ppm. 
 
13C NMR (100 MHz, d6-acetone): δ 172.1, 162.6, 162.1, 157.2, 156.8, 144.5, 138.3, 
135.3, 121.4, 120.2, 117.9, 104.3, 104.0, 99.4, 95.1, 55.5 ppm. 
 
IR (ATR): ṽ = 3194 (br), 1607 (s), 1505 (s), 1287 (s), 1144 (s), 1079 (s), 790 (s) cm–1. 
 
HRMS (ESI):  calcd. for C16H11O7– [M–H]–:   315.0505,  
found:      315.0508. 
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V.	  3. Experimental towards anhydrobase 
 
2-(benzyloxy)-1,3-dimethoxybenzene (177)[52] 
 
 
 
 
 
To a stirred solution of 33 (5.00 g, 32.4 mmol, 1 eq.) in EtOH (40 mL) were 
successively added K2CO3 (2.69 g, 19.4 mmol, 0.6 eq.), benzyl chloride (3.90 mL, 
34.0 mmol, 1.05 eq.), and potassium iodide (490 mg, 3.24 mmol, 0.1 eq.) at room 
temperature. The reaction mixture was stirred for 12 h at this temperature. After 
completion, the reaction mixture was filtered through a plug of celite® and was 
concentrated in vacuo. The residual oil was washed with H2O (120 mL) and was 
extracted with Et2O (3 × 120 mL). The combined organic extracts were washed with 
H2O (100 mL), sat. aq. NaCl (100 mL) and dried (Na2SO4). The crude product was 
purified by flash column chromatography [Isohexane:EtOAc 20:1] to afford 
177 (4.49 g, 57 %) as a pale yellow oil. 
 
Rf : 0.95 (Isohexane:EtOAc 7:3). 
 
1H NMR (300 MHz, CDCl3): δ 7.52 – 7.48 (m, 2H), 7.39 – 7.27 (m, 3H), 7.00 (t, J = 
8.3 Hz, 1H), 6.58 (d, J = 8.3 Hz, 2H), 5.02 (s, 2H), 3.83 (s, 6H) ppm. 
 
13C NMR (75 MHz, CDCl3): δ 154.0, 138.2, 137.4, 128.7, 128.3, 128.0, 123.9, 105.6, 
75.2, 56.3 ppm. 
 
IR (ATR): ṽ = 3062 (w), 3001 (w), 2937 (w), 2835 (w), 1594 (m), 1492 (m), 1475 
(s), 1434 (m), 1294 (s), 1252 (s), 1216 (s), 1105 (s), 1089 (s), 985 (m), 772 (m), 728 
(s), 694 (s) cm–1. 
 
HRMS (EI):  calcd. for C15H16O3+ [M]+:    244.1094, 
found:       244.1091 
MeO
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3-(benzyloxy)-2,4-dimethoxybenzaldehyde (45)[53] 
 
 
 
 
 
To a stirred mixture of benzyl ether 177 (4.49 g, 18.4 mmol, 1 eq.) in DMF (3.00 mL, 
39.0 mmol, 2.1 eq.) was added POCl3 (4.30 mL, 46.0 mmol, 2.5 eq.) at 2 °C over the 
period of 1 h 30 min. After complete addition, the reaction mixture was stirred for 
additional 1 h at room temperature and was then heated to 70 °C for 3 h. After 
completion, the reaction mixture was cooled to room temperature and poured into ice 
water (40 mL). The biphasic mixture was extracted with Et2O (3 ×  50 mL) and the 
combined organic extracts were washed with sat. aq. NaHCO3 (2 × 50 mL), H2O (50 
mL), sat. aq. NaCl (50 mL) and dried (MgSO4). The crude product was purified by 
flash column chromatography [Isohexane:EtOAc 10:1] to afford benzaldehyde 45 
(2.75 g, 55 %) as a yellow oil. 
 
Rf : 0.22 (Isohexane:EtOAc 7:1). 
 
1H NMR (300 MHz, CDCl3): δ 10.25 (d, J = 0.8 Hz, 1H), 7.62 (d, J = 8.8 Hz, 1H), 
7.52 – 7.45 (m, 2H), 7.42 – 7.30 (m, 3H), 6.76 (d, J = 8.8 Hz, 1H), 5.04 (s, 2H), 4.02 
(s, 3H), 3.91 (s, 3H) ppm. 
 
13C NMR (75 MHz, CDCl3): δ 189.1, 159.7, 157.6, 140.7, 137.4, 128.6, 128.6, 128.4, 
124.7, 123.7, 107.7, 75.6, 62.8, 56.4 ppm. 
 
IR (ATR): ṽ = 3337 (w), 3063 (w), 2942 (w), 2840 (w), 1676 (s), 1586 (s), 1493 (s), 
1461 (s), 1384 (m), 1285 (s), 1257 (s), 1219 (m), 1089 (s), 1000 (s), 911 (m), 735 (s) 
cm–1. 
 
HRMS (ESI):  calcd. for C16H16O4+ [M]+:    272.1043, 
found:       272.1045. 
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2-(benzyloxy)-1,3-dimethoxy-4-(2-methoxyvinyl)benzene (47) 
 
 
 
 
 
To a stirred suspension of methoxymethyl triphenylphosphonium chloride (864 mg, 
2.52 mmol, 2 eq.) in THF (3 mL) at 0 °C was added a mixture of KOt-Bu (283 mg, 
2.52 mmol, 2 eq.) in THF (2 mL) dropwise over a period of 10 min. The solution was 
stirred for 30 min at room temperature and after this time 45 (343 mg, 1.26 mmol, 1 
eq.) in THF (1.5 mL) was added at 0 °C dropwise over a period of 5 min. The 
reaction mixture was stirred for 10 h at room temperature. After completion, the 
reaction mixture was poured into H2O (20 mL) and was extracted with EtOAc (3 × 20 
mL). The combined organic extracts were washed with sat. aq. NaCl (20 mL) and 
dried (MgSO4). The crude product was purified by flash column chromatography 
[Isohexane:EtOAc 10:1] to afford methyl enol ether 47 (349 mg, 92 %) as a pale 
yellow oil. 
 
Enol ether 47 was obtained as a mixture of diastereomers 1.5:1 (E:Z). 
 
Rf : 0.59 (Isohexane:EtOAc 7:3). 
 
1H NMR (400 MHz, CDCl3): δ 7.75 (d, J = 8.8 Hz, 1H), 7.54 – 7.48 (m, 4H), 7.43 – 
7.27 (m, 6H), 7.04 (d, J = 13.0 Hz, 1H), 6.97 (dd, J = 8.7, 0.5 Hz, 1H), 6.65 (dd, J = 
16.3, 8.7 Hz, 2H), 6.14 (d, J = 7.2 Hz, 1H), 5.95 (d, J = 13.0 Hz, 1H), 5.53 (d, J = 7.2 
Hz, 1H), 5.02 (s, 2H), 5.01 (s, 2H), 3.86 (s, 3H), 3.85 (s, 3H), 3.83 (s, 3H), 3.82 (s, 
3H), 3.76 (s, 3H), 3.69 (s, 3H) ppm. 
 
13C NMR (100 MHz, CDCl3): δ 152.3, 152.2, 151.0, 148.8, 147.4, 141.9, 141.6, 
138.2, 138.1, 128.5, 128.5, 128.5, 128.4, 128.1, 128.0, 124.6, 123.45, 123.0, 120.3, 
108.2, 107.7, 100.1, 98.8, 75.5, 75.4, 61.5, 61.0, 60.8, 56.6, 56.3, 56.3 ppm. 
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IR (ATR): ṽ = 3413 (br), 2935 (w), 2834 (w), 1648 (m), 1595 (m), 1491 (s), 1456 (s), 
1417 (s), 1372 (m), 1274 (s), 1261 (s), 1220 (s), 1153 (m), 1090 (s), 1009 (s), 809 
(m), 735 (s), 695 (s) cm–1. 
 
HRMS (EI):  calcd. for C18H20O4+ [M]+:    300.1356, 
found:       300.1348. 
 
 
 
 
2-(3-(benzyloxy)-2,4-dimethoxyphenyl)acetaldehyde (44) 
 
 
 
 
 
To a stirred solution of enol ether 47 (100 mg, 333 µmol, 1 eq.) in acetone (3 mL) 
was added aq. HCl (6 M, 0.300 mL, 1.80 mmol, 30 eq.) at room temperature. The 
reaction mixture was stirred for 2 h 30 min at room temperature. After completion, 
the reaction mixture was added to sat. aq. NH4Cl (10 mL) and was extracted with 
Et2O (3 × 10 mL). The combined organic extracts were washed with sat. aq. NaCl (10 
mL) and dried (Na2SO4). The crude product was purified by flash column 
chromatography [Isohexane:EtOAc 8:1] to afford aldehyde 44 (67.0 mg, 70 %) as a 
pale yellow oil.  
 
Rf : 0.55 (Isohexane:EtOAc 7:3). 
 
1H NMR (300 MHz, CDCl3): δ 9.69 (t, J = 2.1 Hz, 1H), 7.51 – 7.47 (m, 2H), 7.41 – 
7.30 (m, 3H), 6.85 (d, J = 8.5 Hz, 1H), 6.66 (d, J = 8.5 Hz, 1H), 5.03 (s, 2H), 3.87 (s, 
3H), 3.84 (s, 3H), 3.61 (d, J = 2.1 Hz, 2H) ppm. 
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13C NMR (75 MHz, CDCl3): δ 200.2, 154.0, 152.7, 141.4, 137.7, 128.5, 128.5, 128.2, 
125.6, 118.7, 107.7, 75.3, 61.2, 56.3, 45.3 ppm. 
 
IR (ATR): ṽ = 3402 (br), 2972 (w), 2937 (w), 1678 (w), 1602 (w), 1494 (s), 1462 (s), 
1374 (m), 1277 (s), 1258 (m), 1195 (m), 1094 (s), 1041 (s), 1011 (s), 798 (s), 737 (s), 
695 (s) cm–1. 
 
HRMS (EI):  calcd. for C17H18O4+ [M]+:    286.1200, 
found:       286.1196. 
 
 
 
 
(Z)-2-(3-(benzyloxy)-2,4-dimethoxyphenyl)-3-(dimethylamino)acrylaldehyde (49) 
 
 
 
 
 
To a stirred solution of acetaldehyde 44 (67.0 mg, 234 µmol, 1 eq.) in DMF (2 mL) 
was added DMF dimethyl acetal (50.0 µL, 376 µmol, 1.6 eq.) at room temperature in 
one portion. The reaction mixture was stirred at this temperature for 12 h. After 
completion, the reaction mixture was poured in H2O (15 mL) and was extracted with 
EtOAc (3 × 15 mL). The combined organic extracts were washed with sat. aq. NaCl 
(10 mL) and dried (Na2SO4). The crude product was purified by flash column 
chromatography [CH2Cl2:MeOH 19:1] to afford 49 (67.0 mg, 85 %) as colorless 
needles. 
 
Rf : 0.57 (CH2Cl2:MeOH 10:1). 
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mp (MeOH): 64.9 – 67.2 °C.  
 
1H NMR (400 MHz, CDCl3): δ 9.09 (s, 1H), 7.53 – 7.42 (m, 2H), 7.39 – 7.26 (m, 3H), 
6.81 (bs, 1H), 6.81 (d, J = 8.5 Hz, 1H), 6.67 (d, J = 8.5 Hz, 1H), 5.11 (d, J = 11.0 Hz, 
1H), 4.99 (d, J = 11.0 Hz, 1H), 3.84 (s, 3H), 3.75 (s, 3H), 2.78 (br s, 6H) ppm. 
 
13C NMR (100 MHz, CDCl3): δ 200.1, 189.8, 159.2, 153.6, 152.8, 141.2, 138.0, 
128.5, 128.4, 128.0, 127.5, 121.2, 111.4, 107.6, 75.0, 61.1, 56.1 ppm. 
 
IR (ATR): ṽ = 2932 (w), 1582 (s), 1496 (m), 1454 (m), 1396 (s), 1272 (s), 1231 (m), 
1194 (m), 1174 (m) 1091 (s), 994 (m), 790 (m), 750 (s), 696 (m) cm–1. 
 
HRMS (ESI):  calcd. for C20H24O4N+ [M+H]+:    342.1700, 
found:        342.1704. 
 
 
 
 
(Z)-2-(3-(benzyloxy)-2,4-dimethoxyphenyl)-3-hydroxyacrylaldehyde (43) 
 
 
 
 
 
To a stirred solution of 49 (100 mg, 400 µmol, 1 eq.) in EtOH (10 mL) was added aq. 
NaOH (1 M, 2.40 mL, 2.40 mmol, 6 eq.) at room temperature. The reaction mixture 
was heated to 70 °C for 6 h. After completion, sat. aq. NH4Cl (10 mL) was added and 
the reaction mixture was extracted with EtOAc (3 ×  20 mL). The combined organic 
extracts were washed with sat. aq. NaCl (10 mL) and dried (Na2SO4). The crude 
product was purified by flash column chromatography [CH2Cl2:MeOH 19:1] to afford 
43 (74.0 mg, 83 %) as a colorless oil. 
MeO
OBn
OMe
O
OH
H
	  86	  
 
Rf : 0.43 (CH2Cl2:MeOH 10:1). 
 
1H NMR (400 MHz, d6-acetone): δ 8.54 (s, 2H), 7.56 – 7.51 (m, 2H), 7.41 – 7.32 (m, 
3H), 6.88 (d, J = 8.5 Hz, 1H), 6.81 (d, J = 8.5 Hz, 1H), 5.02 (s, 2H), 3.88 (s, 3H), 3.76 
(s, 3H) ppm. 
 
13C NMR (100 MHz, d6-acetone): δ 184.0 (*), 155.3, 153.2 (**), 143.0, 139.8, 129.6, 
129.4, 129.1, 126.6 (*), 118.5 (**), 108.8 (*), 109.3, 76.0, 61.8, 57.0 ppm. 
 
IR (ATR): ṽ = 2923 (s), 2852 (s), 1584 (s), 1495 (m), 1414 (s), 1283 (m), 1093 (s), 
1013 (m) cm–1. 
 
HRMS (ESI):  calcd. for C18H17O5– [M–H]–:   313.1081, 
found:       313.1075. 
 
(*) obscured carbon was detected by HSQC. 
(**) obscured carbon was detected by HMBC. 
 
 
tert-butyl(2,6-dimethoxyphenoxy)dimethylsilane (178) 
 
 
 
 
 
To a stirred solution of 2,6-dimethoxyphenol (33) (3.00 g, 19.5 mmol, 1 eq.) in DMF 
(20 mL) at 0 °C was added imidazole (1.46 g, 20.5 mmol, 2.2 eq.), 4-
dimethylaminopyridine (240 mg, 1.95 mmol, 0.1 eq.) and TBSCl (3.09 g, 1.05 mmol, 
1.1 eq.). The reaction mixture was stirred at room temperature for 3 h. After 
completion of the reaction, the mixture was diluted with H2O (15 mL) and extracted 
with diethyl ether (3 × 50 mL). The combined organic extracts were washed with sat. 
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aq. NaCl solution (20 mL) and dried (MgSO4). The crude product was purified by 
flash column chromatography [Isohexane: EtOAc 10:1] to provide 178 (5.05 g, 18.8 
mmol, 97%) as colorless needles.  
 
Rf: 0.56 (Isohexane:EtOAc 10:1).  
 
mp (EtOAc): 42.9 – 43.7 °C. 
 
1H NMR (300 MHz, CDCl3): δ 6.86 (t, J = 8.3 Hz, 1H), 6.57 (d, J = 8.3 Hz, 2H), 3.82 
(s, 6H), 1.04 (s, 9H), 0.16 (s, 6H) ppm. 
 
13C NMR (75 MHz, CDCl3): δ 151.9, 134.5, 120.6, 105.4, 55.8, 25.8, 18.7, –4.6 ppm.  
 
IR (ATR): ṽ = 2996 (w), 2952 (m), 2930 (m), 2896 (m), 2857 (m), 2837 (m), 1594 
(m), 1503 (m), 1476 (m), 1445 (m), 1436 (m), 1390 (w), 1361 (w), 1302 (m), 1246 
(s), 1186 (w), 1171 (s), 1041 (w), 910 (m), 837 (m), 824 (m), 809 (m), 780 (m), 768 
(m), 741 (m), 718 (m) cm–1.  
 
HRMS (ESI):  calcd. for C14H24O3Si– [M–H]–:   268.1495, 
found:       268.1487. 
 
 
 
 
3-((tert-butyldimethylsilyl)oxy)2,4-dimethoxybenzaldehyde (55) 
 
 
 
 
 
To a stirred solution of TMEDA (7.80 mL, 52.2 mmol, 1.4 eq.) in hexane (45 mL) 
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was added n-BuLi (2.5 M solution in hexane; 16.4 mL, 41.0 mmol, 1.1 eq.) and stirred 
for 30 min at 0 °C. A solution of 178 (10.0 g, 37.3 mmol, 1 eq.) in hexane (12 mL) 
was added to the mixture over a period of 1 h at –14 °C. After keeping the mixture at 
–14 °C for 1 h the reaction was allowed to warm to room temperature and stirred for 
additional 22 h. DMF (4.80 mL, 63.4 mmol, 1.7 eq.) was added slowly to the reaction 
mixture and the solution was maintained at 0 °C for 1 h 30 min. After addition of sat. 
aq. NH4Cl (30 mL) it was stirred 10 h at room temperature and the resulting mixture 
was diluted with H2O (100 mL) and extracted with Et2O (4 × 150 mL) The combined 
organic extracts were washed with sat. aq. NaCl (150 mL) and dried (MgSO4). Flash 
column chromatography [Isohexane: EtOAc 30:1] afforded 55 (4.90 g, 50%) as a pale 
yellow solid. 
 
Rf = 0.61 (Isohexane:EtOAc 1:4). 
 
mp (EtOAc) = 29.7 – 30.2 °C. 
 
1H NMR (300 MHz, CDCl3): δ 10.22 (d, J = 0.5 Hz, 1H), 7.49 (d, J = 8.7 Hz, 1H), 
6.73 (dd, J = 8.7, 0.5 Hz, 1H), 3.91 (s, 3H), 3.87 (s, 3H), 1.03 (s, 9H), 0.16 (s, 6H) 
ppm. 
 
13C NMR (75 MHz, CDCl3): δ 189.2, 157.5, 155.2, 138.2, 123.7, 121.8, 107.3, 62.1, 
55.5, 25.7, 18.6, –4.7 ppm. 
 
IR (ATR): ṽ = 2934, 2859, 1680, 1583, 1385, 1361, 831, 816 cm–1. 
 
HRMS (ESI):  calcd. for C15H31O4Si– [M–H]–:  195.1366, 
found:      195.1402. 
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3-bromo-2,6-dimethoxyphenol (57)[26] 
 
 
 
 
 
To a stirred solution of 2,6-dimethoxyphenol (33) (6.00 g, 38.9 mmol, 1 eq.) in CCl4 
(100 mL) was added bromine (6.20 mL, 38.9 mmol, 1 eq.) in CCl4 (40 mL) dropwise 
at –10 °C. After 5 min of stirring at this temperature, the reaction mixture was diluted 
with CCl4 (100 mL) and washed with H2O (3 × 200 mL). The aqueous phase was 
extracted with CH2Cl2 (3 × 50 mL) the combined organic extracts were washed with 
sat. aq. NaCl solution (100 mL) and dried (MgSO4). Concentration in vacuo afforded 
bromide 57 (8.12 g, 98%) as a pale brown oil, which was directly used in the next 
step. 
 
Rf: 0.51 (Isohexane:EtOAc 7:3). 
 
1H NMR (300 MHz, CDCl3): δ 7.03 (d, J = 8.9 Hz, 1H), 6.58 (d, J = 8.9 Hz, 1H), 
5.65 (br, 1H, OH), 3.94 (s, 3H), 3.90 (s, 3H) ppm.  
 
13C NMR (75 MHz, CDCl3): δ 147.3, 144.4, 139.9, 122.4, 108.4, 107.8, 60.7, 56.4 
ppm.  
 
IR (ATR): ṽ = 3493 (m), 3432 (m), 3094 (w), 3005 (w), 2940 (m), 2838 (m), 1601 
(m), 1488 (s), 1468 (s), 1441 (m), 1331 (m), 1291 (m), 1215 (s), 1085 (s), 908 (w), 
876 (m), 786 (m), 700 (w), 642 (w) cm–1. 
 
HRMS (ESI):  calcd. for C8H8BrO3– [M–H]–:   230.9662, 
found:       230.9665. 
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(3-bromo-2,6-dimethoxyphenoxy)(tert-butyl)dimethylsilane (75) 
 
 
 
 
 
To a stirred solution of phenol 57 (7.50 g, 32.3 mmol, 1 eq.) in DMF (40 mL) was 
added successively TBSCl (7.28 g, 48.5 mmol, 1.5 eq.), imidazole (6.58 g, 
96.6 mmol, 3.0 eq.) and 4-dimethylaminopyridine (590 mg, 4.83 mmol, 0.15 eq.) at 
0 °C. The reaction mixture was allowed to warm to room temperature and was stirred 
for 45 min. After completion, the reaction mixture was diluted with H2O (70 mL) and 
extracted with Et2O (3 × 100 mL). The combined organic extracts were washed with 
aq. NaCl solution (10%, 2 × 150 mL), sat. aq. NaCl solution (70 mL) and dried 
(MgSO4). The crude product was purified by flash column chromatography 
[Isohexane:EtOAc 30:1] to provide 75 (6.78 g, 90%) as a colorless oil.  
 
Rf: 0.60 (Isohexane:EtOAc 30:1).  
 
1H NMR (300 MHz, CDCl3): δ 7.10 (d, J = 8.9 Hz, 1H), 6.57 (d, J = 8.9 Hz, 1H), 
3.83 (s, 3H), 3.80 (s, 3H), 1.04 (s, 9H), 0.18 (s, 6H) ppm.  
 
13C NMR (75 MHz, CDCl3): δ 151.8, 149.3, 139.8, 124.0, 108.7, 108.3, 60.2, 55.5, 
25.7, 18.6, –4.8 ppm.  
 
IR (ATR): ṽ = 3085 (w), 2998 (m), 2954 (m), 2933 (s), 2896 (m), 2857 (s), 1574 (m), 
1479 (s), 1462 (s), 1441 (m), 1418 (m), 1301 (m), 1249 (m), 1219 (s), 1092 (s), 1015 
(m), 935 (s), 918 (m), 827 (m), 814 (m), 782 (s) cm–1.  
 
HRMS (ESI):  calcd. for C13H20BrO3Si– [M–CH3]–:   331.0371, 
found:       331.0368. 
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tert-butyl(2,6-dimethoxy-3-(2-methoxyvinyl)phenoxy)dimethylsilane (57) 
 
 
 
 
 
To a stirred solution of methoxymethyl triphenylphosphonium chloride (4.63 g, 13.5 
mmol, 2 eq.) in THF (20 mL), a solution of KOtBu (1.52 g, 13.5 mmol, 2 eq.) in THF 
(20 mL) was added at 0 °C. This mixture was stirred for 30 min at 0 °C, and a 
solution of benzaldehyde 55 (2.00 g, 6.75 mmol, 1 eq.) in THF (20 mL) was added 
during 30 min at room temperature. After stirring for additional 21 h at room 
temperature, the mixture was diluted with sat. aq. NH4Cl (70 mL) and extracted with 
EtOAc (4 ✕ 100 mL). The combined organic extracts were washed with sat. aq. NaCl 
(100 mL) and dried (MgSO4). Flash column chromatography [Isohexane: EtOAc 
30:1] afforded 57 (2.10 g, 96%) as a colorless oil. 
 
Rf = 0.32 (Isohexane: EtOAc 30:1). 
 
1H NMR (200 MHz, CDCl3): δ 7.60 (d, J = 8.9 Hz, 1H), 7.01 (d, J = 13.0 Hz, 1H), 
6.81 (d, J = 8.6 Hz, 1H), 6.58 (t, J = 8.9 Hz, 2H), 6.10 (d, J = 7.2 Hz, 1H), 5.93 (d, J = 
13.1 Hz, 1H), 5.50 (d, J = 7.2 Hz, 1H), 3.79 – 3.64 (m, 18H), 1.01 (s, 9H), 1.01 (s, 
9H), 0.13 (s, 6H), 0.13 (s, 6H) ppm. 
 
This compound was obtained as a mixture of diastereomers (E:Z) 1.7:1 and was 
directly used in the next step without further purification and characterization. 
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2-(3-((tert-butyldimethylsilyl)oxy)-2,4-dimethoxyphenyl)acetaldehyde (58) 
 
 
 
 
 
To a stirred solution of enol ether 57 (2.10 g, 6.50 mmol, 1 eq.) in acetone (65 mL) 
was added slowly aq. HCl (6 M; 6.50 mL, 38.4 mmol, 9.1 eq.). After stirring for 70 
min at room temperature, the reaction mixture was diluted with sat. aq. NaHCO3 (90 
mL) and extracted with EtOAc (3 × 110 mL). The combined organic extracts were 
washed with sat. aq. NaCl and dried (MgSO4). Flash column chromatography 
[Isohexane: EtOAc 20:1] afforded 58 (1.19 g, 59%) as a colorless oil. 
 
Rf = 0.38 (Isohexane: EtOAc 16:1). 
 
1H NMR (300 MHz, CDCl3): δ 9.68 (t, J = 2.3 Hz, 1H), 6.71 (d, J = 8.6 Hz, 1H), 6.62 
(d, J = 8.6 Hz, 1H), 3.79 (s, 3H), 3.75 (s, 3H), 3.59 (d, J = 2.3 Hz, 2H), 1.02 (s, 9H), 
0.15 (s, 6H) ppm. 
 
13C NMR (75 MHz, CDCl3): δ 200.1, 151.8, 150.7, 138.7, 122.4, 118.6, 107.3, 60.1, 
55.4, 45.0, 25.8, 18.6, 4.6 ppm. 
 
IR (ATR): ṽ = 2858, 2837, 2716, 1726, 1600, 1465, 1099, 835 cm–1. 
 
HRMS (ESI):  calcd. for C16H35O4Si+ [M+H]+: 311.1679, 
found:      311.1677. 
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2-(3-((tert-butyldimethylsilyl)oxy)-2,4-dimethoxyphenyl)acetic acid (59) 
 
 
 
 
 
To a stirred solution of arylacetaldehyde 58 (1.19 g, 3.82 mmol, 1 eq.), NaH2PO4 
(1.04 g, 11.5 mmol, 3 eq.) and 2-methyl-2-butene (3.25 mL, 30.6 mmol, 7.9 eq.) in t-
BuOH/water (3:1, 50 mL) was added sodium chlorite (1.04 g, 11.5 mmol, 3 eq.). 
After stirring for 30 min at room temperature, the reaction mixture was diluted with 
sat. aq. NH4Cl (50 mL) and extracted with EtOAc (3 × 70 mL). The combined 
organic extracts were dried (Na2SO4) and concentrated in vacuo. Flash column 
chromatography [Isohexane: EtOAc 3:1] afforded acid 59 (0.990 g, 79%) as a white 
solid.  
 
Rf = 0.11 (Isohexane: EtOAc 10:1). 
 
mp (EtOAc) = 81.3 – 82.2 °C. 
 
1H NMR (300 MHz, CDCl3): δ 6.77 (d, J = 8.4 Hz, 1H), 6.60 (d, J = 8.4 Hz, 1H), 
3.80 (s, 3H), 3.78 (s, 3H), 3.61 (s, 2H), 1.01 (s, 9H), 0.15 (s, 6H) ppm. 
 
13C NMR (75 MHz, CDCl3): δ 176.2(*), 151.7, 150.2, 138.5, 122.1, 119.9, 107.1, 
60.2, 55.3, 35.5, 25.8, 18.6, –4.6 ppm. 
 
(*) obscured C detected by HMBC 
 
IR (ATR): ṽ = 2930, 2858, 1717, 1499, 1466, 1095, 1010, 838 cm–1. 
 
HRMS (ESI):  calcd. for C16H25O5Si– [M–H]–:  325.1471,  
found:      325.1477. 
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3,4-bis(tert-butyldimethylsilyloxy)benzaldehyde (61)[54] 
 
 
 
 
 
To a stirred solution of benzaldehyde 60 (5.03 g, 36.4 mmol, 1 eq.) in DMF (20 mL) 
was added TBSCl (16.5 g, 109 mmol, 3 eq.) imidazole (14.9 g, 218 mmol, 6 eq.), 4-
dimethylaminopyridine (1.33 g, 10.9 mmol, 0.3 eq.) at 0 °C. The reaction mixture was 
allowed to warm to room temperature and was stirred for 7 h. After completion, H2O 
(100 mL) was added to the reaction mixture and was extracted with Et2O (3 × 130 
mL). The combined organic extracts were washed with aq. NaCl (10%, 2 × 70 mL), 
sat. aq. NaCl (70 mL) and dried (MgSO4). The crude product was purified by flash 
column chromatography [Isohexane:EtOAc 30:1] to afford TBS-benzaldehyde 61 
(11.1 g, 83%) as yellow needles. 
 
Rf : 0.49 (Isohexane:EtOAc 10:1). 
 
mp (EtOAc): 45.3 – 47.1 °C.  
 
1H NMR (300 MHz, CDCl3): δ 9.81 (s, 1H), 7.39 – 7.34 (m, 2H), 6.96 – 6.92 (m, 1H), 
1.00 (s, 9H), 1.00 (s, 9H), 0.25 (s, 6H), 0.23 (s, 6H) ppm. 
 
13C NMR (75 MHz, CDCl3): δ 191.0, 153.5, 147.8, 130.9, 125.4, 121.0, 120.7, 26.0, 
26.0, 18.7, 18.6, –3.9, –4.0 ppm. 
 
IR (ATR): ṽ = 2952 (m), 2928 (m), 2856 (m), 1694 (s), 1592 (s), 1506 (s), 1284 (s), 
1251 (s), 1151 (s), 896 (s), 802 (s), 778 (s) cm–1. 
 
HRMS (ESI):  calcd. for C19H35O3Si2+ [M+H]+:   367.2119, 
found:       367.2119. 
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3,4-bis((tert-butyldimethylsilyl)oxy)phenyl formate (62) 
 
 
 
 
 
To a stirred solution of benzaldehyde 61 (500 mg, 1.36 mmol, 1 eq.) in CH2Cl2 (10 
mL) was added mCPBA (352 mg, 2.04 mmol 1.5 eq.). The reaction mixture was 
refluxed for 6 h 20 min at 60 °C, then diluted with aq. NaHCO3 (5 % w/v, 10 mL) and 
extracted with EtOAc (3 × 15 mL). The combined organic extracts were dried 
(MgSO4) and concentrated in vacuo. 62 was obtained as yellow oil (0.532 g, 98%) 
and used for the next reaction without purification. 
 
Rf = 0.28 (Isohexane: EtOAc 30:1). 
 
1H NMR (300 MHz, CDCl3): δ 9.79 (s, 1H), 8.23 (s, 1H), 6.78 (d, J = 8.6 Hz, 1H), 
6.57 (d, J = 8.6 Hz, 1H), 0.99 – 0.94 (m, 18H), 0.20 – 0.16 (m, 12H) ppm. 
 
13C NMR (75 MHz, CDCl3): δ 159.6, 147.4, 145.3, 143.6, 120.8, 114.1, 113.4, 25.9, 
25.9, 18.4 (2C), –4.1, –4.2 ppm. 
 
IR (ATR): ṽ = 2930, 2859, 1691, 1574, 1473, 1094, 897, 837 cm–1. 
 
HRMS (ESI):  calcd. for C19H33O4Si2– [M–H]–:  381.1917,  
found:       381.1923. 
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3,4-bis((tert-butyldimethylsilyl)oxy)phenol (64) 
 
 
 
 
 
To benzaldehyde 61 (499 mg, 1.36 mmol, 1 eq.) in CH2Cl2 (10 mL) was added 
mCPBA (0.352 mg, 2.04 mmol, 1.5 eq.). The reaction mixture was stirred at 60 °C for 
5 h. To the reaction mixture was added aq. NaHCO3 (5% w/v; 10 mL) and was 
extracted with EtOAc (3 ×  15 mL). The organic phases were concentrated in vacuo 
and a mixture of aq. KOH (5%w/v)/MeOH (4:1, 15 mL) was added and stirred at 
room temperature for 1 h 40 min. The reaction mixture was acidified with aq. HCl (2 
M, 4 mL) and was extracted with EtOAc (3 ×  15 mL). The organic phases were 
washed with sat. aq. NaHCO3 (15 mL), sat. aq. NaCl (15 mL) and dried (MgSO4). 
The crude product was purified by flash column chromatography [Isohexane:EtOAc 
20:1] to afford phenol 64 (428 mg, 89%) as a white wax. 
 
Rf = 0.27 (Isohexane: EtOAc 4:1). 
 
1H NMR (300 MHz, CDCl3): δ 6.67 (d, J = 8.6 Hz, 1H), 6.37 (d, J = 3.0 Hz, 1H), 
6.28 (dd, J = 8.6, 3.0 Hz, 1H), 4.32 (s, 1H, OH), 0.98 (s, 9H), 0.97 (s, 9H), 0.20 (s, 
6H), 0.16 (s, 6H) ppm. 
 
13C NMR (75 MHz, CDCl3): δ 149.9, 147.6, 141.2, 121.4, 109.0, 107.8, 26.2, 26.2, 
18.7, 18.6, –3.9, –3.9 ppm. 
 
IR (ATR): ṽ = 3185 (br), 2928 (s), 2885 (m), 2857 (s), 1600 (w), 1510 (s), 1453 (s), 
1361 (w), 1312 (w), 1253 (s), 1226 (s), 1174 (s), 1112 (m), 989 (s), 926 (w), 902 (s), 
838 (s), 776 (s), 695 (m) cm–1. 
 
HRMS (ESI):  calcd. for C18H33O3Si2– [M–H]–:  353.1974,  
found:       353.1967. 
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4,5-bis((tert-butyldimethylsilyl)oxy)-2-hydroxybenzaldehyde (63) 
 
 
 
 
 
a) Fries rearrangement 
To a stirred solution of formylester 62 (100 mg, 0.261 mmol, 1 eq.) in CH2Cl2 (3 mL) 
was added BCl3 (0.316 mL, 1 M in CH2Cl2, 1.2 eq.) at –12 °C. The reaction mixture 
was maintained at –10 °C for 30 min, then warmed up to 0 °C during 1 h. The mixture 
was stirred 2 h at 0 °C, 2 h at room temperature, 1 h at 30 °C and 1 h at 40 °C. After 
the mixture was stirred at 50 °C for 2 h CH2Cl2 was evaporated and replaced by 
dichloroethane. After 24 h at 60 °C, the mixture was diluted with H2O (10 mL) and 
extracted with EtOAc (3 x 15 mL). The combined organic extracts were washed with 
sat. aq. NaCl (12 mL), dried (Na2SO4) and concentrated in vacuo. Flash column 
chromatography (Isohexane: EtOAc 10:1) afforded 63 (26 mg, 26%) as a white solid. 
 
b) Directed ortho-formylation 
To a stirred solution of phenol 64 (3.41 g, 9.61 mmol, 1 eq.) in THF (96 mL) was 
added MgCl2 (1.83 g, 19.2 mmol, 2.0 eq.), NEt3 (2.67 mL, 19.2 mmol, 2.0 eq.) and 
paraformaldehyde (866 mg, 28.8 mmol, 3.0 eq.). The reaction mixture was stirred at 
60 °C for 4 h. After completion, sat. aq. NH4Cl (50 mL) was added to the reaction 
mixture and was extracted with EtOAc (3 ×  100 mL), washed with sat. aq. NaCl (6 
mL) and dried (MgSO4). The crude product was purified by flash column 
chromatography [Isohexane:EtOAc 20:1] to afford 63 (3.18 g, 86%) as a white solid. 
 
Rf: 0.71 (Isohexane: EtOAc 4:1). 
 
mp (EtOAc) = 72.8 – 73.8 °C. 
 
1H NMR (300 MHz, CDCl3): δ 11.02 (s, 1H, OH), 9.61 (s, 1H), 6.88 (s, 1H), 6.39 (s, 
1H), 1.00 – 0.94 (m, 18H), 0.28 – 0.15 (m, 12H) ppm. 
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13C NMR (75 MHz, CDCl3): δ 194.1, 158.2, 156.3, 140.6, 123.3, 114.5, 108.4, 25.9, 
25.8, 18.6, 18.4, –4.0, –4.2 ppm. 
 
IR (ATR): ṽ = 2930, 2897, 2858, 1651, 1497, 1350, 885, 861 cm–1. 
 
HRMS (ESI):  calcd. for C19H33O4Si2– [M–H]–:   381.1917,  
found:       381.1920 
 
 
 
 
3-(3-acetoxy-2,4-dimethoxyphenyl)-2-oxo-2H-chromene-6,7-diyl diacetate (65) 
 
 
 
 
 
To a stirred solution of acid 59 (100 mg, 306 µmol, 1 eq.) and benzaldehyde 63 (117 
mg, 306 µmol, 1 eq.) in acetic anhydride (0.5 mL) was added potassium acetate (54.0 
mg, 551 µmol, 1.8 eq.). The reaction mixture was heated to 135 °C for 1 h. After 
completion, reaction mixture was cooled to room temperature, added to sat. aq. 
NaHCO3 (10 mL) and was extracted with EtOAc (3 × 15 mL). The combined organic 
extracts were washed with sat. aq. NaCl (10 mL) and dried (Na2SO4). The crude 
product was purified by flash column chromatography [Isohexane:EtOAc 3:2] to 
afford acetoxy-santalin AC 65 (33.0 mg, 24 %) as a pale yellow solid. 
 
Rf : 0.60 (CH2Cl2:MeOH 99:1). 
 
mp (EtOAc): 85.3 – 89.7 °C.  
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1H NMR (600 MHz, CDCl3): δ 7.76 (s, 1H), 7.33 (s, 1H), 7.30 (d, J = 8.7 Hz, 1H), 
7.24 (s, 1H), 6.79 (d, J = 8.7 Hz, 1H), 3.86 (s, 3H), 3.73 (s, 3H), 2.37 (s, 3H), 2.34 (s, 
3H), 2.32 (s, 3H) ppm. 
 
13C NMR (150 MHz, CDCl3): δ 168.7, 168.4, 167.8, 160.3, 153.4, 151.5, 151.4, 
144.6, 141.0, 139.1, 133.4, 128.2, 125.3, 121.8, 121.1, 117.9, 112.1, 107.4, 61.6, 56.5, 
20.9, 20.8, 20.8 ppm. 
 
IR (ATR): ṽ = 3071 (w), 2942 (w), 1764 (s), 1719 (s), 1605 (m), 1497 (m), 1423 (m), 
1370 (m), 1290 (m), 1206 (s), 1187 (s), 1170 (s), 1094 (s), 1003 (s), 913 (s), 816 (m) 
cm–1. 
 
HRMS (ESI):  calcd. for C23H21O10+ [M+H]+:   457.1129, 
found:       457.1134. 
 
 
 
 
6,7-dihydroxy-2H-chromen-2-one (esculetin) (71)[30] 
 
 
 
 
 
1,2,4-Triacetoxybenzene (69) (10.0 g, 39.7 mmol, 1 eq.) and malic acid (70) (5.85 g, 
43.6 mmol, 1.1 eq.) were mixed in solid state and ground. After obtaining a fine 
powder, conc. H2SO4 (16 mL) was added and the resulting mixture was stirred at 
room temperature. After 10 min, the reaction mixture was heated to 120 °C for 
2 h 30 min. The resulting mixture was poured into ice water (200 mL) and was cooled 
for 10 h at 0 °C. The resulting brown precipitate was collected and the filtrate was 
extracted with EtOAc (3 × 200 mL). The organic extracts were combined with the 
filtride and dried (Na2SO4). The crude product was purified by flash column 
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chromatography [CH2Cl2:MeOH 19:1] to afford esculetin (71) (3.68 g, 52%) as a 
yellow powder. 
 
Rf: 0.23 (CH2Cl2:MeOH 19:1).  
 
mp (MeOH): 268.9 – 271.0 °C.  
 
1H NMR (400 MHz, d6-acetone): δ 8.65 (br, 2H, OH), 7.77 (dd, J = 9.6, 0.4 Hz, 1H), 
7.05 (s, 1H), 6.77 (d, J = 0.4 Hz, 1H), 6.14 (d, J = 9.6 Hz, 1H) ppm.  
 
13C NMR (100 MHz, d6-acetone): δ 161.4, 150.7, 150.4, 144.6, 143.4, 113.4, 113.2, 
112.5, 103.7 ppm.  
 
IR (ATR): ṽ = 3324 (m), 3191 (m), 3059 (m), 1663 (s), 1608 (s), 1566 (s), 1466 (w), 
1400 (m), 1388 (m), 1364 (m), 1283 (s), 1198 (m), 1147 (m), 1103 (w), 946 (w), 878 
(w), 848 (w), 818 (w), 669 (w), 632 (w) cm–1. 
 
HRMS (ESI):  calcd. for C9H5O4– [M–H]–:  177.0193, 
found:     177.0195. 
 
 
 
 
3-bromo-6,7-dihydroxy-2H-chromen-2-one (72) 
 
 
 
 
 
To a stirred solution of esculetin (71) (3.08 g, 17.3 mmol, 1 eq.) in acetic acid (70 
mL) was added bromine (960 µL, 19.0 mmol, 1.1 eq.) in acetic acid (70 mL) 
dropwise at 0 °C. After 10 h of stirring at the stated temperature the reaction mixture 
O OHO
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was poured into H2O (100 mL). Reaction mixture was extracted with EtOAc (3 × 120 
mL) and the combined organic extractions were washed with sat. aq. NaCl (100 mL). 
Concentration in vacuo and subsequent flash column chromatography [CH2Cl2: 
MeOH 99:1] afforded bromide 72 (3.78 g, 85 %) as pale brown solid. 
 
Rf: 0.24 (CH2Cl2: MeOH 15:1). 
 
mp (acetone): 205.9 – 215.7 °C. 
 
1H NMR (400 MHz, d6-acetone): δ 8.86 (br, 2H, OH), 8.25 (s, 1H), 7.07 (s, 1H), 6.83 
(s, 1H) ppm. 
 
13C NMR (100 MHz, d6-acetone):  δ 158.3, 151.7, 150.2, 146.4, 144.4, 113.6, 113.0, 
108.1, 104.0 ppm. 
 
IR (ATR): ṽ = 3194 (w), 2954 (m), 2869 (m), 1695 (s), 1616 (s), 1550 (s), 1506 (s), 
1387 (s), 1277 (s), 1150 (s), 972 (s), 884 (s), 861 (s), 753 (s) cm–1. 
 
HRMS (ESI):  calcd. for C9H4BrO4– [M–H]–:   254.9298, 
found:       254.9300. 
 
 
 
 
3-bromo-6,7-bis((tert-butyldimethylsilyl)oxy)-2H-chromen-2-one (67) 
 
 
 
 
 
To a stirred solution of bromo esculetin 72 (2.00 g, 7.78 mmol, 1 eq.) in DMF (40 
mL) at 0 °C was added tert-butyldimethylsilylchloride (3.52 g, 23.3 mmol, 3.0 eq.), 
imidazole (2.38 g, 35.0 mmol, 4.5 eq.) and 4-dimethylaminopyridine (0.285 g, 2.33 
O OTBSO
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mmol, 0.3 eq.). The reaction mixture was allowed to come to room temperature and 
was stirred for additional 3 h. After completion of the reaction, the mixture was 
diluted with H2O (50 mL) and extracted with Et2O (3 × 100 mL). The combined 
organic extracts were washed with brine (20 mL) and dried (Na2SO4). Flash column 
chromatography [Isohexane: EtOAc 40:1] afforded TBS protected coumarin 67 (3.72 
g, 82%) as pale yellow solid. 
 
Rf: 0.36 (Isohexane:EtOAc 10:1). 
 
mp (EtOAc): 160.2 – 163.8°C. 
 
1H NMR (300 MHz, CDCl3): δ 7.94 (s, 1H), 6.82 (s, 2H), 0.99 (s, 9H), 0.99 (s, 9H), 
0.26 (s, 6H), 0.21 (s, 6H) ppm. 
 
13C NMR (75 MHz, CDCl3): δ 157.7, 151.7, 148.8, 144.8, 144.2, 116.7, 113.1, 108.4, 
108.3, 25.8, 25.8, 18.6, 18.4, –4.08, –4.21 ppm. 
 
IR (ATR): ṽ = 3052 (w), 2927 (m), 2894 (w), 2856 (w), 1718 (s), 1611 (w), 1545 (m), 
1501 (s), 1470 (m), 1361 (s), 1282 (s), 1248 (s), 1156 (s), 973 (s), 885 (s), 837 (s), 
777 (s) cm–1. 
 
HRMS (ESI):  calcd. for C21H34O4BrSi2+ [M+H]+:   485.1174, 
found:       485.1179. 
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6,7-bis((tert-butyldimethylsilyl)oxy)-2H-chromen-2-one (73)  
 
 
 
 
 
To a stirred solution of esculetin (71) (3.50 g, 19.5 mmol, 1 eq.) in DMF (30 mL) was 
added TBSCl (8.86 g, 58.0 mmol, 3.0 eq.), imidazole (8.00 g, 116 mmol, 6.0 eq.) and 
4-dimethylaminopyridine (0.720 g, 5.88 mmol, 30 mol-%) at 0 °C. The reaction 
mixture was allowed to warm to room temperature and was stirred for 3 h. After 
completion, the reaction mixture was diluted with H2O (70 mL) and extracted with 
Et2O (3 × 100 mL). The combined organic extracts were washed with aq. NaCl (10%, 
3 × 50 mL), sat. aq. NaCl (40 mL) and dried (MgSO4). The crude product was 
purified by flash column chromatography [Isohexane:EtOAc 30:1] to provide 
coumarin 73 (7.68 g, 96%) as a pale yellow solid. 
 
Rf: 0.29 (Isohexane:EtOAc 10:1). 
 
mp (EtOAc): 76.8 – 78.6 °C. 
 
1H NMR (400 MHz, CDCl3): δ 7.55 (d, J = 9.5 Hz, 1H), 6.85 (s, 1H), 6.82 (s, 1H), 
6.25 (d, J = 9.5 Hz, 1H), 1.00 (s, 9H), 0.99 (s, 9H), 0.26 (s, 6H), 0.21 (s, 6H) ppm. 
 
13C NMR (100 MHz, CDCl3): δ 162.0, 151.9, 150.1, 144.8, 143.7, 118.2, 113.1, 
112.5, 109.0, 26.4, 26.4, 19.1, 19.0, –3.5, –3.7 ppm.  
 
IR (ATR): ṽ = 2955 (m), 2931 (m), 2887 (m), 2362 (w), 2340 (w), 1733 (s), 1617 (m), 
1553 (m), 1507 (m), 1472 (m), 1430 (w), 1386 (m), 1363 (w), 1292 (m), 1260 (m), 
1233 (w), 1148 (s), 1097 (m), 1006 (w), 943 (m), 888 (m), 831 (m), 783 (m) cm–1.  
 
HRMS (ESI):  calcd. for C21H35O4Si2+ [M+H]+: 407.2068, 
found:      407.2067. 
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6,7-bis((tert-butyl(dimethylsilyl)oxy)-3-iodo-2H-chromen-2-one (74)  
 
 
 
 
 
To a stirred ZnCl2 solution (1.0 M in THF, 270 µL, 27 µmol, 0.55 eq.) was added 
TMP·MgCl·LiCl (1.0 M in THF/toluene, 540 µL, 540 µmol, 1.1 eq.) dropwise at room 
temperature. The resulting mixture was stirred for 30 min followed by the addition of 
coumarin 73 (200 mg, 490 µmol, 1 eq.). The mixture was stirred for 7 h 30 min at 
room temperature. Afterwards iodine solution (1.0 M in THF, 540 µL, 540 µmol, 1.1 
eq.) was added and stirred for 15 h at room temperature. The mixture was diluted with 
H2O (30 mL) and extracted with EtOAc (3 × 60 mL). The combined organic extracts 
were washed with sat. aq. NaCl solution (50 mL) and dried (MgSO4). The crude 
product was purified by flash column chromatography [Isohexane: EtOAc 30:1] to 
provide iodide 74 (130 mg, 50%) as a yellow powder.  
 
Rf: 0.68 (Isohexane: EtOAc 7:1).  
 
mp (EtOAc): 153.3 – 155.1 °C. 
 
1H NMR (300 MHz, CDCl3): δ 8.21 (s, 1H), 6.83 (s, 2H), 1.02 (s, 9H), 1.01 (s, 9H), 
0.29 (s, 6H), 0.23 (s, 6H) ppm.  
 
13C NMR (75 MHz, CDCl3): δ 158.1, 152.0, 151.8, 149.6, 144.6, 116.4, 114.1, 108.2, 
81.9, 25.8 (2C), 18.6, 18.4, –4.1, –4.2 ppm.  
 
IR (ATR): ṽ = 2951 (m), 2928 (s), 2894 (m), 2856 (m), 2360 (w), 2331 (w), 1710 (s), 
1613 (w), 1539 (m), 1500 (s), 1471 (m), 1409 (m), 1392 (w), 1361 (m), 1283 (s), 
1248 (s), 1181 (m), 1157 (m), 1124 (s), 1000 (w), 963 (m), 919 (m), 886 (m), 836 (s), 
806 (m), 778 (s), 748 (m), 680 (m) cm–1.  
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HRMS (ESI):  calcd. for C21H34IO4Si2+ [M+H]+:   533.1035,  
found:       533.1034. 
 
 
 
 
(3-((tert-butyldimethylsilyl)oxy)-2,4-dimethoxyphenyl)boronic acid (68)[31] 
 
 
 
 
 
a) Synthesis from bromide 75  
To a stirred solution of bromide 75 (300 mg, 0.860 mmol, 1 eq.) in Et2O (23 mL) was 
added t-BuLi (1.7 M in pentane, 1.00 mL, 1.72 mmol, 2.0 eq-) at –85 °C. The reaction 
mixture was stirred for 30 min at this temperature. Then triisopropyl borate (300 µL, 
1.29 mmol, 1.5 eq.) was added dropwise and the resulting mixture was stirred for 20 
min at –85 °C and for additional 20 min at room temperature. During this reaction 
time a white solid precipitated. The organic solvent was removed in vacuo and the 
residual white solid was hydrolyzed in aq. MeOH (10 mL) on silica gel at 45 °C on a 
rotary evaporator. Flash column chromatography [Isohexane:EtOAc 10:1 →  4:1] 
afforded arylboronic acid 76 (226 mg, 84 %) as small colorless needles.  
 
b) Synthesis by ortho-directed metalation of phenol 178  
To a stirred solution of TMEDA (780 µL, 5.22 mmol, 1.4 eq.) in isohexane (4.5 mL) 
was added n-BuLi (2.5 M in hexane, 1.79 mL, 4.48 mmol, 1.2 eq.) dropwise at 0 °C. 
The resulting solution was stirred at this temperature for 30 min. Then the solution 
was cooled down to –14 °C and TBS phenol 178 (1.00 g, 3.73 mmol, 1 eq.) was 
added slowly over 45 min. After stirring for 1 h at –14 °C the reaction mixture was 
allowed to warm to room temperature for 18 h followed by the addition of 
triisopropyl borate (1.19 g, 6.34 mmol, 1.7 eq.) at 0 °C. The resulting solution was 
stirred for 20 min at 0 °C and for 20 min at room temperature. Subsequently the 
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reaction mixture was diluted with sat. aq. NH4Cl (20 mL) and extracted with Et2O (3 
× 30 mL). The combined organic extracts were washed with sat. aq. NaCl solution (15 
mL) and dried (MgSO4). Flash column chromatography [Isohexane: EtOAc 8:1] 
afforded arylboronic acid 68 (180 mg, 15 %) as small colorless needles. 
 
Rf: 0.35 (Isohexane:EtOAc 4:1). 
 
mp (EtOAc): 112.3 – 113.8 °C. 
 
1H NMR (300 MHz, CDCl3): δ 7.42 (d, J = 8.3 Hz, 1H), 6.73 (d, J = 8.3 Hz, 1H), 
5.88 (br, 2 OH), 3.90 (s, 3H), 3.85 (s, 3H), 1.05 (s, 9H), 0.16 (s, 6H) ppm.  
 
13C NMR (75 MHz, CDCl3): δ 157.3, 154.9, 137.2, 128.4, 114.9, 107.7, 61.0, 76.6, 
25.8, 18.6, –4.6 ppm.  
 
IR (ATR): ṽ = 3475 (m), 3377 (m), 3209 (m), 2999 (w), 2947 (m), 2927 (s), 2895 
(m), 2857 (m), 1593 (m), 1502 (m), 1459 (s), 1425 (s), 1361 (m), 1339 (s), 1299 (m), 
1250 (m), 1234 (m), 1214 (m), 1091 (s), 1053 (m), 1008 (m), 956 (m), 911 (m), 831 
(s), 814 (m), 785 (m), 778 (m), 752 (m), 677 (m) cm–1.  
 
HRMS (ESI):  calcd. for C14H26BO7Si– [M+formiat]–:  357.1546, 
found:       357.1545. 
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6,7-bis((tert-butyldimethylsilyl)oxy)-3-(3´-((tert-butyldimethylsilyl)oxy)-2´,4´-
dimethoxyphenyl)-2H-chromen-2-one (66)  
 
 
 
 
 
To a stirred solution of coumarin 73 (1.06 g, 2.60 mmol, 1.3 eq.) in toluene (10 mL) 
was added freshly prepared TMP2Zn•MgCl2•2LiCl solution[4a] (0.37 M in THF, 3.90 
mL, 1.45 mmol, 0.73 eq.) dropwise at 0 °C. The reaction mixture was allowed to 
warm to room temperature and was stirred for 1 h. After complete zincation, the 
reaction solution was degassed and a degassed solution of bromide 75 (659 mg, 2.00 
mmol, 1 eq.) in toluene (5 mL) was added. After subsequent addition of Pd(OAc)2 
(23.0 mg, 100 µmol, 5 mol-%) and SPhos (82.0 mg, 200 µmol, 10 mol-%), the 
reaction mixture was heated to 65 °C for 2 h. After completion, sat. aq. NH4Cl (15 
mL) was added and the mixture was extracted with Et2O (3 × 30 mL). The combined 
organic extracts were washed with sat. aq. NaCl (20 mL) and dried (Na2SO4). The 
crude product was purified by flash column chromatography [Isohexane:EtOAc 50:1] 
to afford coumarin 66 (1.13 g, 84%) as a pale white solid. 
 
Rf: 0.57 (Isohexane:EtOAc 7:1).  
 
mp (EtOAc): 54.1 – 56.8 °C. 
 
1H NMR (600 MHz, CDCl3): δ 7.59 (s, 1H), 6.96 (d, J = 8.6 Hz, 1H), 6.87 (s, 1H), 
6.84 (s, 1H), 6.66 (d, J = 8.6 Hz, 1H), 3.81 (s, 3H), 3.74 (s, 3H), 1.02 (s, 9H), 0.99 (s, 
18H), 0.26 (s, 6H), 0.20 (s, 6H), 0.17 (s, 6H) ppm.  
 
13C NMR (150 MHz, CDCl3): δ 161.9, 152.8, 150.7, 150.2, 149.5, 144.6, 141.9, 
138.9, 122.9, 122.6, 122.1, 118.1, 113.8, 108.6, 107.3, 60.9, 55.8, 26.3 (2C), 26.3, 
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19.1, 19.1, 18.9, –3.6, –3.8, –4.1 ppm.  
 
IR (ATR): ṽ = 2953 (s), 2930 (s), 2897 (m), 2858 (s), 1730 (m), 1615 (w), 1564 (w), 
1499 (m), 1462 (m), 1427 (m), 1372 (w), 1327 (w), 1253 (m), 1205 (w), 1161 (w), 
1127 (w), 1095 (m), 1007 (w), 950 (m), 917 (w), 837 (m), 803 (m), 779 (m) cm–1. 
 
HRMS (ESI):  calcd. for C35H57O7Si3+ [M+H]+:   673.3407, 
found:       673.3406. 
 
 
 
 
santalin AC (21) 
 
 
 
 
 
a) deprotection from acetoxy santalin AC 65 
To a stirred solution of acetoxy-coumarin 65 (20.0 mg, 44.0 µmol, 1 eq.) in MeOH (1 
mL) was added aq. HCl (2 M, 2 mL) at room temperature. Reaction mixture was 
heated to 100 °C for 1 h 30 min. After completion, the reaction mixture was cooled to 
0 °C. After 1 h the formed precipitate was collected by sedimentation with a 
centrifuge and washed with MeOH (2 ×  0.5 mL), which afforded santalin AC (21) 
(13.0 mg, 89%) as a yellow powder. 
 
b) deprotection from TBS santalin AC 66 
To a stirring solution of TBS-coumarin 66 (100 mg, 148 µmol, 1 eq.) in THF (3 mL) 
was added TBAF (1 M solution in THF, 488 µL, 488 µmol, 3.3 eq.) at 0 °C. Reaction  
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mixture was stirred at this temperature for 20 min. After completion, H2O (4 mL) was 
added and the biphasic mixture was extracted with EtOAc (2 × 7 mL). The combined 
organic extracts were washed with sat. aq. NaCl (3 mL) and dried (Na2SO4). The 
crude product was purified by precipitation with MeOH (1 mL). The precipitate was 
collected by sedimentation using a centrifuge. Purification was achieved by washing 
the precipitate with MeOH (2 × 0.3 mL), which afforded santalin AC (21) (31.0 mg, 
63%) as a yellow powder. 
 
Rf: 0.13 (CH2Cl2:MeOH 10:1).  
 
mp (MeOH): 289 °C decomp. 
 
1H NMR (400 MHz, d6-DMSO): δ 10.18 (s, 1H, OH), 9.39 (s, 1H, OH), 8.73 (s, 1H, 
OH), 7.75 (s, 1H), 7.00 (s, 1H), 6.77 (s, 1H), 6.76 (d, J = 8.5 Hz, 1H), 6.71 (d, J = 8.5 
Hz, 1H), 3.81 (s, 3H), 3.64 (s, 3H) ppm.  
 
13C NMR (100 MHz, d6-DMSO): δ 160.8, 150.3, 149.5, 148.4, 146.5, 143.2, 142.2, 
139.5, 122.9, 121.9, 120.3, 112.7, 111.7, 107.3, 102.7, 60.1, 56.4 ppm.  
 
IR (ATR): ṽ = 2960 (m), 2875 (w), 1730 (s), 1573 (m), 1462 (m), 1372 (m), 1289 
(m), 1238 (s), 1089 (s), 1044 (s) cm–1. 
 
HRMS (ESI):  calcd. for C17H15O7+ [M+H]+:   331.0812, 
found:       331.0811. 
 
Number 1H (synthetic) 13C (Synthetic) 1H (Isolated)[2] 13C (Isolated)[2] 
OH 10.18 (s)  -  
OH 9.39 (s)  -  
OH 8.73 (s)  -  
1  160.8  160.3 
2  121.9  122.3 
3 7.75 (s, 1H) 142.2 7.73 (s, 1H) 141.7 
4 7.00 (s, 1H) 112.7 7.00 (s, 1H) 111.9 
5  143.2  143.6 
6  150.3  151.5 
7 6.77 (s, 1H) 102.7 6.67 (s, 1H) 99.7 
8  148.4  147.9 
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9  111.7  112.0 
10  122.9  122.4 
11  146.5  146.1 
12  139.5  139.1 
13  149.5  149.2 
14 6.76 (d, J = 8.5 
Hz, 1H) 
107.3 6.75 (d, J = 8.5 
Hz, 1H) 
106.9 
15 6.71 (d, J = 8.5 
Hz, 1H) 
120.3 6.71 (d, J = 8.5 
Hz, 1H) 
119.8 
16 3.64 (s, 3H) 60.1 3.64 (s, 3H) - 
17 3.81 (s, 3H) 56.4 3.81 (s, 3H) - 
 
 
 
 
6,7-bis((tert-butyldimethylsilyl)oxy)-3-(3´-((tert-butyldimethylsilyl)oxy)-2´,4´-
dimethoxyphenyl)-2H-chromen-2-ol (82)  
 
 
 
 
 
To a stirred solution of coumarin 66 (2.02 g, 3.00 mmol, 1 eq.) in CH2Cl2 (20 mL) 
was added DIBAL-H (1 M solution in CH2Cl2, 3.15 mL, 3.15 mmol, 1.05 eq.) 
dropwise (3 mL/h) at –78 °C and the reaction mixture was stirred for 1 h at this 
temperature. After completion, H2O (10 mL) was added at –78 °C and was allowed to 
warm to room temperature over a period of 20 min. The resulting slurry was extracted 
with Et2O (3 × 40 mL) the combined organic extracts were washed with sat. aq. NaCl 
solution (50 mL) and dried (Na2SO4). The crude product was purified by flash column 
chromatography [Isohexane:EtOAc 15:1] to provide 82 (1.72 g, 85%) as a pale 
yellow foam.  
 
Slow addition of DIBAL-H to a vigorously stirring solution is necessary, otherwise 
overreduction takes place! 
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Rf: 0.30 (Isohexane:EtOAc 10:1). 
 
1H NMR (600 MHz, d3-MeCN): δ 6.97 (d, J = 6.9 Hz, 1H), 6.92 (d, J = 6.9 Hz, 1H), 
6.81 (s, 1H), 6.79 (s, 1H), 6.79 (s, 1H), 6.08 (d, J = 6.0 Hz, 1H), 3.77 (s, 3H), 3.61 (s, 
3H), 1.00 (s, 9H), 0.97 (s, 9H), 0.96 (s, 9H), 0.18 (s, 6H), 0.14 (s, 6H), 0.11 (s, 6H) 
ppm.  
 
13C NMR (150 MHz, d3-MeCN): δ 151.5, 149.8, 146.8, 145.0, 140.7, 138.2, 129.4, 
124.7, 122.3, 121.6, 118.6, 115.8, 108.9, 108.0, 91.5, 60.3, 55.9, 26.2, 26.2, 26.1, 
18.8, 18.5, 18.5, –3.7, –3.8, –3.8, –3.8, –4.1, –4.2 ppm. 
 
IR (ATR): ṽ = 2952 (w), 1613 (w), 1570 (w), 1292 (m), 1252 (m), 1203 (w), 1165 
(w), 1040 (w), 988 (m), 777 (s), 682 (m) cm-1. 
 
HRMS (ESI):  calcd. for C35H57O6Si3+ [M–OH]+:  657.3457, 
  found:       657.3463. 
 
 
 
 
6,7-dihydroxy-3-(3-hydroxy-2,4-dimethoxyphenyl)chromenylium perchlorate 
(83) 
 
 
 
 
To a stirred solution of lactol 82 (500 mg, 740 µmol, 1 eq.) in acetic acid (5 mL) was 
added perchloric acid (aq. 65 %, 408 µL, 4.39 mmol, 6 eq.) at room temperature. The 
reaction mixture was stirred for 8 h, upon which precipitation started. After stirring 
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for an additional 1 h at room temperature, the reaction mixture was transferred into a 
falcon tube. The precipitate was collected by sedimentation using a centrifuge. 
Purification was achieved by washing the precipitate with CH2Cl2 (2 ×  0.5 mL), 
which afforded isoflavylium salt 83 (234 mg, 76%) as a pale orange powder. 
 
X-ray quality crystals were obtained by dissolving the orange salt in MeCN and then 
adding AcOH (1:1), followed by slow evaporation of the solvent at room temperature 
over time. 
 
Precipitation can be forced by addition of isoflavylium salt or scratching at glass 
wall! 
 
Rf: 0.50 (CH2Cl2:MeOH 10:1). 
 
UV (MeOH): λmax = 395 nm. 
 
mp (AcOH/MeCN): 189.3 – 190.7 °C. 
 
1H-NMR (400 MHz, d3-MeCN): δ  9.85 (s, 1H, OH), 9.41 (d, J = 2.1 Hz, 1H), 9.29 
(ddd, J = 2.1, 0.8, 0.4 Hz, 1H), 8.84 (s, 1H, OH) 7.63 (d, J = 0.8 Hz, 1H), 7.62 (s, 
1H), 7.05 (d, J = 8.6 Hz, 1H), 6.95 (d, J = 8.6 Hz, 1H), 6.85 (s, 1H, OH), 3.95 (s, 3H), 
3.74 (s, 3H) ppm. 
 
13C NMR (100 MHz, d3-MeCN): δ 162.7, 162.5, 157.3, 154.4, 151.4, 150.8, 146.2, 
140.9, 129.9, 124.6, 121.4, 119.3, 111.3, 109.3, 104.0, 61.8, 57.5 ppm. 
 
IR (ATR): ṽ = 3246 (w), 2348 (s), 1741, 1573 (s), 1408 (s), 1286 (s), 1100 (s), 1071 
(s), 824 (s) cm-1. 
 
HRMS (ESI):  calcd. for C17H15O6+ [M–ClO4]+:   315.0863, 
found:       315.0865. 
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6-hydroxy-3-(3-hydroxy-2,4-dimethoxyphenyl)-7H-chromen-7-one (30) 
 
 
 
 
 
To a stirred solution of isoflavylium perchlorate 83 (500 mg, 1.33 mmol, 1 eq.) in 
degassed MeCN (13 mL) was added di-tert-butylpyridine (320 µL, 1.40 mmol, 1.05 
eq.) in one portion at 0 °C. The reaction was stirred for 10 min, whereupon product 
precipitated. Reaction was stirred for 1 h and the precipitate was collected by 
sequential transfer into a falcon tube and by subsequent sedimentation in a centrifuge. 
The crude product was purified by washing the precipitate with cold MeCN (2 × 0.5 
mL), which afforded anhydrobase 30 (372 mg, 89%) as an orange powder.  
 
Rf: 0.48 (CH2Cl2:MeOH 10:1). 
 
UV (MeOH): λmax = 441 nm. 
 
mp (MeCN): 168.7 – 170.1 °C. 
 
1H NMR (400 MHz, CDCl3): δ 8.09 (d, J = 1.7 Hz, 1H), 7.86 (ddd, J = 1.7, 1.1, 0.5 
Hz, 1H), 6.83 (d, J = 0.5 Hz, 1H), 6.82 (d, J = 8.6 Hz, 1H), 6.74 (d, J = 8.6 Hz, 1H), 
6.67 (d, J = 1.1 Hz, 1H), 3.95 (s, 3H), 3.77 (s, 3H) ppm. 
 
13C NMR (100 MHz, CDCl3): δ  176.5, 158.9, 152.9, 148.6, 147.5, 144.8, 139.3, 
137.4, 123.8, 120.5, 120.4, 119.5, 107.0, 102.8, 101.4, 60.9, 56.6 ppm. 
 
IR (ATR): ṽ = 3447 (w), 3382 (w), 3089 (w), 2348 (w), 1525 (s), 1373 (s), 1283 (s), 
1052 (s), 851 (s), 808 (s) cm–1. 
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HRMS (ESI):  calcd. for C17H15O6+ [M+H]+:   315.0863, 
found:       315.0865. 
 
 
 
 
V.	  4. Experimental towards santalin Y and santalin Y 
benzoxanthenone 
 
3-(allyloxy)phenol (87)[55] 
 
 
 
 
 
To a stirred solution of resorcinol (86) (9.36 g, 85.0 mmol, 1 eq.) in DMF (50 mL) 
was added successively anhydrous K2CO3 (11.8 g, 85.0 mmol, 1 eq.) and potassium 
iodide (2.82 g, 17.0 mmol, 0.2 eq.). After stirring for 10 min, allylbromide (7.35 mL, 
85 mmol, 1 eq.) was added at room temperature. The reaction mixture was stirred for 
12 h and after completion, sat. aq. NH4Cl (150 mL) was added and extracted with 
CH2Cl2 (3 × 100 mL). The organic layers were washed with sat. aq. NaCl (40 mL) 
and dried (Na2SO4). Flash column chromatography [Isohexane:EtOAc 16:1 → 8:1] 
afforded mono allyl protected resorcinol 87 (5.73 g, 45 %) as a pale yellow oil. 
 
Rf: 0.14 (Isohexane:EtOAc 10:1). 
 
1H NMR (300 MHz, CDCl3): δ 7.13 (t, J = 8.3 Hz, 1H), 6.51 (ddd, J = 8.3, 2.2, 1.0 
Hz, 1H), 6.46 – 6.39 (m, 2H), 6.15 – 5.94 (m, 1H), 5.41 (dq, J = 17.3, 1.5 Hz, 1H), 
5.29 (dq, J = 17.3, 1.5 Hz, 1H), 4.71 (s, 1H, OH), 4.51 (dt, J = 5.3, 1.5 Hz, 2H) ppm. 
 
13C NMR (75 MHz, CDCl3): δ 160.2, 156.8, 133.4, 130.3, 117.9, 108.1, 107.5, 102.6, 
69.1 ppm. 
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IR (ATR): ṽ = 3375 (br), 3081 (w), 2983 (w), 2919 (w), 1592 (s), 1489 (s), 1456 (s), 
1422 (m), 1278 (s), 1171 (s), 1141 (s), 1022 (s), 993 (s), 925 (s), 827 (s), 759 (s) cm–1. 
 
HRMS (EI):  calc. for C9H10O2 [M]+:   150.0675, 
found:      150.0677. 
 
 
 
 
(3-(allyloxy)phenoxy)(tert-butyl)diphenylsilane (88)[36] 
 
 
 
 
 
To a stirred mixture of allyl resorcinol 87 (2.02 g, 13.4 mmol, 1 eq.) and DMF 
(20 mL) was added successively imidazole (1.54 g, 22.6 mmol, 1.7 eq.), and 
TBDPSCl (4.39 g, 16.0 mmol, 1.3 eq.). The reaction mixture was warmed to room 
temperature and stirred for additional 2 h. After completion H2O (30 mL) was added 
and was extracted with Et2O (4 × 40 mL), the organic extracts were washed with aq. 
NaCl (10%, 2 × 20 mL), sat. aq. NaCl (10 mL) and were dried (MgSO4). Purification 
of the crude product by flash column chromatography [Isohexane] afforded 88 (5.11 
g, 99%) as a colorless oil. 
 
Rf: 0.74 (Isohexane:EtOAc 10:1). 
 
1H NMR (300 MHz, CDCl3): δ 7.74 – 7.70 (m, 4H), 7.45 – 7.32 (m, 6H), 6.96 (t, J = 
8.3 Hz, 1H), 6.45 (ddd, J = 8.3, 2.2, 1.1 Hz, 1H), 6.38 – 6.35 (m, 2H), 5.92 (ddt, J = 
17.2, 10.6, 5.3 Hz, 1H), 5.27 (dq, J = 17.2, 1.6 Hz, 1H), 5.18 (dq, J = 10.6, 1.4 Hz, 
1H), 4.29 (dt, J = 5.4, 1.5 Hz, 2H), 1.10 (s, 9H) ppm. 
 
TBDPSO
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13C NMR (75 MHz, CDCl3): δ 159.7, 156.9, 135.8, 133.4, 133.2, 130.1, 129.7, 128.0, 
117.7, 112.6, 108.2, 106.7, 68.9, 26.8, 19.7 ppm. 
 
IR (ATR): ṽ = 3049 (w), 3070 (w), 2956 (w), 2930 (w), 2857 (w), 1593 (s), 1488 (s), 
1427 (s), 1289 (s), 1266 (s), 1175 (s), 1145 (s), 1112 (s), 1105 (s), 997 (s), 967 (s), 
925 (s), 834 (s), 821 (s), 698 (s) cm–1. 
 
HRMS (EI):  calc. for C25H28O2Si+ [M]+:   388.1853, 
found:      388.1860. 
 
 
 
 
2-allyl-5-((tert-butyldiphenylsilyl)oxy)phenol (91)[36] 
 
 
 
 
 
To a stirred solution of allyl ether 88 (999 mg, 2.68 mmol, 1 eq.) in n-hexane (10 mL) 
was added dropwise Et2AlCl (1 M in hexane, 5.36 mL, 5.36 mmol, 2 eq.) at 0 °C. 
After stirring for 50 min at 0 °C and 2 h at room temperature the mixture was cooled 
to 0 °C, acidified dropwise with aq. HCl (2 M, 20 mL) and extracted with Et2O (3 × 
60 mL). The combined organic extracts were dried (MgSO4) and concentrated in 
vacuo. Flash column chromatography [Isohexane: EtOAc 40:1] afforded 91 (632 mg, 
64%) as a colorless oil.  
 
Rf: 0.25 (Isohexane:EtOAc 10:1). 
 
1H NMR (400 MHz, CDCl3): δ 7.72 – 7.70 (m, 4H), 7.42 – 7.34 (m, 6H), 6.78 (d, J = 
8.6 Hz, 1H), 6.30 – 6.27 (m, 2H), 5.96 – 5.91 (m, 1H), 5.10 (t, J = 1.5 Hz, 1H), 5.07 
TBDPSO
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(dq, J = 6.3, 1.6 Hz, 1H), 4.72 (s, 1H, OH), 3.27 (dt, J = 6.3, 1.6 Hz, 2H), 1.08 (s, 9H) 
ppm. 
 
13C NMR (100 MHz, CDCl3): δ 155.6, 154.7, 137.0, 135.7, 133.2, 130.7, 130.1, 
128.0, 118.0, 116.3, 112.5, 107.7, 34.8, 26.7, 19.7 ppm. 
 
IR (ATR): ṽ = 3070 (w), 3957 (w), 2930 (m), 2857 (m), 1594 (s), 1488 (s), 1427 (s), 
1289 (s), 1266 (s), 1175 (s), 1145 (s), 1112 (s), 997 (s), 821 (s), 698 (s) cm–1. 
 
HRMS (ESI):  calc. for C25H27O2Si– [M–H]–:   387.1786, 
found:       387.1780. 
 
 
 
 
(4-allyl-3-methoxyphenoxy)(tert-butyl)diphenylsilane (92) 
 
 
 
 
 
To a stirred solution of phenol 91 (8.60 g, 22.1 mmol, 1 eq.) in CH2Cl2 (120 mL) 
were added molecular sieve 4Å (11 g), proton sponge (7.19 g, 53.0 mmol, 2.2 eq.) 
and trimethyloxonium tetrafluoroborate (11.4 g, 48.6 mmol, 2.2 eq.). After stirring for 
7 h at room temperature the reaction mixture was filtered and the filtrate was 
concentrated in vacuo. Flash column chromatography [Isohexane: EtOAc 100:0 → 
99:1] afforded 92 (2.39 g, 80 %) as a colorless oil.  
 
Rf: 0.69 (Isohexane:EtOAc 10:1). 
 
1H NMR (300 MHz, CDCl3): δ 7.75 – 7.70 (m, 4H), 7.46 – 7.33 (m, 6H), 6.81 (d, J = 
8.1 Hz, 1H), 6.31 (dd, J = 8.1, 2.3 Hz, 1H), 6.26 (d, J = 2.3 Hz, 1H), 5.92 (m, 1H), 
5.01 – 4.92 (m, 2H), 3.50 (s, 3H), 3.23 (d, J = 6.7 Hz, 2H), 1.11 (s, 9H) ppm. 
TBDPSO
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13C NMR (75 MHz, CDCl3): δ 157.8, 155.2, 137.6, 135.7, 133.3, 130.0, 129.8, 127.9, 
121.1, 115.0, 111.4, 103.3, 55.3, 33.7, 26.8, 19.7 ppm. 
 
IR (ATR): ṽ = 3071 (w), 2998 (w), 2955 (m), 2930 (m), 2856 (m), 1606 (s), 1584 (s), 
1502 (s), 1427 (s), 1290 (s), 1199 (s), 1159 (s), 1112 (s), 979 (s), 820 (s), 697 (s) cm-1. 
 
HRMS (ESI):  calcd. for C26H31O2Si+ [M+H]+:  403.2088,  
found:       403.2089. 
 
 
 
(3-(allyloxy)phenoxy)(tert-butyl)dimethylsilane (181)[56] 
 
 
 
 
 
To a stirred mixture of allyl resorcinol 87 (3.00 g, 20.0 mmol, 1 eq.) and DMF (25 
mL) was added successively imidazole (3.54 g, 52.0 mmol, 2.6 eq.), and TBSCl (3.92 
g, 26.0 mmol, 1.3 eq.). The mixture was warmed to room temperature and stirred for 
2 h. After completion H2O (30 mL) was added and was extracted with Et2O (4 × 40 
mL), the organic extracts were washed with aq. NaCl (10% w/v, 2 × 20 mL) and sat. 
aq. NaCl (10 mL) and dried (MgSO4). Purification of the crude product by flash 
column chromatography [Isohexane] afforded 181 (4.75 g, 90%) as a colorless oil. 
 
Rf: 0.69 (Isohexane:EtOAc 10:1). 
 
1H NMR (300 MHz, CDCl3): δ 7.11 (t, J = 7.9 Hz, 1H), 6.56 – 6.39 (m, 3H), 6.13 – 
5.95 (m, 1H), 5.40 (dq, J = 17.3, 1.6 Hz, 1H), 5.28 (dq, J = 10.5, 1.4 Hz, 1H), 4.51 (t, 
J = 1.7 Hz, 1H), 4.49 (t, J = 1.7 Hz, 1H0.98 (s, 9H), 0.20 (s, 6H) ppm. 
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13C NMR (75 MHz, CDCl3): δ 159.9, 157.0, 133.6, 129.9, 117.8, 113.0, 107.9, 107.4, 
69.1, 25.9, 18.4, –4.2 ppm. 
 
IR (ATR): ṽ = 2955 (m), 2928 (m), 2884 (w), 2857 (m), 1593 (s), 1488 (s), 1471 (s), 
1287 (s), 1257 (s), 1174 (s), 1144 (s), 998 (m), 834 (s), 778 (s) cm–1. 
 
HRMS (EI):  calcd. for C15H24O2Si+ [M]+:  264.1540, 
found:      264.1525. 
 
 
 
 
2-allyl-5-(tert-butyldimethylsilyloxy)phenol (182)[36] 
 
 
 
 
 
To a stirred solution of allyl ether 181 (2.43 g, 9.20 mmol, 1 eq.) in n-hexane (41 mL) 
was added dropwise Et2AlCl (1 M in hexane, 20.2 mmol, 20.2 mL, 2.2 eq.) at 0 °C. 
After stirring for 30 min at 0 °C and for 2 h at room temperature the mixture was 
cooled to 0 °C, acidified dropwise with aq. HCl (2 M, 10 mL) and extracted with Et2O 
(3 × 250 mL). The combined organic extracts were dried (MgSO4) and concentrated 
in vacuo. Flash column chromatography [Isohexane: EtOAc 45:1] afforded 182 (2.85 
g, 59%) as a colorless oil.  
 
Rf : 0.62 (Isohexane:EtOAc 7:1).  
 
1H NMR (300 MHz, CDCl3): δ 6.92 (d, J = 6.9 Hz, 1H), 6.40 – 6.35 (m, 2H), 6.04 – 
5.95 (m, 1H), 5.18 – 5.13 (m, 2H), 4.86 (s, 1H, OH), 3.33 (d, J = 3.3 Hz, 2H), 0.97 (s, 
9H), 0.19 (s, 6H) ppm.  
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13C NMR (75 MHz, CDCl3): δ 155.5, 154.8, 136.8, 130.6, 117.8, 116.2, 112.6, 108.0, 
34.7, 25.7, 18.2, –4.4 ppm.  
 
IR (ATR): ṽ = 3077 (w), 2955 (w), 1638 (m), 1614 (w), 1590 (w), 1292 (m), 1254 
(m), 986 (s), 866 (s) cm–1. 
 
HRMS (ESI):  calcd. for C15H25O2Si+ [M+H]+:   265.1618, 
found:      265.1627. 
 
 
 
 
(4-allyl-3-methoxyphenoxy)(tert-butyl)dimethylsilane (183)  
 
 
 
 
 
To a stirred solution of phenol 182 (2.85 g, 10.8 mmol, 1 eq.) in CH2Cl2 (50 mL) 
were added molecular sieve 4Å (5.5 g), proton sponge (5.70 g, 26.9 mmol, 2.5 eq.) 
and trimethyloxonium tetrafluoroborate (3.50 g, 23.7 mmol, 2.2 eq.). After stirring for 
4 h at room temperature the reaction mixture was filtered and the filtrate was 
concentrated in vacuo. Flash column chromatography [Isohexane] afforded 183 (2.39 
g, 80%) as a colorless oil.  
 
Rf : 0.63 (Isohexane: EtOAc 30:1).  
 
1H NMR (300 MHz, CDCl3): δ 6.94 (d, J = 7.0 Hz, 1H), 6.39 (d, J = 6.3 Hz, 1H), 
6.37 (s, 1H), 6.02 – 5.92 (m, 1H), 5.04 – 5.02 (m, 1H), 4.99 (t, J = 1.4 Hz, 1H), 3.78 
(s, 3H), 3.30 (d, J = 3.3 Hz, 2H), 0.99 (s, 9H), 0.20 (s, 6H) ppm.  
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13C-NMR (75 MHz, CDCl3): δ 157.9, 155.1, 137.5, 129.8, 121.3, 114.9, 111.4, 103.5, 
55.4, 33.6, 25.7, 18.2, –4.4 ppm. 
 
IR (ATR): ṽ = 2955 (w), 1638 (w), 1502 (s), 1289 (m), 1255 (m), 1199 (s), 1039 (m), 
977 (s), 777 (s) cm–1.  
 
HRMS (ESI):  calcd. for C16H27O2Si+ [M+H]+:   279.1775, 
found:       279.1782. 
 
 
 
 
4-allyl-3-methoxyphenol (84)[57] 
 
 
 
 
 
To a stirred solution of TBS protected phenol 183 (2.40 g, 8.6 mmol, 1 eq.) in THF (1 
mL) was added TBAF (1 M solution in THF, 9.30 mL, 9.30 mmol, 1.1 eq.) at 0 °C. 
The reaction mixture was stirred for 30 min at 0 °C. After completion, reaction 
mixture was diluted with H2O (10 mL) and was extracted with Et2O (3 × 15 mL). The 
crude product was purified by flash column chromatography [Isohexane/EtOAc 7:1] 
to afford 84 (1.00 g, 85%) of the pure product as a colorless oil.  
 
Rf: 0.16 (Isohexane:EtOAc 10:1) 
 
1H NMR (300 MHz, CDCl3): δ 6.96 (d, J = 6.9 Hz, 1H), 6.39 (d, J = 6.4 Hz, 1H), 
6.34 (dd, J = 6.4 Hz, 1H), 6.02 – 5.90 (m, 1H), 5.03 – 5.02 (m, 1H), 4.99 (t, 1H), 3.79 
(s, 3H), 3.29 (d, J = 3.3 Hz, 2H) ppm. 
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13C NMR (75 MHz, CDCl3): δ 158.2, 155.0, 137.3, 130.1, 120.8, 114.9, 106.5, 98.8, 
55.4, 33.5 ppm.  
 
IR (ATR): ṽ = 3325 (m), 3076 (w), 2935 (w), 1638 (w), 1597 (s), 1505 (s), 1277 (m), 
1234 (w), 1199 (s), 1152 (s), 827 (s) cm–1.  
 
HRMS (ESI): calcd. for C10H12O2+ [M+H]+:   164.0837,  
found:      164.0832. 
 
 
 
 
(4-vinyl-1,2-phenylene)bis(oxy)bis(tert-butyldimethylsilane) (94)[58] 
 
 
 
 
 
To a stirred solution of methyltriphenylphosphoniumbromide (1.08 g, 3.03 mmol, 1.1 
eq.) in THF (20 mL) was added n-BuLi (2.4 M in hexanes, 1.25 mL, 3.00 mmol, 1.1 
eq.) followed by dropwise addition of aldehyde 61 (1.00 g, 2.73 mmol, 1 eq.). After 4 
h sat. aq. NH4Cl (20 mL) was added and the mixture was extracted with CH2Cl2 (3 
×  40 mL). The combined organic extracts were dried (MgSO4) and concentrated in 
vacuo. Flash column chromatography [Isohexane] afforded styrene 94 (618 mg, 62%) 
as a pale yellow oil. 
 
Rf: 0.76 [Isohexane: EtOAc 16:1]. 
 
1H NMR (300 MHz, CDCl3): δ 6.90 (d, J = 2.2 Hz, 1H), 6.86 (ddd, J = 8.2, 2.2, 0.4 
Hz, 1H), 6.77 (d, J = 8.2 Hz, 1H), 6.59 (ddd, J = 17.6, 10.8, 0.4 Hz, 1H), 5.54 (dd, J = 
17.6, 1.0 Hz, 1H), 5.10 (dd, J = 10.8, 1.0 Hz, 1H), 1.00 (s, 9H), 0.99 (s, 9H), 0.21 (s, 
6H), 0.20 (s, 6H) ppm. 
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13C NMR (75 MHz, CDCl3): δ 147.1, 147.0, 136.6, 131.5, 121.1, 119.8, 118.9, 111.8, 
26.1, 26.1, 18.7, 18.6, –3.9, –3.9 ppm. 
 
HRMS (ESI):  calcd. for C20H37O2Si2+ [M+H]+:   365.2327, 
found:       365.2326. 
 
 
 
(4-(prop-1-enyl)-1,2-phenylene)bis(oxy)bis(tert-butyldimethylsilane) (93) 
 
 
 
 
 
To a stirred solution of ethyltriphenylphosphonium bromide (1.12 g, 3.03 mmol, 1.1 
eq.) in THF (20 mL) was added n-BuLi (2.4 M solution in hexanes, 1.25 mL, 3.00 
mmol, 1.1 eq.) followed by dropwise addition of aldehyde 61 (1.00 g, 2.73 mmol, 1 
eq.). After 4 h sat. aq. NH4Cl (20 mL) was added and the mixture was extracted with 
CH2Cl2 (3 ×  40 mL). The combined organic extracts were dried (MgSO4) and 
concentrated in vacuo. Flash column chromatography [Isohexane] afforded an 
inseparable mixture of E and Z isomers (1.7:1) of 93 (652 mg, 63%) as a pale yellow 
oil. 
 
Rf : 0.74 (Isohexane: EtOAc 16:1). 
 
1H NMR (300 MHz, CDCl3): δ 6.84 – 6.71 (m, 6H), 6.30 (dq, J = 11.6, 1.8 Hz, 1H), 
6.27 (dq, J = 15.7, 1.6 Hz, 1H), 6.03 (dq, J = 15.7, 6.6 Hz, 1H), 5.66 (dq, J = 11.6, 7.2 
Hz, 1H), 1.89 (dd, J = 7.2, 1.8 Hz, 3H), 1.84 (dd, J = 6.6, 1.6 Hz, 3H), 0.99 (s, 9H), 
0.99 (s, 9H), 0.99 (s, 9H), 0.98 (s, 9H), 0.21 (s, 6H), 0.20 (s, 6H), 0.20 (s, 6H), 0.19 
(s, 6H) ppm. 
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13C NMR (75 MHz, CDCl3): δ 146.9, 146.5, 146.1, 145.6, 131.8, 131.4, 130.7, 129.7, 
125.1, 123.7, 122.4, 121.7, 121.1, 120.8, 119.2, 118.6, 26.1, 26.1, 18.6, 18.5, –3.9, –
3.9 ppm. 
 
HRMS (ESI):  calcd. for C21H39O2Si2+ [M+H]+:   379.2483, 
found:       379.2482. 
 
 
 
 
(E)-4-(3-(3,4-bis(tert-butyldimethylsilyloxy)phenyl)allyl)-3-methoxyphenol (96)  
 
 
 
 
 
To a stirred solution of allylphenol 84 (1.00 g, 6.09 mmol, 1 eq.) and styrene 93 (2.30 
g, 6.09 mmol, 1 eq.) in CH2Cl2 (15 mL) was added Grubbs II catalyst (258 mg, 0.31 
mmol, 6 mol-%). The reaction mixture was stirred for 7 h at 50 °C in a pressure tube. 
After completion, the reaction mixture was concentrated in vacuo. The crude product 
was purified by flash column chromatography [Isohexane: EtOAc 12:1] to give 
benzylstyrene 96 (1.89 g, 62%) as a pale yellow oil.  
 
Rf = 0.43 (Isohexane:EtOAc 30:1). 
 
1H NMR (400 MHz, CD2Cl2): δ 6.99 (d, J = 8.1 Hz, 1H), 6.84 (d, J = 2.1 Hz, 1H), 
6.81 (dd, J = 8.2, 2.1 Hz, 1H), 6.75 (dd, J = 8.2, 0.6 Hz, 1H), 6.42 (d, J = 2.2 Hz, 1H), 
6.35 (ddd, J = 8.1, 2.4, 1.0 Hz, 1H), 6.27 (d, J = 15.9 Hz, 1H), 6.16 (dtd, J = 15.7, 6.5, 
1.0 Hz, 1H), 4.98 (s, 1H, OH), 3.80 (s, 3H), 3.39 (d, J = 6.5 Hz, 2H), 0.99 (s, 9H), 
0.98 (s, 9H), 0.20 (s, 6H), 0.19 (s, 6H) ppm. 
 
TBSO
TBSO
OMe
OH
	  125	  
13C NMR (100 MHz, CD2Cl2): δ 158.9, 156.0, 147.4, 146.7, 132.2, 130.7, 130.4, 
127.9, 121.6, 121.5, 119.8, 119.2, 107.1, 99.4, 56.0, 33.2, 26.3, 26.3, 19.0, 18.9, –3.8, 
–3.8 ppm. 
 
IR (ATR): ṽ = 3407 (w), 2956 (w), 2929 (w), 1615 (w), 1597 (w), 1507 (s), 1287 (s), 
1251 (s), 1238 (s), 1041 (m), 866 (s), 779 (s) cm–1.  
 
HRMS (ESI):  calcd. for C28H44O4Si2+ [M+H]+:  500.2778, 
found:       500.2861. 
 
 
 
 
(E)-4-(3-(4-hydroxy-2-methoxyphenyl)prop-1-enyl)benzene-1,2-diol (27)  
 
 
 
 
 
To a stirred solution of benzylstyrene 96 (260 mg, 0.600 mmol, 1 eq.) in THF (10 
mL) was added TBAF (1.0 M solution in THF, 1.20 mL, 1.20 mmol, 2 eq.) at 0 °C. 
The reaction mixture was stirred for 30 min at 0 °C. After completion, the reaction 
mixture was added H2O (10 mL) and was extracted with Et2O (3 × 20 mL). The 
combined organic phases were dried (Na2SO4), filtered and concentrated in vacuo. 
The crude product was purified by flash column chromatography [CH2Cl2:MeOH 
97:3] to give 27 (112 mg, 69%) of the product as a pale red oil.  
 
Rf: 0.21 (CH2Cl2: MeOH 20:1). 
 
1H NMR (400 MHz, d3-MeCN): δ 6.95 (d, J = 8.1 Hz, 1H), 6.84 (s, 1H), 6.71 (s, 2H), 
6.43 (d, J = 2.3 Hz, 1H), 6.34 (dd, J = 8.1, 2.4 Hz, 1H), 6.25 (d, J = 15.9 Hz, 1H), 
6.14 (dt, J = 15.9, 6.6 Hz, 1H), 3.78 (s, 3H), 3.34 (d, J = 6.5 Hz, 2H) ppm. 
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13C NMR (100 MHz, d3-MeCN): δ 159.6, 158.0, 146.0, 145.2, 132.0, 131.5, 131.1, 
128.3, 121.3, 119.8, 116.6, 113.8, 108.0, 100.3, 56.4, 33.6 ppm. 
 
IR (ATR): ṽ = 3295 (s), 2941 (m), 2834 (m), 1597 (s), 1507 (s), 1278 (s), 1243 (m), 
1194 (s), 1109 (s), 1041 (s), 785 (m) cm–1. 
 
HRMS (ESI):  calcd. for C16H16O4+ [M+H]+:   272.1049, 
found:       272.1125. 
 
 
 
 
santalin Y benzoxanthenone isomer (97) 
 
 
 
 
 
Benzylstyrene 27 (4.00 mg, 14.0 µmol, 1 eq.) and anhydrobase 30 (5.00 mg, 14.0 
µmol, 1 eq.) were dissolved in MeOH (0.5 mL). The reaction vessel was sealed and 
was heated for 12 h. After this time, the reaction mixture was concentrated in vacuo. 
Purification by sephadex column chromatography (LH-20, MeOH) afforded 
benzoxanthenone 97 (3.00 mg, 36%) as a dark red oil. 
 
Rf: 0.16 (CH2Cl2: MeOH 10:1). 
 
UV (MeCN): λmax = 441, 467, 499 nm. 
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1H NMR (600 MHz, d6-DMSO): δ 9.62 (br, 1H, OH), 9.52 (s, 1H), 9.13 (br, 4H, OH), 
7.05 (s, 1H), 6.85 (d, J = 8.0 Hz, 1H), 6.75 (s, 1H), 6.65 (d, J = 2.1 Hz, 1H), 6.51 (dd, 
J = 8.0, 2.1 Hz, 1H), 6.40 (d, J = 8.3 Hz, 1H), 6.36 (d, J = 2.3 Hz, 1H), 6.10 (dd, J = 
8.3, 2.3 Hz, 1H), 6.05 (d, J = 1.1 Hz, 1H), 3.95 (d, J = 15.6 Hz, 1H), 3.91 (s, 3H), 
3.90 (d, J = 15.6 Hz, 1H), 3.75 (s, 3H), 3.64 (s, 3H) ppm. 
 
13C NMR (100 MHz, d6-DMSO): δ 177.4 (**), 157.5, 156.7(**), 156.3, 152.3, 149.3, 
148.5, 145.3, 144.9, 143.8, 141.7, 133.8 (*), 129.0, 128.3, 124.4, 124.3, 121.5 (**), 
120.5 (*), 118.6, 117.3, 116.8, 115.6, 113.0, 107.0, 106.6 (*), 105.1 (*), 104.0 (*), 
101.1 (*), 98.8, 59.5, 55.5, 55.2, 26.6 ppm. 
 
IR (ATR): ): ṽ = 3166 (m), 2923 (m), 2897 (m), 2362 (w), 2253 (w), 1653 (w), 1551 
(m), 1497 (s), 1456 (s), 1344 (s), 1293 (s), 1201 (s), 1023 (s), 999 (s), 823 (s) cm–1.  
 
HRMS (ESI):  calc. for C33H27O10 [M+H]+:   583.1599, 
found:      583.1603. 
 
(*) C obscured, detected by HSQC 
(**) C obscured, detected by HMBC 
 
 
 
 
3-bromo-6,7-bis((tert-butyldimethylsilyl)oxy)-2H-chromen-2-ol (106) 
 
 
 
 
 
To a stirred solution of protected coumarin 67 (178 mg, 0.367 mmol, 1 eq.) in CH2Cl2 
(8 mL) at –78 °C was added DIBAL-H (1 M in toluene, 0.404 ml, 0.404 mmol, 1.1 
eq.). The reaction mixture was stirred at –78 °C for 2 h. After completion the reaction 
the mixture was diluted with H2O (50 mL) and extracted with CH2Cl2 (3 ×  15 mL). 
The combined organic extracts were washed with sat. aq. NaCl solution (50 mL) and 
O OHTBSO
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dried (Na2SO4). The crude product was purified by flash column chromatography 
[Isohexane: EtOAc 16:1] to provide 106 (170 mg, 95%) as white foam.  
 
Rf: 0.29 (Isohexane:EtOAc 10:1). 
 
1H NMR (400 MHz, d3-MeCN): δ 6.95 (s, 1H), 6.69 (s, 1H), 6.48 (s, 1H), 5.82 (d, J = 
7.1 Hz, 1H), 5.00 (d, J = 7.1 Hz, 1 OH), 0.98 (s, 18H), 0.22 (s, 3H), 0.22 (s, 3H), 0.19 
(s, 3H), 0.18 (s, 3H) ppm. 
 
13C NMR (100 MHz, d3-MeCN): δ 149.0, 145.0, 142.6, 127.7, 118.8, 115.5, 114.3, 
110.3, 94.1, 26.4, 26.3, 19.2, 19.1, –3.7, –3.8, –3.8, –3.9 ppm. 
 
IR (ATR): ṽ = 3400 (br), 2953 (m), 2928 (m), 2884 (w), 2856 (m), 1612 (w), 1566 
(w), 1501 (s), 1471 (m), 1417 (m), 1326 (s), 1252 (s), 1225 (s), 1168 (s), 1140 (s), 
1003 (m), 923 (s), 835 (s), 778 (s) cm–1. 
 
HRMS (ESI):  calcd. for C21H34O4BrSi2– [M–H]–:   485.1184, 
found:       485.1178. 
 
 
 
 
3-bromo-6,7-dihydroxychromenylium perchlorate (105) 
 
 
 
 
 
To a stirred solution of lactol 106 (133 mg, 273 µmol, 1 eq.) in acetic acid (1.5 mL) 
was added perchloric acid (aq. 70 %, 100 µL, 1.16 mmol, 4.3 eq.) at room 
temperature. The reaction mixture was stirred for 30 min, while it precipitates. After 
an additional hour of stirring at room temperature, reaction mixture was transferred in 
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a falcon tube. The precipitate was collected by sedimentation using a centrifuge. The 
precipitate was washed with CH2Cl2 twice. Product 105 (47 mg, 50 %) was obtained 
as yellow powder. 
 
Rf: 0.31 (CH2Cl2: MeOH 15:1). 
 
mp (CH2Cl2): 213.5 °C decomp. 
 
1H NMR (600 MHz, d3-MeCN): δ 10.19 (br, 1H, OH), 9.31 (d, J = 2.1 Hz, 1H), 9.25 
(ddd, J = 2.1, 0.8, 0.4 Hz, 1H), 9.05 (br, 1H, OH), 7.61 (d, J = 0.8 Hz, 1H), 7.55 (d, J 
= 0.4 Hz, 1H) ppm. 
 
13C NMR (100 MHz, d3-MeCN): δ 164.2, 161.5, 158.3, 155.6, 151.7, 126.0, 112.8, 
111.0, 104.2 ppm. 
 
IR (ATR): ṽ = 3230 (br), 1625 (m), 1501 (s), 1451 (m), 1322 (s), 1304 (s), 1202 (s), 
1046 (s), 944 (s), 859 (s) cm–1. 
 
HRMS (ESI):  calcd. for C9H6O3Br+ [M–ClO4]+:   240.9495, 
found:       240.9498. 
 
 
 
 
3-bromo-2-(5-(3-(3,4-dihydroxyphenyl)allyl)-2-hydroxy-4-methoxyphenyl)-2H-
chromene-6,7-diol (107) 
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To a stirred mixture of bromo flavylium salt 105 (10.0 mg, 29.0 µmol, 1 eq.) in 
MeCN (2 mL) was added 2,6-di-tert-butyl pyridine (6.30 µL, 29.0 µ mol, 1 eq.) 
dropwise at 0 °C. After 10 min a solution of benzylstyrene 27 (8.70 mg, 32 µmol, 1.1 
eq.) in MeCN was added and upon complete addition, reaction mixture was heated to 
50 °C for 2 h. After completion, the reaction mixture was concentrated in vacuo and 
redissolved in MeOH. The crude product was purified by Sephadex column 
chromatography (LH-20, MeOH) to afford flavene 107 (9.00 mg, 63 %) as a pale 
orange wax. 
 
Rf: 0.45 (CH2Cl2: MeOH 10:1). 
 
1H NMR (600 MHz, d6-DMSO): δ 9.71 (s, 1H, OH), 9.13 (s, 1H, OH), 8.84 (s, 1H, 
OH), 8.79 (s, 1H, OH), 8.47 (s, 1H, OH), 6.99 (s, 1H), 6.86 (s, 1H), 6.67 (d, J = 1.9 
Hz, 1H), 6.64 (d, J = 8.1 Hz, 1H), 6.51 (s, 1H), 6.50 (dd, J = 8.1, 1.9 Hz, 1H), 6.49 (s, 
1H), 6.06 (s, 1H), 6.05 (d, J = 15.7 Hz, 1H), 6.03 (s, 1H), 5.87 (dt, J = 15.7, 6.6 Hz, 
1H), 3.73 (s, 3H), 3.23 (dd, J = 15.7, 6.6 Hz, 1H), 3.11 (dd, J = 15.7, 6.6 Hz, 1H) 
ppm. 
 
13C NMR (150 MHz, d6-DMSO): δ 158.1, 155.1, 146.6, 145.2, 144.7, 143.7, 139.4, 
129.8, 129.1, 128.9, 126.7, 125.4, 118.3, 117.5, 115.7, 114.4, 113.5, 112.9, 112.8, 
112.7, 103.9, 99.1, 74.0, 55.3, 32.2 ppm. 
 
IR (ATR): ṽ = 3399 (w), 3215 (w), 2903 (m), 2375 (w), 2254 (w), 2127 (w), 1537 
(m), 1472 (s), 1317 (s), 1261 (s), 1242 (s), 823 (s), 761 (s) cm–1. 
 
HRMS (ESI):  calc. for C25H21BrO7– [M–H]–:   511.0398, 
found:       511.0392. 
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2,3-diphenylaziridin-1-yl)isoindoline-1,3-dione (179)[41a] 
 
 
 
 
 
To a stirred solution of N-aminophtalimide (1.00 g, 5.55 mmol, 1 eq.) and (E)-stilbene 
(5.00 g, 27.8 mmol, 5 eq.) in CH2Cl2 (15 mL) was added Pb(OAc)4 (2.59 g, 5.55 
mmol, 1 eq.) in small portions over a period of 10 min at room temperature. The 
reaction mixture was stirred for 30 min at room temperature. After completion, the 
reaction mixture was filtered through a pad of celite and washed with CH2Cl2 (2 × 3 
mL). The combined organic phases were transferred to pentane (80 mL) at 0 °C. After 
10 min a precipitate starts forming, which was collected by filtration. The residue was 
redissolved in CH2Cl2 (11 mL) and was stirred with silica (1 g). The organic mixture 
was filtered through a pad of celite, washed with CH2Cl2 (2 ×  5 mL) and was 
concentrated in vacuo. Phtalimide 179 (849 mg, 45%) was obtained as a white solid 
with high purity and was used without further purification in the next step. 
 
Rf: 0.39 (Isohexane:EtOAc 7:3). 
 
mp (CH2Cl2): 149.3 – 151.2 °C. 
 
1H NMR (300 MHz, CDCl3): δ 7.71 – 7.29 (m, 14H), 4.95 (d, J = 5.9 Hz, 1H), 3.97 
(d, J = 5.9 Hz, 1H) ppm. 
 
13C NMR (75 MHz, CDCl3): δ 165.7, 137.6, 136.8, 134.1, 131.5, 130.3, 129.6, 128.9, 
128.9, 128.9, 128.9, 128.8, 128.5, 128.4, 127.8, 127.8, 127.4, 126.7, 123.8, 123.1, 
53.8, 46.7 ppm. 
 
N
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IR (ATR): ṽ = 3055 (w), 1773 (w), 1709 (s), 1603 (w), 1464 (m), 1452 (m), 1367 (m), 
1353 (m), 1308 (m), 1134 (m), 1053 (m), 972 (s), 894 (s), 751 (s), 705 (s), 697 (s) 
cm–1. 
 
HRMS (EI):  calcd. for C22H16O2N2 [M]+:   340.1206, 
found:      340.1205. 
 
 
 
 
2,3-diphenylaziridin-1-amine (111)[41a] 
 
 
 
 
 
To a stirred suspension of phtalimide 179 (700 mg, 2.06 mmol, 1 eq.) in EtOH (5.2 
mL) was added N2H4H2O (5.14 mL, 105 mmol, 51 eq.) at room temperature. The 
reaction mixture was stirred at 42 °C (rotary evaporator) for 40 min. After 
completion, the remaining suspension was filtered through a pad of celite. The filtrate 
was poured in Et2O/ice (14 mL : 7 g). The organic phase was washed with ice water 
(3 ×  10 mL), dried (K2CO3) and filtered through a pad of celite. The filtrate was 
concentrated to a volume of 10 mL, pentane (15 mL) was added and resulting solution 
was stored at –25 °C for 10 h upon which colorless needles crystallize. Amino 
aziridine 111 (302 mg, 71 %) was obtained as colorless needles. 
 
Rf: 0.48 (Isohexane:EtOAc 7:3). 
 
mp (pentane): 103.1 – 105.7 °C. 
 
1H NMR (300 MHz, CDCl3): δ 7.50 – 7.09 (m, 10H), 3.28 (d, J = 4.8 Hz, 1H), 3.14 
(d, J = 4.8 Hz, 1H), 3.10 (br s, 2H, NH2) ppm. 
 
N
NH2
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13C NMR (75 MHz, CDCl3): δ 139.0, 132.1, 130.7, 128.9, 128.7, 128.7, 128.5, 127.5, 
126.7, 126.5, 53.6, 50.0 ppm. 
 
IR (ATR): ṽ = 3292 (w), 3223 (w), 3139 (w), 1599 (m), 1494 (m), 1449 (m), 1312 
(w), 1097 (m), 1086 (m), 1029 (m), 776 (m), 735 (s), 719 (s), 694 (s) cm–1. 
 
HRMS (ESI):  calcd. for C14H12 [M–N2H2]+:   180.0934, 
found:       180.0933. 
 
 
 
 
1-phenylethane-1,2-diyl dimethanesulfonate (180)[41a] 
 
 
 
 
 
To a stirred solution of styrene glycol (4.31 g, 31.3 mmol, 1 eq.) in pyridine (11.3 
mL) was added MsCl (5.46 mL, 70.0 mmol, 2.2 eq.) at 0 °C dropwise over a period of 
1 h. Reaction mixture was stirred at this temperature for 4 h. After completion, the 
reaction mixture was poured in ice (75 g). The resulting mixture was acidified to pH 3 
by adding aq. HCl (2 M). The precipitate was collected by filtration and washed with 
ice water (2 ×  13 mL). The precipitate was dissolved in CH2Cl2 (25 mL) and was 
washed with H2O (3 mL). The organic extract was dried (MgSO4), pentane (35 mL) 
was added to the remaining solution and was stored at –25 °C. The resulting crystals 
were washed with pentane (2 × 5 mL), which yielded dimesylate 180 (7.75 g, 84%) as 
a white solid. 
 
Rf: 0.70 (CH2Cl2:MeOH 99:1). 
 
mp (CH2Cl2/pentane): 118.3 °C decomp. 
 
OMs
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1H NMR (300 MHz, CDCl3): δ 7.49 – 7.38 (m, 5H), 5.80 (dd, J = 8.6, 3.3 Hz, 1H), 
4.53 (dd, J = 11.8, 8.6 Hz, 1H), 4.40 (dd, J = 11.8, 3.3 Hz, 1H), 3.08 (s, 3H), 2.87 (s, 
3H) ppm. 
 
13C NMR (75 MHz, CDCl3): δ 133.5, 130.4, 129.5, 127.1, 80.9, 70.0, 39.4, 38.4 ppm. 
 
IR (ATR): ṽ = 3015 (w), 2934 (w), 1496 (w), 1454 (w), 1413 (w), 1355 (s), 1341 (s), 
1179 (s), 1109 (w), 1017 (m), 985 (s), 966 (s), 928 (s), 870 (s), 814 (s), 740 (m), 702 
(s) cm–1. 
 
HRMS (ESI):  calcd. for C10H14NaO6S2 [M+Na]+:   317.0124, 
found:       317.0128. 
 
 
 
 
2-phenylaziridin-1-amine (110)[41a] 
 
 
 
 
 
To a stirred solution of N2H4H2O (12.5 mL, 255 mmol, 15 eq.) was added 
dimesylate 180 (5.00 g, 17.0 mmol, 1 eq.) at room temperature. Pentane (150 mL) 
was added and was stirred for 24 h at room temperature. The reaction mixture was 
extracted with pentane (2 × 10 mL). Concentration in vacuo afforded amino aziridine 
110 (1.85 g, 81 %) as a white solid. 
 
Rf: 0.28 (Isohexane:EtOAc 7:3). 
 
mp (pentane): 18 °C. 
 
1H NMR (300 MHz, CDCl3): δ 7.40 – 7.15 (m, 5H), 3.59 (br s, 2H, NH2), 2.61 (dd, J 
= 7.8, 4.7 Hz, 1H), 2.04 (dd, J = 4.7, 0.6 Hz, 1H), 2.01 (dd, J = 7.8, 0.6 Hz, 1H) ppm. 
 
 
N
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13C NMR (75 MHz, CDCl3): δ 139.1, 128.5, 127.2, 126.3, 45.7, 41.7 ppm. 
 
IR (ATR): ṽ = 3309 (w), 3247 (w), 3159 (w), 3061 (w), 2985 (w), 1604 (m), 1494 
(m), 1455 (m), 1377 (w), 1087 (m), 1066 (m), 915 (m), 731 (s), 695 (s) cm–1. 
 
HRMS (EI):  calcd. for C8H8 [M –N2H2]+:  104.0621, 
found:      104.0613. 
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V.	  5. Experimental towards santalin A and B 
 
3-((tert-butyldimethylsilyl)oxy)phenol (123)[28] 
 
 
 
 
 
To a stirred mixture of resorcinol 86 (5.00 g, 45.4 mmol, 1 eq.) in DMF (15 mL) was 
added TBSCl (9.55 g, 47.7 mmol, 1.05 eq.) and imidazole (6.50 g, 95.5 mmol, 2.1 
eq.) at 0 °C. After 2 h stirring at this temperature, the reaction mixture was allowed to 
warm to room temperature and was stirred for an additional 2 h. After completion, 
H2O (30 mL) was added to the reaction mixture and the biphasic mixture was 
extracted with Et2O (3 × 50 mL). The combined organic extracts were washed with 
aq. NaCl (10%, 2 × 30 mL), sat. aq. NaCl (50 mL) and dried (MgSO4). The crude 
product was purified by flash column chromatography [Isohexane:EtOAc 16:1 → 
10:1) to afford TBS resorcinol 123 (4.58 g, 45%) as a pale yellow oil. 
 
Rf: 0.42 (Isohexane: EtOAc 7:1). 
 
1H NMR (400 MHz, CDCl3): δ 7.07 (t, J = 8.1 Hz, 1H), 6.44 – 6.41 (m, 2H), 6.35 (t, 
J = 2.3 Hz, 1H), 4.68 (s, 1H, OH), 0.98 (s, 9H), 0.19 (s, 6H) ppm. 
 
13C NMR (100 MHz, CDCl3): δ 157.2, 156.7, 130.1, 112.9, 108.6, 107.7, 25.9, 18.4, –
4.2 ppm. 
 
IR (ATR): ṽ = 3340 (m), 2956 (w), 2930 (w), 1591 (m), 1472 (m), 1143 (s), 979 (s), 
835 (s), 780 (s) cm–1. 
 
HRMS (EI):  calcd. for C12H20O2Si+ [M]+:  224.1227, 
found:      224.1215. 
 
TBSO
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4-((tert-butyldimethylsilyl)oxy)-2-hydroxybenzaldehyde (124)[28] 
 
 
 
 
 
To a stirred solution of TBS resorcinol 123 (4.00 g, 17.9 mmol, 1 eq.) in THF 
(150 mL) was added successively anhydrous MgCl2 (3.39 g, 35.7 mmol, 2 eq.), NEt3 
(5.00 mL, 35.7 mmol, 2 eq.) and (CH2O)n (1.61 g, 53.6 mmol, 3 eq.) and the resulting 
suspension was heated to 70 °C for 2 h 30 min. After completion, the reaction mixture 
was cooled to room temperature and Et2O (200 mL) was added. After washing with 
aq. HCl (1 M, 2 × 70 mL), H2O (2 × 70 mL) and sat. aq. NaCl (100 mL), the organic 
phase was dried (MgSO4). The crude product was purified by flash column 
chromatography [Isohexane:EtOAc 7:1] to afford benzaldehyde 124 (3.92 g, 87%) as 
a colorless oil. 
 
Rf: 0.52 (Isohexane: EtOAc 10:1). 
 
1H NMR (400 MHz, CDCl3): δ 11.33 (s, 1H, OH), 9.73 (d, J = 0.5 Hz, 1H), 7.40 (d, 
J = 8.5 Hz, 1H), 6.47 (dd, J = 8.5, 2.2 Hz, 1H), 6.39 (d, J = 2.2 Hz, 1H), 0.98 (s, 9 H), 
0.26 (s, 6H) ppm. 
 
13C NMR (100 MHz, CDCl3): δ 194.8, 164.3, 164.0, 135.7, 116.0, 113.3, 107.9, 25.7, 
18.5, –4.1 ppm. 
 
IR (ATR): ṽ = 3055 (w), 2931 (m), 2744 (w), 1646 (s), 1623 (s), 1218 (s), 804 (s), 
780 (s), 704 (s) cm–1. 
 
HRMS (EI): calcd. for C13H20O3Si+ [M]+:  252.1176, 
found:      252.1175. 
 
 
TBSO
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4-((tert-butyldimethylsilyl)oxy)-2-methoxybenzaldehyde (125)[59] 
 
 
 
 
 
To a stirred solution of benzaldehyde 124 (2.82 g, 11.2 mmol, 1 eq.) in Et2O (45 mL) 
was added successively MeI (3.50 mL, 56.0 mmol, 5 eq.) and Ag2O (10.4 g, 44.8 
mmol, 4.0 eq.) at room temperature. Reaction mixture was stirred for 10 h. After 
completion, the solids were removed by filtration through a plug of celite and washed 
with Et2O (20 mL). The filtrate was washed with sat. aq. NH4Cl (60 mL) and the 
aqueous layer was extracted with Et2O (3 × 40 mL). The combined organic extracts 
were washed with sat. aq. NaCl (30 mL) and dried (MgSO4). The crude product was 
purified by flash column chromatography [Isohexane:EtOAc 30:1] to afford 
benzaldehyde 125 (2.41 g, 81%) as a colorless solid. 
 
Rf: 0.48 (Isohexane:EtOAc 7:1). 
 
mp (EtOAc): 54.9 – 57.6 °C. 
 
1H NMR (400 MHz, CDCl3): δ 10.29 (d, J = 0.8 Hz, 1H), 7.74 (d, J = 8.5 Hz, 1H), 
6.47 (ddd, J = 8.5, 2.1, 0.8 Hz, 1H), 6.39 (d, J = 2.1 Hz, 1H), 3.88 (s, 3H), 0.99 (s, 
9H), 0.25 (s, 6H) ppm. 
 
13C NMR (100 MHz, CDCl3): δ 188.7, 163.8, 163.2, 130.6, 119.6, 112.7, 103.5, 55.8, 
25.8, 18.5, –4.1 ppm. 
 
IR (ATR): ṽ = 2923 (w), 2856 (w), 1673 (m), 1594 (m), 1206 (s), 1165 (s), 833 (s), 
776 (s) cm–1. 
 
HRMS (EI): calcd. for C14H22O3Si+ [M]+:   266.1333, 
found:      266.1330. 
TBSO
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1-(4-((tert-butyldimethylsilyl)oxy)-2-methoxyphenyl)prop-2-en-1-ol (126) 
 
 
 
 
 
To a stirred solution of benzaldehyde 125 (3.00 g, 11.3 mmol, 1 eq.) in THF (25 mL) 
was added vinylmagnesiumbromide (1 M solution in THF, 13.6 mL, 13.6 mmol, 1.2 
eq.) at 0 °C. The reaction mixture was stirred for 3 h at 0 °C. Upon completion, aq. 
sat. NH4Cl (15 mL) was added and extracted with Et2O (3 x 30 mL). The organic 
phases were combined and washed with aq. sat. NaCl (30 mL) and dried (Na2SO4). 
The crude product was purified by flash column chromatography [Isohexane: EtOAc 
12:1] to afford allylic alcohol 126 (2.19 g, 66 %) as a colorless oil. 
 
Rf: 0.23 (Isohexane: EtOAc 7:1). 
 
1H NMR (300 MHz, CDCl3): δ 7.11 (d, J = 8.0 Hz, 1H), 6.44 – 6.39 (m, 2H), 6.12 
(ddd, J = 17.2, 10.4, 5.5 Hz, 1H), 5.38 – 5.25 (m, 2H), 5.15 (dt, J = 10.4, 1.6 Hz, 1H), 
3.81 (s, 3H), 2.67 (d, J = 5.9 Hz, 1H), 0.99 (s, 9H), 0.21 (s, 6H) ppm. 
 
13C NMR (75 MHz, CDCl3): δ 158.0, 156.6, 139.9, 128.2, 124.0, 114.5, 112.0, 103.9, 
71.3, 55.6, 25.9, 18.4, –4.2, –4.2 ppm. 
 
IR (ATR): ṽ = 3355 (br), 2954 (m), 2928 (m), 2856 (m), 1740 (w), 1603 (w), 1509 
(s), 1463 (m), 1279 (s), 1249 (s), 1229 (s), 1153 (s), 1037 (s), 915 (s), 837 (s), 821 (s), 
779 (s) cm–1. 
 
HRMS (ESI):  calcd. for C16H25O2Si+ [M–OH]+:   277.1618, 
found:       277.1622. 
 
 
 
 
OHOMe
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1-(4-((tert-butyldimethylsilyl)oxy)-2-methoxyphenyl)allyl acetate (130) 
 
 
 
 
 
To a solution of allylic alcohol 126 (200 mg, 0.680 mmol, 1 eq.) in CH2Cl2 (3 mL) 
was added acetic anhydride (100 µL, 1.02 mmol, 1.5 eq.), pyridine (110 µL, 1.36 
mmol, 2 eq.) and 4-dimethlyaminopyridine (2.00 mg, 6.80 µmol, 1 mol-%) at 0 °C. 
The reaction mixture was stirred at 0 °C for 3 h. After completion, H2O (5 mL) was 
added to reaction mixture and was extracted with Et2O (3 ×  10 mL). The organic 
extracts were washed with sat. aq. NaCl (4 mL) and dried (Na2SO4). The crude 
product was purified by flash column chromatography [Isohexane:EtOAc 7:1] to 
afford acetoxy allyl phenol 130 (119 mg, 52 %) as a colorless oil. 
 
Rf: 0.39 (Isohexane:EtOAc 10:1). 
 
1H NMR (300 MHz, CDCl3): δ 7.28 (d, J = 9.0 Hz, 1H), 6.88 (d, J = 16.0 Hz, 1H), 
6.41 (dd, J = 8.3, 2.3 Hz, 1H), 6.36 (d, J = 2.2 Hz, 1H), 6.21 (dt, J = 16.0, 6.7 Hz, 
1H), 4.70 (dd, J = 6.7, 1.1 Hz, 2H), 3.81 (s, 3H), 2.08 (s, 3H), 0.99 (s, 9H), 0.21 (s, 
6H) ppm. 
 
13C NMR (75 MHz, CDCl3): δ 171.2, 158.2, 157.2, 129.7, 128.1, 121.7, 118.9, 112.3, 
103.8, 66.2, 55.6, 25.9, 21.3, 18.5, –4.1 ppm. 
 
IR (ATR): ṽ = 3415 (w), 2955 (m), 2929 (m), 2857 (m), 1739 (s), 1603 (s), 1574 (m), 
1500 (s), 1450 (m), 1289 (s), 1228 (s), 1201 (s), 1162 (s), 1034 (m), 976 (s), 836 (s), 
778 (s) cm–1. 
 
HRMS (ESI):  calcd. for C16H25O2Si+ [M–OAc]+:   277.1618, 
found:       277.1622. 
 
OMe
TBSO
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4-bromo-2-methoxyphenol (135)[60] 
 
 
 
 
 
To a stirred solution of guaiacol 134 (4.97 g, 40.0 mmol, 1 eq.) in DMF (35 mL) was 
added N-bromosuccinimide (7.14 g, 40.1 mmol, 1 eq.) in small portions at 0 °C. The 
reaction mixture was stirred for 1 h at this temperature. After completion, sat. aq. 
Na2S2O3 (20 mL) was added to reaction mixture and the resulting biphasic mixture 
was extracted with Et2O (2 × 50 mL). The combined organic extracts were washed 
with aq. NaCl (10%, 2 ×  50 mL), sat. aq. NaCl (30 mL) and dried (Na2SO4). The 
crude product was purified by flash column chromatography [Isohexane:EtOAc 10:1] 
to afford bromoguaiacol 135 (5.14 g, 63%) as a pale brown oil. 
 
Rf: 0.26 (Isohexane:EtOAc 7:1). 
 
1H NMR (300 MHz, CDCl3): δ 7.01 – 6.96 (m, 2H), 6.79 (dd, J = 8.0, 0.6 Hz, 1H), 
5.55 (s, 1H, OH), 3.88 (s, 3H) ppm. 
 
13C NMR (75 MHz, CDCl3): δ 147.4, 145.1, 124.4, 116.0, 114.4, 111.8, 56.4 ppm. 
 
IR (ATR): ṽ = 3476 (m), 3393 (m), 2972 (w), 2929 (w), 2840 (w), 1590 (m), 1492 (s), 
1453 (m), 1433 (m), 1331 (s), 1287 (s), 1256 (s), 1221 (s), 1173 (s), 1124 (s), 1023 
(s), 855 (s), 797 (s), 759 (s) cm–1. 
 
HRMS (ESI):  calcd. for C7H7O2Br+ [M]+:    201.9624, 
found:       201.9621 
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(4-bromo-2-methoxyphenoxy)(tert-butyl)dimethylsilane (136)[61] 
 
 
 
 
 
To a stirred solution of bromo guaiacol 135 (5.14 g, 25.3 mmol, 1 eq.) in DMF (20 
mL) was added TBSCl (4.58 g, 30.4 mmol, 1.2 eq.), imidazole (4.13 g, 30.4 mmol, 
2.4 eq.) and 4-dimethylaminopyridine (309 mg, 2.53 mmol, 10 mol-%) at 0 °C. The 
reaction mixture was allowed to warm to room temperature and was stirred for 6 h. 
After completion, H2O (30 mL) was added and the biphasic mixture was extracted 
with Et2O (3 × 30 mL). The combined organic extracts were washed with aq. NaCl 
(10%, 2 × 15 mL), sat. aq. NaCl (20 mL) and dried (Na2SO4). The crude product was 
purified by flash column chromatography [Isohexane] to afford TBS phenol 136 (6.72 
g, 84%) as colorless oil. 
 
Rf: 0.58 (Isohexane:EtOAc 10:1). 
 
1H NMR (300 MHz, CDCl3): δ 6.96 – 6.91 (m, 2H), 6.71 (d, J = 8.1 Hz, 1H), 3.79 (s, 
3H), 0.98 (s, 9H), 0.14 (s, 6H) ppm. 
 
13C NMR (75 MHz, CDCl3): δ 152.0, 144.6, 123.9, 122.3, 115.7, 113.6, 55.9, 25.9, 
18.7, –4.5 ppm. 
 
IR (ATR): ṽ = 2953 (m), 2928 (m), 2855 (m), 1585 (m), 1494 (s), 1471 (m), 1444 
(m), 1397 (m), 1297 (m), 1266 (s), 1254 (s), 1222 (s), 1178 (s), 908 (s), 832 (s), 779 
(s) cm–1. 
 
HRMS (EI):  calcd. for C13H21BrO2Si+ [M]+:   316.0489, 
found:       316.0468. 
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(4-((tert-butyldimethylsilyl)oxy)-3-methoxyphenyl)boronic acid (137) 
 
 
 
 
 
To a stirred solution of bromide 136 (200 mg, 0.630 mmol, 1 eq.) in toluene/THF 
(1:1, 2 mL) was added B(OiPr)3 (175 µl, 0.756 mmol, 1.2 eq.) at –78 °C. After 5 min, 
n-BuLi (2.5 M in THF, 302 µL, 0.756 mmol, 1.2 eq.) was added dropwise at -78 °C. 
The reaction mixture was stirred for 1 h 30 min at this temperature. After completion, 
aq. HCl (2 M, 3 mL) was added and the reaction mixture was warmed to room 
temperature. After 1 h, the biphasic mixture was extracted with Et2O (3 ×  20 mL), 
washed with sat. aq. NaCl (3 mL) and dried (Na2SO4). The crude product was purified 
by flash column chromatography [Isohexane:EtOAc 5:3] to afford boronic acid 137 
(91.0 mg, 51%) as a white wax. 
 
Rf: 0.20 (Isohexane:EtOAc 7:3). 
 
1H NMR (400 MHz, D2O/d6-acetone): δ 7.43 (d, J = 1.5 Hz, 1H), 7.34 (dd, J = 7.8, 
1.5 Hz, 1H), 6.79 (d, J = 7.8 Hz, 1H), 3.78 (s, 3H), 0.94 (s, 9H), 0.11 (s, 6H) ppm. 
 
13C NMR (100 MHz, D2O/d6-acetone): δ 150.2, 147.0, 127.6, 120.0, 117.8, 54.8, 
25.2, 18.1, –5.3 ppm. 
 
(C-B is obscured)  
 
IR (ATR): ṽ = 3218 (br), 2955 (m), 2928 (m), 2856 (m), 1596 (m), 1510 (m), 1463 
(m), 1449 (m), 1405 (s), 1333 (s), 1311 (s), 1271 (s), 1215 (s), 1177 (s), 1124 (s), 
1037 (m), 924 (s), 876 (s), 836 (s), 780 (s), 713 (s) cm–1. 
 
HRMS (ESI):  calcd. for C13H22BO4Si–[M–H]–:   281.1386, 
found:       281.1372. 
OMe
OTBS
(HO)2B
	  144	  
(E)-tert-butyl(4-(3-(4-((tert-butyldimethylsilyl)oxy)-2-methoxyphenyl)allyl)-2-
methoxyphenoxy)dimethylsilane (138) 
(E)-3-(4-((tert-butyldimethylsilyl)oxy)-2-methoxyphenyl)prop-2-en-1-ol (140) 
 
 
 
 
 
To a mixture of allylic alcohol 126 (442 mg, 1.5 mmol, 1 eq.) and boronic acid 137 
(444 mg, 1.57 mmol, 1.05 eq.) in CH2Cl2 (15 mL) was added Pd(PPh3)4 (104 mg, 
0.09 mmol, 6 mol-%) in a pressure tube. The reaction mixture was heated to 80 °C for 
10 h. After completion, sat. aq. NH4Cl (5 mL) was added and the biphasic mixture 
was extracted with CH2Cl2 (3 × 30 mL). The combined organic extracts were washed 
with sat. aq. NaCl (15 mL) and dried (Na2SO4). The crude product was purified by 
flash column chromatography [Isohexane:EtOAc 50:1] to afford benzylstyrene 138 
(215 mg, 28 %)  and allyl alcohol 140 (260 mg, 59 %) as a pale yellow oil. 
 
 
(E)-tert-butyl(4-(3-(4-((tert-butyldimethylsilyl)oxy)-2-methoxyphenyl)allyl)-2-
methoxyphenoxy)dimethylsilane (138) 
 
Rf : 0.38 (Isohexane:EtOAc 10:1). 
 
1H NMR (400 MHz, CDCl3): δ 7.27 (d, J = 8.3 Hz, 1H), 6.77 (d, J = 8.0 Hz, 1H), 
6.73 (d, J = 2.1 Hz, 1H), 6.70 (dd, J = 2.1, 0.7 Hz, 1H), 6.67 (dd, J = 8.0, 0.5 Hz, 1H), 
6.40 (dd, J = 8.2, 2.3 Hz, 1H), 6.37 (d, J = 2.3, 1H), 6.22 (dt, J = 15.8, 7.0 Hz, 1H), 
3.80 (s, 3H), 3.78 (s, 3H), 3.47 (dd, J = 7.0, 0.7 Hz, 2H), 1.00 (s, 9H), 0.99 (s, 9H), 
0.20 (s, 6H), 0.15 (s, 6H) ppm. 
 
13C NMR (100 MHz, CDCl3): δ 157.6, 156.2, 151.0, 143.4, 134.4, 128.4, 127.3, 
125.3, 120.9, 120.9, 120.3, 113.0, 112.2, 103.8, 55.7, 55.6, 39.7, 26.0, 25.9, 18.7, 
18.5, –4.1, –4.4 ppm. 
MeO
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IR (ATR): ṽ = 2954 (m), 2929 (m), 2895 (w), 2857 (m), 1603 (m), 1510 (s), 1500 (s), 
1284 (s), 1252 (s), 1201 (s), 1162 (s), 1037 (s), 978 (s), 835 (s), 777 (s) cm–1. 
 
HRMS (ESI):  calcd. for C29H45O4Si2+  [M–H]+:   513.2862, 
found:       513.2856. 
 
 
(E)-3-(4-((tert-butyldimethylsilyl)oxy)-2-methoxyphenyl)prop-2-en-1-ol (140) 
 
Rf : 0.24 (Isohexane:EtOAc 4:1). 
 
1H NMR (300 MHz, CDCl3): δ 7.29 (d, J = 8.3 Hz, 1H), 6.84 (d, J = 16.1 Hz, 1H), 
6.42 (dd, J = 8.3, 2.3 Hz, 1H), 6.37 (d, J = 2.3 Hz, 1H), 6.29 (dt, J = 16.1, 6.1 Hz, 
1H), 4.30 (dd, J = 6.1, 1.1 Hz, 2H), 3.81 (s, 3H), 0.99 (s, 9H), 0.22 (s, 6H) ppm. 
 
13C NMR (75 MHz, CDCl3): δ 158.0, 156.9, 127.8, 127.3, 126.6, 119.3, 112.3, 103.8, 
64.8, 55.6, 25.9, 18.5, –4.1 ppm. 
 
IR (ATR): ṽ = 3338 (br), 2953 (m), 2929 (m), 2857 (m), 2360 (w), 1603 (s), 1574 
(w), 1500 (s), 1463 (m), 1450 (w), 1413 (w), 1290 (s), 1256 (m), 1202 (s), 1163 (s), 
978 (s), 863 (s), 838 (s), 779 (s) cm–1. 
 
HRMS (ESI):  calcd. for C16H25O2Si [M–OH]+:   277.1618, 
found:       277.1623 
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5-bromo-2-methoxyphenol (142)[62] 
 
 
 
 
 
To a stirred solution of acetoxy guaiacol (141) (4.00 g, 24.0 mmol, 1 eq.) in MeCN 
(60 mL) was added N-bromo-succinimide (4.71 g, 26.5 mmol, 1.1 eq.) and the 
resulting reaction mixture was heated at 60 °C for 4 h. After completion, the reaction 
mixture was cooled to room temperature, H2O (100 mL) was added and the resulting 
mixture was extracted with EtOAc (3 × 100 mL). The organic extracts were washed 
successively with H2O (100 mL), sat. aq. Na2SO3 (70 mL), H2O (100 mL), sat. aq. 
NaCl (70 mL) and dried (Na2SO4).  
 
The crude product was redissolved in MeOH (150 mL) and KOH (2.80 g, 50 mmol, 
2.1 eq.) dissolved in MeOH (20 mL) was added. The reaction mixture was heated at 
70 °C for 6 h. After completion, reaction mixture was cooled to room temperature and 
aq. HCl (6 M, 40 mL) was added carefully. The resulting mixture was extracted with 
CH2Cl2 (2 × 100 mL) and the organic phases were washed with H2O (70 mL), sat. aq. 
NaCl (70 mL) and were dried (Na2SO4). The crude product was purified by flash 
column chromatography [Isohexane:EtOAc 4:1] to afford bromo guaiacol 142 (4.20 
g, 87%) as white crystals. 
 
Rf: 0.41 (Isohexane:EtOAc 10:1). 
 
mp (EtOAc): 64.9 – 67.2°C. 
 
1H NMR (300 MHz, CDCl3): δ 7.07 (d, J = 2.4 Hz, 1H), 6.96 (dd, J = 8.6, 2.4 Hz, 
1H), 6.71 (d, J = 8.6 Hz, 1H), 5.65 (s, 1H, OH), 3.87 (s, 3H) ppm. 
 
13C NMR (75 MHz, CDCl3): δ 146.7, 146.1, 123.0, 118.0, 113.5, 112.1, 56.3 ppm. 
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IR (ATR): ṽ = 3476 (m), 3393 (br), 2972 (w), 2839 (w), 1590 (m), 1492 (s), 1453 
(m), 1432 (m), 1331 (m), 1288 (m), 1257 (s), 1222 (s), 1173 (s), 1023 (s), 855 (s), 797 
(s) cm–1. 
 
HRMS (EI):  calcd. for C7H7O2Br+ [M]+:    201.9624, 
found:       201.9620. 
 
 
 
 
(5-bromo-2-methoxyphenoxy)(tert-butyl)dimethylsilane (143)[63] 
 
 
 
 
 
To a stirred solution of bromo guaiacol 142 (3.40 g, 16.8 mmol, 1 eq.) in DMF (30 
mL) was added TBSCl (3.70 g, 24.5 mmol, 1.5 eq.), imidazole (2.90 g, 42.5 mmol, 
2.5 eq.) and 4-dimethylaminopyridine (204 mg, 1.68 mmol, 10 mol-%) at 0 °C. The 
reaction mixture was allowed to warm to room temperature and was stirred for 4 h. 
After completion, H2O (50 mL) was added and the biphasic mixture was extracted 
with Et2O (3 × 50 mL). The combined organic extracts were washed with aq. NaCl 
(10%, 2 × 30 mL), sat. aq. NaCl (30 mL) and dried (Na2SO4). The crude product was 
purified by flash column chromatography [Isohexane] to afford TBS phenol 143 (4.30 
g, 81%) as colorless oil. 
 
Rf: 0.75 (Isohexane:EtOAc 10:1). 
 
1H NMR (300 MHz, CDCl3): δ 7.02 (dd, J = 8.5, 2.4 Hz, 1H), 6.98 (d, J = 2.4 Hz, 
1H), 6.71 (d, J = 8.5 Hz, 1H), 3.78 (s, 3H), 0.99 (s, 9H), 0.16 (s, 6H) ppm. 
 
13C NMR (75 MHz, CDCl3): δ 150.7, 146.2, 124.6, 124.3, 113.5, 112.6, 55.8, 25.9, 
18.7, –4.5 ppm. 
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IR (ATR): ṽ = 2954 (m), 2928 (m), 2894 (w), 2855 (m), 1586 (m), 1495 (s), 1444 
(m), 1397 (m), 1297 (m), 1266 (s), 1254 (s), 1222 (s), 1120 (s), 1037 (m), 908 (s), 832 
(s), 779 (s) cm–1. 
 
HRMS (EI):  calcd. for C13H21BrO2Si+ [M]+:   316.0475, 
found:       316.0468. 
 
 
(3-((tert-butyldimethylsilyl)oxy)-4-methoxyphenyl)boronic acid (144)[64] 
 
 
 
 
 
To a stirred solution of bromide 143 (317 mg, 1.00 mmol, 1 eq.) in THF (3 mL) was 
added n-BuLi (2.5 M in THF, 480 µL, 1.20 mmol, 1.2 eq.) dropwise at –78 °C. After 
30 min, B(Oi-Pr)3 (283 µL, 1.20 mmol, 1.2 eq.) was added and was stirred at –78 °C 
for 1 h 30 min. The reaction mixture was warmed to room temperature and aq. HCl (2 
M, 4 mL) was added. After 20 min, the biphasic mixture was extracted with Et2O (3 × 
25 mL), washed with sat. aq. NaCl (3 mL) and dried (Na2SO4). The crude product 
was purified by flash column chromatography [Isohexane:EtOAc 5:3] to afford 
boronic acid 144 (104 mg, 37%) as a white wax. 
 
Rf: 0.36 (Isohexane:EtOAc 7:3). 
 
1H NMR (400 MHz, D2O/d6-acetone): δ 7.45 (dd, J = 8.3, 1.8 Hz, 1H), 7.36 (d, J = 
1.8 Hz, 1H), 6.92 (d, J = 8.3 Hz, 1H), 3.80 (s, 3H), 0.97 (s, 9H), 0.11 (s, 6H) ppm. 
 
13C NMR (100 MHz, D2O/d6-acetone): δ 153.8, 144.9, 129.5, 127.2, 112.1, 55.6, 
26.1, 19.0, –4.5 ppm. 
 
(C-B is obscured) 
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IR (ATR): ṽ = 3210 (br), 2953 (m), 2928 (m), 2894 (w), 2856 (s), 1596 (m), 1503 (s), 
1470 (s), 1454 (s), 1406 (m), 1264 (s), 1223 (s), 1193 (s), 1113 (m), 1032 (m), 903 
(s), 836 (s), 779 (s) cm–1. 
 
HRMS (ESI):  calc. for C13H22BO4Si– [M–H]–:   281.1386, 
found:       281.1376. 
 
 
 
 
(E)-tert-butyl(5-(3-(4-((tert-butyldimethylsilyl)oxy)-2-methoxyphenyl)allyl)-2-
methoxyphenoxy)dimethylsilane (145) 
 
 
 
 
 
To a mixture of allylic alcohol 126 (155 mg, 0.510 mmol, 1 eq.) and boronic acid 144 
(156 mg, 0.550 mmol, 1.05 eq.) in CH2Cl2 (12 mL) was added Pd(PPh3)4 (35.0 mg, 
40.0 µmol, 6 mol-%) in a pressure tube. The reaction mixture was heated to 80 °C for 
9 h. After completion, sat. aq. NH4Cl (7 mL) was added and the biphasic mixture was 
extracted with CH2Cl2 (3 × 20 mL). The combined organic extracts were washed with 
sat. aq. NaCl (10 mL) and dried (Na2SO4). The crude product was purified by flash 
column chromatography [Isohexane:EtOAc 50:1] to afford benzylstyrene 145 (110 
mg, 41 %) as a pale yellow oil. 
 
Rf : 0.42 (Isohexane:EtOAc 10:1). 
 
1H NMR (600 MHz, CDCl3): δ 7.24 (d, J = 8.3 Hz, 1H), 6.80 – 6.72 (m, 3H), 6.65 (d, 
J = 15.9 Hz, 1H), 6.38 (dd, J = 8.3, 2.3 Hz, 1H), 6.35 (d, J = 2.3 Hz, 1H), 6.19 (dt, J = 
15.9, 7.0 Hz, 1H), 3.79 (s, 3H), 3.78 (s, 3H), 3.42 (dd, J = 7.0, 1.3 Hz, 2H), 0.99 (s, 
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MeO
OMe
OTBS
	  150	  
9H), 0.98 (s, 9H), 0.20 (s, 6H), 0.15 (s, 6H) ppm. 
 
13C NMR (150 MHz, CDCl3): δ 157.5, 156.2, 149.5, 145.1, 133.7, 128.5, 127.3, 
125.3, 121.7, 121.7, 120.4, 112.5, 112.2, 103.8, 55.9, 55.6, 39.2, 26.0, 25.9, 18.7, 
18.5, –4.1, –4.4 ppm. 
 
IR (ATR): ṽ = 2952 (m), 2945 (m), 2861 (m), 1597 (s), 1574 (s), 1510 (s), 1475 (s), 
1450 (s), 1414 (m), 1276 (s), 1259 (s), 1162 (s), 983 (s), 850 (s), 790 (s) cm–1. 
 
HRMS (ESI):  calcd. for C29H45O4Si2+  [M–H]+:   513.2862, 
found:       513.2856. 
 
 
 
 
4-bromobenzene-1,2-diol (147)[65] 
 
 
 
 
 
To a stirred solution of catechol (146) (2.30 g, 20.0 mmol, 1 eq.) in MeCN (15 mL) 
was added HBF4Et2O (5.10 mL, 20.0 mmol, 1 eq.) at –20 °C. After 5 min, N-bromo-
succinimide (3.70 g, 21.0 mmol, 1.05 eq.) was added in small portions over a period 
of 10 min. After 30 min, reaction was warmed to room temperature and was stirred at 
this temperature for 10 h. After completion, H2O (50 mL) was added to reaction 
mixture and was extracted with Et2O (3 × 70 mL). The organic extracts were washed 
with aq. NaHSO3 (4% w/v, 2 ×  50 mL), sat. aq. NaCl (50 mL) and dried (Na2SO4). 
The crude product was purified by flash column chromatography [Isohexane:EtOAc 
4:1] to afford bromocatechol 147 (2.37 g, 63%) as a colorless solid. 
 
Rf: 0.19 (Isohexane:EtOAc 10:1). 
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mp (EtOAc): 86.7 – 88.3 °C. 
 
1H NMR (300 MHz, CDCl3): δ 7.02 (d, J = 2.3 Hz, 1H), 6.93 (dd, J = 8.5, 2.3 Hz, 
1H), 6.74 (d, J = 8.5 Hz, 1H), 5.45 (s, 1H, OH), 5.32 (s, 1H, OH) ppm. 
 
13C NMR (75 MHz, CDCl3): δ 144.6, 142.9, 124.2, 118.9, 116.9, 112.8 ppm. 
 
IR (ATR): ṽ = 3337 (br), 1596 (m), 1499 (s), 1425 (s), 1350 (m), 1324 (m), 1264 (s), 
1234 (s), 1175 (s), 1104 (s), 1068 (m), 881 (s), 847 (m), 797 (s), 775 (s) cm–1. 
 
HRMS (EI):  calcd. for C6H5O2Br+ [M]+:   187.9467, 
found:      187.9463 
 
 
((4-bromo-1,2-phenylene)bis(oxy))bis(tert-butyldimethylsilane) (148)[66] 
 
 
 
 
 
To a stirred solution of bromo catechol 147 (1.08 g, 5.70 mmol, 1 eq.) in DMF (20 
mL) was added TBSCl (1.72 g, 11.4 mmol, 2.4 eq.), imidazole (1.86 g, 4.80 mmol, 
4.8 eq.) and 4-dimethylaminopyridine (139 mg, 0.200 mmol, 20 mol-%) at 0 °C. The 
reaction mixture was allowed to warm to room temperature and was stirred for 10 h. 
After completion, H2O (30 mL) was added and the biphasic mixture was extracted 
with Et2O (3 × 50 mL). The combined organic extracts were washed with aq. NaCl 
(10%, 20 mL), sat. aq. NaCl (30 mL) and dried (Na2SO4). The crude product was 
purified by flash column chromatography [Isohexane] to afford TBS phenol 148 (2.44 
g, 99%) as colorless solid. 
 
Rf: 0.87 (Isohexane:EtOAc 30:1). 
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mp (Isohexane): 41.6 – 45.7 °C. 
 
1H NMR (300 MHz, CDCl3): δ 6.95 (d, J = 2.3 Hz, 1H), 6.92 (dd, J = 8.4, 2.3 Hz, 
1H), 6.69 (d, J = 8.4 Hz, 1H), 0.98 (s, 9H), 0.97 (s, 9H), 0.20 (s, 6H), 0.18 (s, 6H) 
ppm. 
 
13C NMR (75 MHz, CDCl3): δ 148.1, 146.6, 124.5, 124.4, 122.4, 112.9, 26.1, 26.1, 
18.7, 18.7, –3.9, –3.9 ppm. 
 
IR (ATR): ṽ = 2953 (m), 2928 (m), 2857 (m), 1581 (m), 1491 (s), 1471 (s), 1396 (m), 
1287 (s), 1252 (s), 1210 (s), 1119 (s), 935 (s), 894 (s), 836 (s), 777 (s) cm–1. 
 
HRMS (EI):  calcd. for C18H33BrO2Si2+ [M]+:   416.1197, 
found:       416.1189. 
 
 
 
 
((4-(3,3,4,4-tetramethylborolan-1-yl)-1,2-phenylene)bis(oxy))bis(tert-
butyldimethylsilane) (150)[67] 
 
 
 
 
 
To a stirred solution of bromide 148 (84.0 mg, 0.200 mmol, 1 eq.) in THF (2 mL) was 
added n-BuLi (2.5 M in THF, 96.0 µL, 0.240 mmol, 1.2 eq.) dropwise at –78 °C. 
After 40 min, B(OiPr)(pinacol) (49.0 µL, 0.240 mmol, 1.2 eq.) was added and was 
stirred at –78 °C for 2 h. After completion, H2O (5 mL) was added and the biphasic 
mixture was extracted with Et2O (3 × 15 mL), washed with sat. aq. NaCl (10 mL) and 
dried (Na2SO4). The crude product was purified by flash column chromatography 
B
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[Isohexane:EtOAc 40:1] to afford boronic acid 150 (80.0 mg, 86%) as a white 
powder. 
 
Rf: 0.81 (Isohexane:EtOAc 30:1). 
 
mp (EtOAc): 51.2 – 53.7°C. 
 
1H NMR (400 MHz, CDCl3): δ 7.28 (dd, J = 7.9, 1.6 Hz, 1H), 7.25 (d, J = 1.6 Hz, 
1H), 6.82 (d, J = 7.9 Hz, 1H), 1.32 (s, 12H), 1.00 (s, 9H), 0.98 (s, 9H), 0.20 (s, 6H), 
0.20 (s, 6H) ppm. 
 
13C NMR (100 MHz, CDCl3): δ 150.2, 146.6, 128.8, 127.7, 120.9, 83.7, 26.2, 26.2, 
25.1, 18.8, 18.6, –3.8, –3.9 ppm. 
 
IR (ATR): ṽ = 2956 (m), 2928 (m), 2857 (m), 1597 (m), 1511 (m), 1402 (s), 1351 (s), 
1283 (s), 1251 (s), 1211 (s), 1144 (s), 1124 (s), 970 (s), 953 (s), 897 (s), 833 (s), 779 
(s) cm–1. 
 
HRMS (EI):  calc. for C24H45BO4Si2+ [M]+:   464.2944, 
found:       464.2946. 
 
 
 
 
4-bromobenzene-1,3-diol (154)[68] 
 
 
 
 
 
A stirred mixture of 2,4-dihydroxybenzoic acid (153) (10.0 g, 64.9 mmol, 1 eq.) and 
acetic acid (75 mL) was heated to 50 °C. After cooling to 35 °C a solution of bromine 
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(3.30 mL, 10.4 g, 64.9 mmol, 1 eq.) in acetic acid (55 mL) was added dropwise over a 
period of 1 h 30 min. The mixture was poured in H2O (1 L) and kept over night at 
0 °C. The precipitate was collected, washed with ice cold H2O (100 mL) and air dried 
over night. Afterwards the solid was suspended in H2O (325 mL), heated to reflux for 
1 h, hot filtrated and cooled in an ice bath for 1 h. The precipitate was collected and 
washed with ice cold H2O (20 mL). Then the precipitate was again suspended in H2O 
(175 mL), refluxed for 29 h, filtered and cooled to room temperature. After addition 
of sat. aq. NaCl (10 mL) the resulting solution was extracted with Et2O (2 × 100 mL), 
the combined organic phases washed with sat. aq. NaCl (50 mL) and dried (MgSO4). 
Removal of the solvent in vacuo afforded 154 (6.48 g, 53%) as a colorless solid. 
 
Rf: 0.34 (Isohexane: EtOAc 7:3). 
 
mp (acetone): 100.2 – 101.8 °C. 
 
1H NMR (400 MHz, CDCl3): δ 7.28 (d, J = 8.7 Hz, 1H), 6.54 (d, J = 2.9 Hz, 1 H), 
6.34 (dd, J = 8.7, 2.9 Hz, 1H), 5.47 (s, 1H, OH), 4.84 (s, 1H, OH) ppm. 
 
13C NMR (100 MHz, CDCl3): δ 156.6, 153.2, 132.4, 109.6, 103.6, 101.3 ppm. 
 
IR (ATR): ṽ = 3462 (m), 3317 (m), 1619 (m), 1505 (s), 1157 (s), 1119 (s), 966 (s), 
834 (s) cm−1. 
 
HRMS (ESI):  calcd. for C6H4BrO2– [M–H]−:  186.9400, 
found       186.9401. 
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4-bromo-3-methoxyphenyl 4-methylbenzenesulfonate (155)[68] 
 
 
 
 
 
To a stirred solution of 3-bromobenzene-1,2-diol 154 (1.00 g, 5.29 mmol, 1 eq.) in 
acetone (75 mL) was added tosyl chloride (1.11 g, 5.82 mmol, 1.1 eq.) and K2CO3 
(2.20 g, 15.9 mmol, 1.5 eq.). After heating at 80 °C for 24 h MeI (0.660 mL, 11.0 
mmol, 2.1 eq.) was added and heating continued for 3 h 30 min. The mixture was 
cooled to room temperature, the solids removed by filtration and washed with acetone 
(50 mL). Then the filtrate was concentrated in vacuo to 25 mL volume. After addition 
of H2O (50 mL) and sat. aq. NaCl (20 mL) the solution was extracted with EtOAc (3 
× 50 mL). The combined organic phases were washed with H2O (20 mL), sat. aq. 
NaCl (5 mL) and dried (MgSO4). Removal of the solvent in vacuo afforded 155 (1.85 
g, 98%) as a colorless solid. 
 
Rf: 0.45 (Isohexane: EtOAc 4:1). 
 
mp (acetone): 68.2 – 70.6 °C. 
 
1H NMR (300 MHz, CDCl3): δ 7.74 – 7.70 (m, 2H), 7.40 (d, J = 8.6 Hz, 1H), 7.35 – 
7.31 (m, 2H), 6.60 (d, J = 2.6 Hz, 1H), 6.41 (dd, J = 8.6, 2.6 Hz, 1H), 3.78 (s, 3H), 
2.45 (s, 3H) ppm. 
 
13C NMR (75 MHz, CDCl3): δ 156.7, 149.7, 145.8, 133.5, 132.3, 130.0, 128.8, 115.4, 
110.1, 107.2, 56.5, 21.9 ppm. 
 
IR (ATR): ṽ = 2939 (w), 1594 (m), 1177 (s), 1136 (s), 946 (s), 783 (s) cm−1. 
 
HRMS (EI): calcd. for C14H13BrO4S+ [M•]+:  355.9718, 
found:       355.9715. 
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4-bromo-3-methoxyphenol (156)[68] 
 
 
 
 
 
To a stirred solution of 4-bromo-3-methoxyphenyl 4-methylbenzenesulfonate 155 
(1.71 g, 4.79 mmol, 1 eq.) in MeOH (60 mL) was added aq. NaOH (2 M, 11.0 mL, 
880 mg, 22.0 mmol, 4.6 eq.). The mixture was heated to 60 °C for 3 h. Then the 
mixture was concentrated in vacuo and the residue was neutralized under ice bath 
cooling with aq. HCl (2 M). After addition of sat. aq. NaCl (10 mL) the mixture was 
extracted with CH2Cl2 (3 × 60 mL). The combined organic phases were washed with 
H2O (40 mL), sat. aq. NaCl (50 mL) and dried (Na2SO4). The solvent was removed in 
vacuo and the crude product purified by flash column chromatography [Isohexane: 
EtOAc 7:1] to provide 156 (831 mg, 85%) as a colorless solid. 
 
Rf: 0.51 (Isohexane: EtOAc 7:3). 
 
mp (EtOAc): 71.1 – 73.4 °C. 
 
1H NMR (300 MHz, CDCl3): δ 7.34 (d, J = 8.5 Hz, 1H), 6.45 (d, J = 2.7 Hz, 1H), 
6.33 (dd, J = 8.5, 2.7 Hz, 1H), 4.97 (s, 1H, OH), 3.85 (s, 3H) ppm. 
 
13C NMR (75 MHz, CDCl3): δ 156.9, 156.3, 133.5, 108.7, 102.4, 100.6, 56.3 ppm. 
 
IR (ATR): ṽ = 3454 (m), 1582 (m), 1296 (s), 1042 (s), 821 (s), 791 (s) cm−1. 
 
HRMS (ESI): calcd. for C7H6BrO2– [M–H]−:  200.9557, 
found:      200.9558. 
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(4-bromo-3-methoxyphenoxy)(tert-butyl)dimethylsilane (157)[49] 
 
 
 
 
 
To a stirred solution of 4-bromo-3-methoxyphenol (156) (379 mg, 1.87 mmol, 1 eq.) 
in DMF (5 mL) was added successively imidazole (166 mg, 2.44 mmol, 1.3 eq.), 4-
dimethylaminopyridine (18 mg, 0.15 mmol, 8 mol-%) and TBSCl (489 mg, 2.44 
mmol, 1.3 eq.). The mixture was warmed to room temperature and after 2 h H2O (10 
mL) was added. Then the mixture was extracted with Et2O (4 × 10 mL), the organic 
extracts were washed with aq. NaCl (10%, 15 mL) and sat. aq. NaCl (10 mL). Drying 
(MgSO4), removal of the solvent in vacuo and purification of the crude product by 
flash column chromatography [Isohexane] afforded 157 (290 mg, 49%) as a colorless 
oil. 
 
Rf: 0.54 (Isohexane: EtOAc 16:1). 
 
1H NMR (300 MHz, CDCl3): δ 7.33 (d, J = 8.5 Hz, 1H), 6.41 (d, J = 2.6 Hz, 1H), 
6.34 (dd, J = 8.5, 2.6 Hz, 1H), 3.85 (s, 3H), 0.98 (s, 9H), 0.20 (s, 6H) ppm. 
 
13C NMR (75 MHz, CDCl3): δ 156.6, 156.4, 133.2, 113.4, 105.2, 103.2, 56.3, 25.8, 
18.4, –4.3 ppm. 
 
IR (ATR): ṽ = 2954 (m), 2929 (m), 1587 (m), 1202 (s), 975 (s), 834 (s), 778 (s) cm−1. 
 
HRMS (EI): calcd. for C13H21BrO2Si+ [M•]+: 316.0494, 
found:     316.0486. 
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4-iodo-3-methoxyphenol (159)[69] 
 
 
 
 
 
To a stirred solution of 3-methoxyphenol 158 (4.00 g, 32.2 mmol, 1 eq.) in MeOH 
(100 mL) was added NaOH (1.29 g, 32.2 mmol, 1 eq.) and NaI (4.83 g, 38.6 mmol, 1 
eq.) and the mixture was cooled to 0 °C. Bleach (containing 13% active chlorine, 22.1 
g, corresponding to 2.87 g, 38.6 mmol, 1.2 eq. NaOCl) was added dropwise over a 
period of 1 h. After addition the mixture was warmed to room temperature, stirred for 
45 min and sat. aq. Na2S2O3 (40 mL) was added. The mixture was acidified with aq. 
HCl (2 M) to pH 6. The solids were removed and washed with Et2O (30 mL). The 
organic phase of the filtrate was removed and the aqueous phase was extracted with 
Et2O (100 mL, 50 mL). The combined organic phases were washed with H2O (30 
mL), sat. aq. NaCl (100 mL) and dried (MgSO4). The solvent was removed in vacuo 
and purification of the crude product by flash column chromatography [CH2Cl2: 
Isohexane 3:7 → 1:1] afforded iodide 159 (1.95 g, 41%) as a slightly pink solid. 
 
Rf: 0.52 (Isohexane: EtOAc 7:3). 
 
mp (CH2Cl2): 66.4 – 70.4 °C. 
 
1H NMR (300 MHz, CDCl3): δ 7.55 (d, J = 8.4 Hz, 1H), 6.40 (d, J = 2.6 Hz, 1H), 
6.26 (dd, J = 8.4, 2.6 Hz, 1H) 5.24 (s, 1H, OH), 3.83 (s, 3H) ppm. 
 
13C NMR (75 MHz, CDCl3): δ 159.2, 157.4, 139.5, 109.7, 99.9, 74.6, 56.4 ppm. 
 
IR (ATR): ṽ = 3351 (m), 2975 (w), 2941 (w), 1581 (s), 1194 (s), 1033 (s), 1016 (s), 
826 (s) cm−1. 
 
HRMS (ESI): calcd. for C7H6IO2– [M–H]−:  248.9418, 
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found:      248.9420. 
 
 
 
 
4-allylbenzene-1,2-diol (161)[50] 
 
 
 
 
 
To a stirred suspension of IBX (7.50 g, 26.8 mmol, 2.2 eq.) in THF (150 mL) was 
added eugenol (160) (2.00 g, 12.2 mmol, 1 eq.) and the mixture was stirred in the dark 
for 24 h. Then a solution of Na2S2O4 (12.7 g, 73.2 mmol. 6.0 eq.) in H2O (50 mL) was 
added and stirring in the dark was continued for 2 h 30 min. Then phases were 
separated and sat. aq. NH4Cl (20 mL) was added to the aqueous phase. The aqueous 
phase was extracted with Et2O (2 × 20 mL) and the combined organic phases were 
concentrated in vacuo. The residue was resuspended in EtOAc (100 mL), filtered, 
washed with sat. aq. NaHCO3 (3 × 50 mL), H2O (30 mL), sat. aq. NaCl (30 mL) and 
dried (Na2SO4). The crude product was purified by flash column chromatography 
[Isohexane:EtOAc 4:1] to afford allylcatechol 161 (1.19 g, 65%) as a pale red solid. 
 
Rf: 0.47 (Isohexane:EtOAc). 
 
mp (EtOAc): 42.8 – 43.7 °C. 
 
1H NMR (300 MHz, CDCl3): δ 6.80 (d, J = 8.0 Hz, 1H), 6.72 (d, J = 2.0 Hz, 1H), 
6.64 (dd, J = 8.0, 2.0 Hz, 1H), 5.92–5.86 (m, 1H), 5.41 (s, 2H, OH), 5.09–5.03 (m, 
2H), 3.27 (d, J = 6.7 Hz, 2H) ppm. 
 
13C NMR (75 MHz, CDCl3): δ 143.6, 141.8, 137.8, 133.6, 121.3, 116.0, 115.8, 115.6, 
39.7 ppm. 
HO
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IR (ATR): ṽ = 3242 (w), 2895 (w), 1603 (w), 1515 (w), 1252 (s), 1185 (s), 1109 (s), 
787 (s) cm–1. 
 
HRMS (ESI):  calculated for C9H9O2– [M–H]–:  149.0608 
found:      149.0608. 
 
 
 
 
((4-allyl-1,2-phenylene)bis(oxy))bis(tert-butyldimethylsilane) (162)[70] 
 
 
 
 
 
To a stirred mixture of allylcatechol 161 (1.19 g, 7.92 mmol, 1 eq.) in DMF (15 mL) 
was added TBSCl (2.80 g, 19.0 mmol, 2.4 eq.), imidazole (2.59 g, 38.0 mmol. 4.8 eq.) 
and 4-dimethylaminopyridine (232 mg, 1.90 mmol, 24 mol-%) at 0 °C. The reaction 
mixture was allowed to warm to room temperature and was stirred for 4 h. After 
completion, H2O (30 mL) was added and the biphasic mixture was extracted with 
Et2O (3 × 30 mL). The combined organic extracts were washed with aq. NaCl (10%, 
2 × 20 mL), sat. aq. NaCl (20 mL) and dried (MgSO4). The crude product was 
purified by flash column chromatography [Isohexane] to afford allyl species 162 
(2.43 g, 81%) as a colorless oil. 
 
Rf: 0.21 (Isohexane). 
 
1H NMR (300 MHz, CDCl3): δ 6.75 (d, J = 8.0 Hz, 1H), 6.65 (d, J = 2.2 Hz, 1H), 
6.61 (dd, J = 8.0, 2.2 Hz, 1H), 6.00–5.87 (m, 1H), 5.07–5.02 (m, 2H), 3.26 (d, J = 6.7 
Hz, 2H), 1.00 (s, 9H), 1.00 (s, 9H), 0.20 (s, 6H), 0.20 (s, 6H) ppm. 
 
TBSO
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13C NMR (75 MHz, CDCl3): δ 146.8, 145.2, 138.0, 133.3, 121.7, 121.5, 121.0, 115.5, 
39.7, 26.2 (2C), 18.7, 18.7, –3.9, –3.9 ppm. 
 
IR (ATR): ṽ = 2928 (w), 2857 (w), 1576 (w), 1507 (s), 1251 (s), 902 (s), 835 (s), 777 
(s) cm–1. 
 
HRMS (EI):  calcd. for C21H38O2Si2+ [M]+:   378.2405, 
found       378.2404. 
 
 
 
 
4-hydroxy-2-methoxybenzaldehyde (184)[71] 
 
 
 
 
 
To a stirred suspension of NaH (60%, 77 mg, 3.20 mmol, 2 eq.) in dry THF (20 mL) 
was added 4-iodo-3-methoxyphenol 159 (400 mg, 1.60 mmol, 1 eq.). After 30 min the 
mixture was cooled to –78 °C and n-BuLi (2.49 M in hexane, 1.29 mL, 3.20 mmol, 2 
eq.) was added dropwise. After 40 min dry DMF (0.370 mL, 4.80 mmol, 3 eq.) was 
added dropwise, the mixture warmed to 0 °C and stirred for 1 h. Sat. aq. NH4Cl (4 
mL) and H2O (20 mL) were added at 0 °C. The mixture was extracted with EtOAc (3 
× 40 mL), the organic extracts washed with sat. aq. NaCl (40 mL) and dried (MgSO4). 
Removal of the solvent in vacuo and purification of the crude product by flash 
column chromatography [Isohexane: EtOAc 4:1 → 0:1) afforded benzaldehyde 184 
(157 mg, 64%) as a pale yellow solid. 
 
Rf: 0.17 (Isohexane: EtOAc 7:3). 
 
mp (EtOAc): 152.0 – 155.0 °C. 
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1H NMR (400 MHz, d6-acetone): δ 10.23 (d, J = 0.8 Hz, 1H), 9.35 (s, 1H, OH), 7.64 
(d, J = 8.5 Hz, 1H), 6.57 (d, J = 2.1 Hz, 1H), 6.53 (ddd, J = 8.5, 2.1, 0.8 Hz, 1H), 3.91 
(s, 3H) ppm.  
 
13C NMR (400 MHz, d6-acetone): δ 187.3, 165.6, 165.1, 130.7, 119.1, 109.1, 99.7, 
56.1 ppm. 
 
IR (ATR): ṽ = 3135 (m), 1658 (m), 1569 (s), 1266 (s), 1245 (s), 1208 (s), 837 (s) 
cm−1. 
 
HRMS (EI): calcd. for C8H8O3+ [M•]+:  152.0473, 
found:      152.0475. 
 
 
 
 
tert-butyl(3-methoxy-4-vinylphenoxy)dimethylsilane (185) 
 
 
 
 
 
To a stirred mixture of Ph3PMeBr (54.0 mg, 0.150 mmol, 1 eq.) and THF (1.5 mL) 
was added n-BuLi (2.49 M in hexane, 60.0 µL, 0.150 mmol, 1 eq.) dropwise at 0 °C. 
After 1 h 30 min benzaldehyde 125 (40.0 mg, 0.150 mmol, 1 eq.) was added and the 
mixture was slowly warmed to room temperature over a period of 3 h 30 min. Then 
sat. aq. NH4Cl (3 mL) was added dropwise at 0 °C. After addition of H2O the mixture 
was extracted with CH2Cl2 (3 × 3 mL) and the organic extracts were dried (MgSO4). 
Removal of the solvent in vacuo and purification of the crude product by flash 
column chromatography [Isohexane: EtOAc 1:0 → 50:1) afforded styrene 185 (25.0 
mg, 63%) as a yellow oil  
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Rf: 0.50 (Isohexane: EtOAc 16:1). 
 
1H NMR (400 MHz, d6-acetone): δ 7.38 (d, J = 8.3 Hz, 1H), 6.92 (dd, J = 17.8, 11.2 
Hz, 1H), 6.49 (d, J = 2.3 Hz, 1H), 6.46 (dd, J = 8.3 Hz, 2.3 Hz, 1H), 5.63 (dd, J = 
17.8, 1.7 Hz, 1H), 5.08 (dd, J = 11.2, 1.7 Hz, 1H), 3.82 (s, 3H), 1.00 (s, 9H), 0.23 (s, 
6H) ppm. 
 
13C NMR (100 MHz, d6-acetone): δ 158.8, 157.6, 132.2, 127.7, 120.9, 112.8, 112.3, 
104.4, 55.8, 26.0, 18.8, –4.3 ppm. 
 
IR (ATR): ṽ = 2930 (w), 2858 (w), 1603 (m), 1572 (w), 1201 (s), 977 (s), 837 (s), 778 
(s) cm−1. 
 
HRMS (EI): calcd. for C15H24O2Si+ [M•]+:  264.1546, 
found:     264.1539. 
 
 
 
 
3-methoxy-4-(prop-1-en-1-yl)phenol (165) 
 
 
 
 
 
To a stirred mixture of Ph3PEtBr (3.99 g, 10.8 mmol, 1.4 eq.) in THF (40 mL) was 
added n-BuLi (2.49 M in hexane, 4.23 mL, 10.5 mmol, 1.4 eq.) dropwise at 0 °C. 
After 1 h benzaldehyde 125 (2.00 g, 7.52 mmol, 1 eq.) was added and the reaction 
mixture was slowly allowed to warm to room temperature over a period of 2 h. After 
completion, the reaction was quenched by slow addition of sat. aq. NH4Cl (40 mL) at 
TBSO
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0 °C and the mixture was diluted with H2O (20 mL). The mixture was extracted with 
Et2O (3 × 80 mL) and the combined organic extracts were washed with sat. aq. NaCl 
(20 mL) and dried (MgSO4). The crude product was purified by flash column 
chromatography [Isohexane:EtOAc 60:1] to afford propenephenol 165 (1.32 g, 63%) 
in a E/Z ratio of 2.1:1 as a pale yellow oil. 
 
For characterization purposes a pure sample of the E- isomer was obtained by 
repeated flash column chromatography and evaluated; subsequent reactions were 
carried out with the 2.1:1 E/Z mixture!  
 
Rf: 0.30 (Isohexane: EtOAc 16:1). 
 
1H NMR (300 MHz, CDCl3): δ  7.22 (d, J = 8.3 Hz, 1H), 6.61 (dd, J = 15.8, 1.8 Hz, 
1H), 6.39 (ddd, J = 8.3, 2.3, 0.4 Hz, 1H), 6.35 (d, J = 2.3 Hz, 1H), 6.10 (dq, J = 15.8, 
6.6 Hz, 1H), 3.80 (s, 3H), 1.87 (dd, J = 6.6, 1.8 Hz, 3H), 0.98 (s, 9H), 0.20 (s, 6H) 
ppm. 
 
13C NMR (75 MHz, CDCl3): δ  157.3, 155.9, 127.1, 125.5, 124.7, 120.8, 112.2, 103.8, 
55.6, 25.9, 19.1, 18.5, –4.1 ppm. 
 
IR (ATR): ṽ = 2954 (s), 2928 (s), 2856 (s), 1601 (s), 1498 (s), 1289 (w), 1252 (s), 
1200 (s), 1161 (s), 977 (s), 836 (s), 777 (s) cm–1. 
 
HRMS (EI):  calc. for C16H26O2Si+ [M] +:   278.1697, 
found:      278.1694. 
 
 
 
 
 
 
 
 
 (E)-4-(3-(4-hydroxy-2-methoxyphenyl)allyl)benzene-1,2-diol (120) 
	  165	  
 
 
 
 
 
To a stirred solution of TBS protected allylcatechol 162 (985 mg, 2.60 mmol, 2.5 eq.) 
and propenephenol 165 (290 mg, 1.04 mmol, 1 eq.) in CH2Cl2 (7 mL) was added 
Grubbs 2nd generation catalyst (53.0 mg, 0.062 mmol, 6 mol-%) in one portion and 
the reaction mixture was heated to 50 °C for 8 h. After completion, silica was added 
to the reaction mixture and was concentrated in vacuo. The crude product was 
purified by flash column chromatography [Isohexane:EtOAc 30:1] to afford a mixture 
of TBS protected benzylstyrene and homocoupling products. 
 
To a stirred solution of the mixture of metathesis products (assumed 1.04 mmol) in 
THF (3 mL) was added TBAF (1 M solution in THF, 3.12 mL, 3.12 mmol, 3.0 eq.) at 
0 °C. Reaction mixture was stirred at this temperature for 30 min. After completion, 
H2O (4 mL) was added and the biphasic mixture was extracted with Et2O (3 × 
10 mL). The combined organic extracts were washed with sat. aq. NaCl (3 mL) and 
dried (Na2SO4). The crude product was purified by flash column chromatography 
[CH2Cl2:MeOH 97:3] to afford only benzylstyrene 120 (135 mg, 48% over two steps) 
as a red oil. 
 
Rf: 0.33 (CH2Cl2:MeOH 10:1). 
 
1H NMR (400 MHz, d3-MeCN): δ 7.24 (d, J = 8.3 Hz, 1H), 6.73 (d, J = 8.1 Hz, 1H), 
6.69 (d, J = 1.9 Hz, 1H), 6.60 – 6.56 (m, 2H), 6.41 (d, J = 2.3 Hz, 1H), 6.35 (ddd, J = 
8.3, 2.3, 0.4 Hz, 1H), 6.16 (dt, J = 15.9, 7.0 Hz, 1H), 3.77 (s, 3H), 3.35 (dd, J = 7.0, 
1.5 Hz, 2H) ppm. 
  
13C NMR (100 MHz, d3-MeCN): δ  159.0, 158.8, 145.8, 144.1, 134.5, 129.0, 128.6, 
126.2, 121.5, 119.7, 116.9, 116.6, 108.6, 100.3, 56.5, 40.0 ppm. 
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IR (ATR): ṽ = 3320 (m), 2974 (m), 2894 (w), 1608 (m), 1504 (s), 1279 (s), 1193 (s), 
1106 (s), 954 (s), 831 (m) cm–1. 
  
HRMS (ESI):  calcd. for C16H15O4+ [M–H]+:   271.0965, 
found:       271.0964. 
 
 
 
 
santalin A (17) 
 
 
 
 
 
Benzylstyrene 120 (5.00 mg, 18.0 µmol, 1 eq.) and anhydrobase 30 (15.0 mg, 47.0 
µmol, 2.6 eq.) were dissolved in MeCN/MeOH (5:1, 0.6 mL). The reaction vessel was 
sealed and heated to 80 °C for 11 h. After this time, an orange precipitate formed and 
was collected from the reaction mixture by transferring the mixture to an Eppendorf 
tube and by sedimentation with a centrifuge. The precipitate was washed with MeOH 
(2 × 0.2 mL) and santalin A (17) (7.00 mg, 67 %) could be obtained as a dark red 
powder. 
 
Rf: 0.24 (CH2Cl2:MeOH 10:1). 
 
UV (CH2Cl2): λmax = 443, 470, 502 nm. 
 
mp (MeOH): 278 °C decomp. 
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1H NMR (600 MHz, CDCl3): δ  9.74 (s, 1H, OH), 9.60 (s, 1H, OH), 9.51 (s, 1H), 9.28 
(s, 1H, OH), 8.61 (s, 1H, OH), 8.51 (s, 1H, OH), 7.06 (s, 1H), 6.96 (d, J = 8.1 Hz, 
1H), 6.65 (s, 1H), 6.62 (d, J = 2.2 Hz, 1H), 6.55 (dd, J = 8.2, 2.2 Hz, 1H), 6.51 (d, J = 
8.2 Hz, 1H), 6.51 (d, J = 2.2 Hz, 1H), 6.37 (d, J = 1.2 Hz, 1H), 6.34 (dd, J = 8.2, 
2.2 Hz, 1H), 3.93 (d, J = 14.7 Hz, 1H), 3.89 (s, 3H), 3.79 (d, J = 14.7 Hz, 1H), 3.63 
(s, 3H), 3.58 (s, 3H) ppm. 
 
13C NMR (100 MHz, d6-DMSO): δ 177.3, 158.9, 157.6, 156.0, 152.2, 149.0, 148.4, 
144.7, 143.5, 143.1, 141.3, 141.3, 133.6, 131.5, 130.9, 125.9, 124.6, 121.3, 119.1, 
116.9, 116.6, 115.9, 115.2, 113.1, 107.4, 105.1, 103.4, 101.2, 99.4, 59.5, 55.4, 55.1, 
33.1 ppm. 
 
IR (ATR): ṽ = 3166 (m), 2923 (m), 2897 (m), 2362 (w), 1551 (m), 1497 (s), 1456 (s), 
1344 (s), 1293 (s), 1201 (s), 1023 (s) cm–1. 
 
HRMS (ESI):  calcd. for C33H27O10+ [M+H]+:   583.1599, 
found:       583.1607. 
 
Number 1H (Synthetic) 13C (Synthetic) 1H (Isolated)[2] 13C (Isolated)[2] 
OH 9.74 (s)  -  
OH 9.60 (s)  -  
OH 9.28 (s)  -  
OH 8.61 (s)  -  
OH 8.51 (s)  -  
1  149.0  149.0 
2  113.1  113.1 
3 9.51 (s) 133.6 9.52 (d, J = 0.4 
Hz) 
133.6 
4 7.06 (s) 105.1 7.06 (d, J = 0.4 
Hz) 
104.9 
5  152.2  152.1 
6  177.3  177.2 
7 6.37 (d, J = 1.2 
Hz) 
101.2 6.38 (d, J = 1.3 
Hz) 
101.1 
8  156.0  156.0 
9  121.3  121.2 
10  116.9  116.9 
11  143.5  143.5 
12  141.3  141.2 
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13  148.4  148.3 
14 6.65 (s) 103.4 6.67 (s) 103.4 
15  124.6  124.6 
16 3.79, 3.93 (ABq, 
J = 14.7 Hz)  
33.1 3.82, 3.95 (ABq, 
J = 14.8 Hz) 
33.0 
17  125.9  125.9 
18  141.3  141.3 
19  157.6  157.7 
20  99.4  99.3 
21 6.62 (d, J = 2.2 
Hz) 
158.9 6.65 (d, J = 2.2 
Hz) 
158.9 
22  107.4  107.3 
23 6.55 (d, J = 8.2, 
2.2 Hz) 
131.5 6.57 (dd, J = 8.2, 
2.2 Hz) 
131.4 
24 6.96 (d, J = 8.2 
Hz) 
116.6 6.97 (d, J = 8.2 
Hz) 
116.6 
25  130.9  130.9 
26 6.51 (s) 115.9 6.54 (d, J = 2.2 
Hz) 
115.8 
27  144.7  144.6 
28  143.1  143.0 
29 6.51 (d, J = 8.1 
Hz) 
115.2 6.54 (d, J = 8.2 
Hz) 
115.1 
30 6.34 (dd, J = 
8.2, 2.2 Hz) 
119.1 6.36 (dd, J = 8.2, 
2.2 Hz) 
119.1 
31 3.89 (s) 59.5 3.91 (s) 59.4 
32 3.63 (s) 55.4 3.65 (s) 55.3 
33 3.58 (s) 55.1 3.59 (s) 55.0 
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(E)-4-(3-(4-((tert-butyldimethylsilyl)oxy)-2-methoxyphenyl)allyl)-2-
methoxyphenol (166) 
 
 
 
 
 
To a stirred solution of eugenol (160) (354 mg, 2.16 mmol, 3 eq.) and propenephenol 
165 (200 mg, 0.720 mmol, 1 eq.) in CH2Cl2 (6 mL) was added Grubbs 2nd generation 
catalyst (61.0 mg, 0.0700 mmol, 0.1 eq.) in one portion and the reaction mixture was 
heated at 50 °C for 8 h. After completion, silica was added to the reaction mixture and 
was concentrated in vacuo. The crude product was purified by flash column 
chromatography [Isohexane:EtOAc 10:1] to afford benzylstyrene 166 (244 mg, 85%) 
as a dark-yellow oil. 
 
Rf: 0.28 (Isohexane: EtOAc 7:1). 
 
1H NMR (600 MHz, d3-MeCN): δ  7.26 (d, J = 8.3 Hz, 1H), 6.83 (d, J = 2.0 Hz, 1H), 
6.75 (d, J = 8.0 Hz, 1H), 6.68 (dd, J = 8.0, 2.0 Hz, 1H), 6.62 (d, J = 15.8 Hz, 1H), 
6.44 (d, J = 2.2 Hz, 1H), 6.40 (dd, J = 8.3, 2.2 Hz, 1H), 6.32 (s, 1H, OH), 6.24 (td, J = 
15.8, 7.0 Hz, 1H), 3.83 (s, 3H), 3.77 (s, 3H), 3.43 (dd, J = 7.0, 1.5 Hz, 2 H), 0.99 (s, 
9H), 0.20 (s, 6H) ppm. 
 
13C NMR (150 MHz, d3-MeCN): δ 158.8, 157.45, 148.6, 145.7, 133.9, 129.9, 128.4, 
126.1, 122.2, 121.4, 116.0, 113.5, 113.4, 105.1, 57.0, 56.6, 40.3, 26.4, 19.3, –3.8 ppm. 
 
IR (ATR): ṽ = 3423 (w), 2954 (m), 2928 (m), 2856 (m), 1601 (s), 1499 (s), 1462 (m), 
1287 (s), 1199 (s), 975 (s), 834 (s), 778 (s) cm–1. 
 
HRMS (ESI):  calcd. for C23H31O4Si+ [M–H]+:  399.1986, 
found:      399.1988. 
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(E)-4-(3-(4-hydroxy-2-methoxyphenyl)allyl)-2-methoxyphenol (167) 
 
 
 
 
 
To a stirred solution of metathesis product 166 (87.0 mg, 0.220 mmol, 1 eq.) in THF 
(2 mL) was added TBAF (1 M solution in THF, 262 µL, 0.260 mmol, 1.2 eq.) at 0 °C. 
The reaction mixture was stirred at this temperature for 30 min and after completion, 
H2O (3 mL) was added. The reaction mixture was extracted with Et2O (3 × 8 mL) and 
combined organic extracts were washed with sat. aq. NaCl (2 mL) and dried 
(Na2SO4). The crude product was purified by flash column chromatography 
[CH2Cl2:MeOH 99:1] to afford benzylstyrene 167 (30.0 mg, 48%) as a yellow oil.  
 
Rf: 0.47 (CH2Cl2: MeOH 10:1). 
 
1H NMR (400 MHz, CDCl3): δ 7.24 (d, J = 8.4 Hz, 1H), 6.94 (br, 1H, OH) 6.83 (d, J 
= 1.9 Hz, 1H), 6.74 (d, J = 8.0 Hz, 1H), 6.68 (dd, J = 8.0, 1.9 Hz, 1H), 6.60 (dt, J = 
15.9, 1.5 Hz, 1H), 6.41 (d, J = 2.3 Hz, 1H), 6.34 (ddd, J = 8.4, 2.3, 0.4 Hz, 1H), 6.30 
(br, 1H, OH), 6.20 (dt, J = 15.9, 7.0 Hz, 1H), 3.83 (s, 3H), 3.77 (s, 3H), (dd, J = 7.0, 
1.5 Hz, 2H) ppm. 
 
13C NMR (100 MHz, CDCl3): δ 159.0, 158.8, 148.5, 145.7, 134.1, 129.0, 128.7, 
126.2, 122.2, 119.7, 115.9, 113.4, 108.6, 100.3, 57.0, 56.5, 40.3 ppm. 
 
IR (ATR): ṽ = 3378 (m), 2936 (m), 2836 (w), 1599 (s), 1504 (s), 1462 (s), 1429 (s), 
1266 (s), 1194 (s), 1154 (s), 1030 (s), 954 (s) cm–1. 
 
HRMS (ESI):  calcd. for C17H17O4+ [M–H]+:   285.1121, 
found:       285.1129. 
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santalin B (18) 
 
 
  
 
 
Benzylstyrene 167 (4.00 mg, 14.0 µmol, 1 eq.) and anhydrobase 30 (11.0 mg, 35.0 
µmol, 2.5 eq.) were dissolved in MeCN/MeOH (5:1, 0.6 mL). The reaction vessel was 
sealed and was heated for 12 h. After this time, the reaction mixture was concentrated 
in vacuo. Purification by Sephadex column chromatography (LH-20, MeOH) afforded 
santalin B (18) (5.00 mg, 62%) as a dark red oil. 
 
Rf: 0.33 (CH2Cl2: MeOH 10:1). 
 
UV (CH2Cl2): λmax = 447, 470, 502 nm. 
 
1H NMR (600 MHz, d6–DMSO): δ  9.77 (s, 1H, OH), 9.61 (s, 1H, OH), 9.51 (s, 1H), 
9.28 (s, 1H, OH), 8.62 (s, 1H, OH), 7.06 (s, 1H), 6.98 (d, J = 8.1 Hz, 1H), 6.66 (s, 
1H), 6.65 (d, J = 2.2 Hz, 1H), 6.63 (d, J = 1.9 Hz, 1H), 6.56 (dd, J = 8.3, 2.2 Hz, 1H), 
6.56 (d, J = 8.2 Hz, 2H), 6.51 (d, J = 8.2, 1.9 Hz, 1H), 6.42 (d, J = 1.1 Hz, 1H), 4.05 
(d, J = 14.6 Hz, 2H), 3.89 (s, 3H), 3.89 (d, J = 14.6 Hz, 1H), 3.64 (s, 3H), 3.63 (s, 
3H), 3.59 (s, 3H) ppm. 
 
13C NMR (100 MHz, d6-DMSO): δ  177.1, 159.0, 157.7, 156.0, 152.1, 148.9, 148.4, 
147.0, 144.5, 143.5, 141.3, 141.2, 133.5, 131.6, 130.8, 125.9, 124.6, 121.3, 120.7, 
116.9, 116.6, 115.0, 113.2, 112.6, 107.3, 104.9, 103.3, 101.0, 99.6, 59.5, 55.4, 55.4, 
55.2, 33.1 ppm. 
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IR (ATR): ṽ = 3142 (m), 3002 (m), 2928 (m), 1608 (m), 1550 (m), 1494 (s), 1460 (s), 
1433 (s), 1288 (s), 1257 (s), 1083 (s), 1007 (s) cm–1. 
 
HRMS (ESI):  calcd. for C34H29O10+ [M+H]+:   597.1755, 
found:       597.1762. 
 
Number 1H (synthetic) 13C (Synthetic) 1H (Isolated)[2] 13C (Isolated)[2] 
OH 9.77 (s)  -  
OH 9.61 (s)  -  
OH 9.28 (s)  -  
OH 8.62 (s)  -  
1  148.9  148.9 
2  113.2  113.1 
3 9.51 (s) 133.5 9.52 (d, J = 0.3 
Hz) 
133.6 
4 7.06 (s) 104.9 7.07 (d, J = 0.3 
Hz) 
105.0 
5  152.1  152.1 
6  177.1  177.2 
7 6.42 (d, J = 1.1 
Hz) 
101.0 6.44 (d, J = 1.0 
Hz) 
101.1 
8  156.0  156.0 
9  121.3  121.2 
10  116.9  116.9 
11  143.5  143.5 
12  141.3  141.3 
13  148.4  148.3 
14 6.66 (s) 103.3 6.68 (s) 103.4 
15  124.6  124.5 
16 3.89, 4.05 
(ABq, J = 14.6 
Hz) 
33.1 3.90, 4.05 
(ABq, J = 14.5 
Hz) 
33.0 
17  125.9  125.8 
18  141.2  141.2 
19  157.7  157.7 
20  159.0  159.0 
21 6.65 (d, J = 2.2 
Hz) 
99.6 6.67 (d, J = 2.2 
Hz) 
99.5 
22  116.6   116.6 
23 6.57 (dd, J = 
8.3, 2.2 Hz) 
107.3 6.59 (dd, J = 
8.3, 2.0 Hz) 
107.4 
24 6.98 (d, J = 8.2 
Hz) 
131.6 7.00 (d, J = 8.3 
Hz) 
131.7 
25  130.8  130.8 
26 6.63 (d, J = 1.9 
Hz) 
112.6 6.65 (d, J = 1.9 
Hz) 
112.7 
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27  147.0  147.0 
28  144.5  144.4 
29 6.56 (d, J = 8.2 
Hz) 
115.0 6.59 (d, J = 8.2 
Hz) 
115.1 
30 6.51 (dd, J = 
8.2, 1.9 Hz) 
120.7 6.36 (dd, J = 
8.2, 1.9 Hz) 
120.6 
31 3.89 (s) 59.5 3.91 (s) 59.4 
32 3.63 (s) 55.4 3.65 (s) 55.3 
33 3.59 (s) 55.2 3.59 (s) 55.2 
34 3.64 (s) 55.4 3.66 (s) 55.4 
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V.	  6. Experimental towards santarubin A and B 
 
 
4-((tert-butyldimethylsilyl)oxy)-3-methoxybenzaldehyde (172)[72] 
 
 
 
 
 
To a stirred mixture of vanillin (171) (6.00 g, 39.4 mmol, 1 eq.) in dry DMF (30 mL) 
was added TBSCl (7.15 g, 47.3 mmol, 1.2 eq.) and imidazole (6.44 g, 94.6 mmol, 
2.40 eq.) at 0 °C. After 30 min the mixture was warmed to room temperature and 
stirring continued for 4 h 30 min. After completion H2O (20 mL) was added and the 
reaction mixture was extracted with Et2O (3 x 50 mL) and the organic extracts were 
washed with aq. NaCl (10%, 2 x 20 mL), sat. aq. NaCl (20 mL) and dried (Na2SO4). 
The crude product was purified by flash column chromatography [Isohexane: EtOAc 
30:1) to afford benzaldehyde 172 (10.4 g, 98%) as a colorless oil. 
 
Rf: 0.27 (Isohexane: EtOAc 16:1). 
 
1H NMR (300 MHz, CDCl3): δ 9.85 (s, 1H), 7.40 (d, J = 1.9 Hz, 1H), 7.37 (dd, J = 
8.0, 1.9 Hz, 1H), 6.97 (d, J = 8.0 Hz, 1H), 3.87 (s, 3H), 1.00 (s, 9H), 0.19 (s, 6H) 
ppm. 
 
13C NMR (75 MHz, CDCl3): δ 191.2, 151.9, 151.6, 131.2, 126.4, 120.9, 110.4, 55.7, 
25.8, 18.7, –4.3 ppm. 
 
IR (ATR): ṽ = 2954 (m), 2929 (m), 2885 (w), 2856 (m), 1695 (s), 1683 (s), 1592 (s), 
1505 (s), 1463 (s), 1283 (s), 1233 (s), 1150 (s), 894 (s), 838 (s), 779 (s) cm–1.  
 
HRMS (EI):  calcd. for C14H21O3Si+ [M]+:   265.1254, 
found:       265.1261. 
MeO
TBSO
O
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1-(4-((tert-butyldimethylsilyl)oxy)-3-methoxyphenyl)prop-2-en-1-ol (169) 
 
 
 
 
 
To a stirred solution of benzaldehyde 172 (6.00 g, 22.5 mmol, 1 eq.) in THF (50 mL) 
was added vinylmagnesiumbromide (1 M solution in THF, 27.0 mL, 27.0 mmol, 1.2 
eq.) at 0 °C. The reaction mixture was stirred for 1 h 50 min at this temperature and 
upon completion, aq. sat. NH4Cl (30 mL) was added. The reaction mixture was 
extracted with Et2O (3 × 60 mL) and the combined organic extracts were washed with 
sat. aq. NaCl (20 ml) and dried (Na2SO4). The crude product was purified by flash 
column chromatography [Isohexane:EtOAc 8:1) to afford allylic alcohol 169 (5.36 g, 
81%) as a colorless oil. 
 
Rf: 0.25 (Isohexane:EtOAc 7:1). 
 
1H NMR (300 MHz, CDCl3): δ  6.89 – 6.80 (m, 3H), 6.06 (ddd, J = 17.1, 10.3, 5.8 
Hz, 1H), 5.34 (dt, J = 17.1, 1.5 Hz, 1H), 5.20 (dt, J = 10.3, 1.5 Hz, 1H), 5.14 (d, J = 
5.8 Hz, 1H), 3.81 (s, 3H), 1.00 (s, 9H), 0.16 (s, 6H) ppm.  
 
13C NMR (75 MHz, CDCl3): δ  151.3, 144.9, 104.5, 136.3, 121.0, 119.0, 115.1, 110.5, 
75.4, 55.7, 25.9, 18.7, –4.4 ppm. 
 
IR (ATR): ṽ = 3358 (w), 2954 (s), 2929 (s), 2856 (s), 1510 (s), 1279 (s), 1249 (s), 
1230 (s), 916 (s), 838 (s), 779 (s) cm–1. 
 
HRMS (ESI):  calcd. for C16H25O3Si– [M–H]–:   293.1578, 
found:       293.1575. 
 
 
 
MeO
TBSO
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(E)-((4-(3-(2,4-dimethoxyphenyl)prop-1-en-1-yl)-1,2-phenylene)bis(oxy))bis(tert-
butyldimethylsilane) (173) 
 
 
 
 
 
To a solution of allylic alcohol 169 (1.18 mg, 3.00 mmol, 1 eq.) and O,O’-
dimethylresorcinol 170 (1.24 mg, 9.00 mmol, 3 eq.) in CH2Cl2 (20 mL) was added 
successively molecular sieves 4 Å (1.00 g) and Cu(OTf)2 (110 mg, 300 µmol, 10 mol-
%) at 0 °C and the reaction mixture was stirred at this temperature for 30 min. Upon 
completion, sat. aq. NH4Cl (30 mL) was added and the mixture was extracted with 
Et2O (3 × 70 mL). The combined organic extracts were washed with sat. aq. NaCl 
(30 mL) and dried (Na2SO4). The crude product was purified by flash column 
chromatography [Isohexane:EtOAc 80:1] to afford benzylstyrene 173 (1.00 g, 81%) 
as a colorless oil. 
 
Rf: 0.27 (Isohexane:EtOAc 16:1). 
 
1H NMR (300 MHz, CDCl3): δ  7.09 (d, J = 8.1 Hz, 1H), 6.87 (d, J = 1.8 Hz, 1H), 
6.81 (dd, J = 8.2, 1.9 Hz, 1H), 6.76 (d, J = 8.1 Hz, 1H), 6.48 (d, J = 2.3 Hz, 1H), 6.45 
(dd, J = 8.1, 2.4 Hz, 1H), 6.33 (d, J = 15.8 Hz, 1H), 6.20 (dt, J = 15.7, 6.4 Hz, 1H), 
3.83 (s, 3H), 3.81 (s, 3H), 3.80 (s, 3H), 3.45 (d, J = 6.3 Hz, 2H), 1.00 (s, 9H), 0.15 (s, 
6H) ppm. 
 
13C NMR (75 MHz, CDCl3): δ  159.6, 158.4, 151.1, 144.5, 132.1, 130.4, 130.3, 127.6, 
121.5, 121.1, 119.2, 109.8, 104.2, 98.8, 55.7, 55.7, 55.6, 32.8, 26.0, 18.7, –4.4 ppm. 
 
IR (ATR): ṽ = 2998 (w), 2953 (m), 2929 (m), 2902 (m), 1612 (m), 1505 (s), 1463 
(m), 1277 (s), 1206 (s), 1153 (s), 1123 (s), 1036 (s), 893 (s), 835 (s), 780 (s) cm–1. 
 
 
MeO
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HRMS (ESI):  calc. for C24H33O4Si+ [M–H]+:   413.2143, 
found:       413.2145. 
 
 
 
 
(E)-tert-butyl(4-(3-(2,4-dimethoxyphenyl)prop-1-en-1-yl)-2-
methoxyphenoxy)dimethylsilane (168) 
 
 
 
 
 
To a stirred solution of styrene 173 (200 mg, 480 µmol, 1 eq.) in THF (4 mL) was 
added TBAF (1 M solution in THF, 580 µL, 580 µmol, 1.2 eq.) at 0 °C. The reaction 
mixture was stirred for 30 min at this temperature and after completion, the reaction 
mixture was quenched by addition of H2O (10 mL) and the biphasic mixture was 
extracted with Et2O (3 × 20 mL). The combined organic extracts were washed with 
sat. aq. NaCl (5 mL) and dried (Na2SO4). The crude product was purified by flash 
column chromatography [CH2Cl2:MeOH 99:1] to afford benzylstyrene 168 (68.0 mg, 
47.0 %) as a pale red oil.  
 
Rf: 0.66 (CH2Cl2: MeOH 99:1). 
 
1H NMR (300 MHz, CDCl3): δ  7.09 (d, J = 8.1 Hz, 1H), 6.87 – 6.83 (m, 3H), 6.48 (s, 
1H), 6.45 (d, J = 8.1 Hz, 1H) 6.33 (d, J = 16.0 Hz, 1H), 6.19 (dt, J = 16.0, 6.5 Hz, 
1H), 3.88 (s, 3H), 3.83 (s, 3H), 3.81 (s, 3H), 3.45 (d, J = 6.5 Hz, 2H) ppm. 
 
13C NMR (75 MHz, CDCl3): δ  159.6, 158.4, 146.7, 145.1, 130.7, 130.3 (2C), 127.3, 
121.5, 119.9, 114.5, 108.3, 104.2, 98.9, 56.1, 55.6, 55.6, 32.8 ppm. 
 
IR (ATR): ṽ = 3501 (w), 3427 (w), 2958 (m), 2834 (m), 1610 (m), 1587 (m), 1504 (s), 
1462 (m), 1260 (s), 1205 (s), 1152 (s), 1117 (s), 1031 (s), 819 (m) cm–1. 
MeO
HO
OMe
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HRMS (ESI):  calcd. for C18H19O4+ [M–H]+:   299.1278, 
found:       299.1277. 
 
 
 
 
santarubin A (19) 
 
 
  
 
 
Benzylstyrene 168 (6.00 mg, 20.0 µmol, 1 eq.) and anhydrobase 30 (16.0 mg, 50.0 
µmol, 2.5 eq.) were dissolved in MeCN/MeOH (5:1, 0.6 mL). The reaction vessel was 
sealed and heated to 80 °C for 9 h. After this time, an orange precipitate formed, 
which upon cooling to room temperature could be collected from reaction mixture by 
transferring the suspension into an Eppendorf tube and sedimentation with a 
centrifuge. The precipitate was washed with MeOH (2 × 0.3 mL) affording santarubin 
A (19) (10.0 mg, 83%) as a bright red powder. 
 
Rf: 0.42 (CH2Cl2:MeOH 10:1). 
 
UV (CH2Cl2): λmax = 443, 470, 501 nm. 
 
mp (MeOH): 287 °C decomp. 
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1H NMR (600 MHz, CDCl3): δ  9.77 (s, 1H), 7.02 (d, J = 8.0 Hz, 1H), 7.01 (s, 1H), 
6.81 (s, 1H), 6.77 (dd, J = 8.0, 1.9 Hz, 1H), 6.60 (d, J = 1.9 Hz, 1H), 6.58 (s, 1H), 
6.54 (d, J = 8.4 Hz, 1H), 6.42 (d, J = 2.4 Hz, 1H), 6.22 (dd, J = 8.4, 2.4 Hz, 1H), 4.16 
(d, J = 15.9 Hz, 1H), 4.06 (s, 3H), 4.03 (d, J = 15.9 Hz, 1H), 3.78 (s, 3H), 3.78 (s, 
3H), 3.73 (s, 3H), 3.65 (s, 3H) ppm. 
 
13C NMR (150 MHz, CDCl3): δ 176.3 (*), 159.6, 158.0, 157.4, 151.6, 150.9 (*), 
147.4, 146.6, 146.2, 145.5, 143.4, 140.5, 136.8 (**), 130.0, 128.8, 126.2, 125.9, 
122.7, 122.0, 121.2, 117.8, 114.7, 112.2, 106.3 (**), 104.5 (**), 104.1, 104.1, 101.6, 
98.4, 60.4, 56.3, 56.0, 55.7, 55.5, 27.1 ppm. 
 
(*) obscured carbon was detected by HMBC 
(**) obscured carbon was detected by HSQC 
 
IR (ATR): ṽ = 3278 (w), 2934 (w), 2836 (w), 1570 (m), 1496 (s), 1456 (s), 1342 (s), 
1291 (s), 1200 (s), 1073 (s), 1119 (m), 1037 (s), 825 (s) cm–1. 
 
HRMS (ESI):  calcd. for C35H31O10+ [M+H]+:   611.1912, 
found:       611.1903. 
 
Number 1H (Synthetic) 13C (Synthetic) 1H (Isolated)[1] 
1  150.9  
2  106.3  
3 9.77 (s, 1H) 136.5 9.66 (1H) 
4 7.01 (s, 1H) 104.5 7.1–6.1 (m, 
9H)*** 
5  151.6  
6  176.3  
7 6.58 (s, 1H) 101.6 7.1–6.1 (m, 
9H)*** 
8  157.4  
9  122.0  
10  117.8  
11  143.4  
12  140.5  
13  147.4  
14 6.81 (s, 1H) 104.1 7.1–6.1 (m, 
9H)*** 
15  125.9  
16 4.16, 4.03 27.1 4.01 (2H) 
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(ABq, J = 15.9 
Hz, 2H) 
17  126.2  
18  146.2  
19  130.0  
20 6.60 (d, J = 1.9 
Hz, 1H) 
112.2 7.1–6.1 (m, 
9H)*** 
21  146.6  
22  145.5  
23 7.02 (d, J = 8.0 
Hz, 1H) 
114.7 7.1–6.1 (m, 
9H)*** 
24 6.77 (dd, J = 
8.0, 1.9 Hz, 
1H) 
122.7 7.1–6.1 (m, 
9H)*** 
25  121.2  
26  158.0  
27 6.42 (d, J = 2.4 
Hz, 1H) 
98.4 7.1–6.1 (m, 
9H)*** 
28  159.6  
29 6.22 (dd, J = 
8.4, 2.4 Hz, 
1H) 
104.1 7.1–6.1 (m, 
9H)*** 
30 6.54 (d, J = 8.4 
Hz, 1H) 
128.8 7.1–6.1 (m, 
9H)*** 
31 3.78 (s, 3H) 56.3 3.78 (3H) 
32 4.06 (s, 3H) 60.4 4.06 (3H) 
33 3.65 (s, 3H) 56.0 3.66 (3H) 
34 3.78 (s, 3H) 55.7 3.78 (3H) 
35 3.73 (s, 3H) 55.5 3.74 (3H) 
 
*** 9 aromatic protons were described as a multiplet in the range of 7.1–6.1 ppm 
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1-(3,4-bis((tert-butyldimethylsilyl)oxy)phenyl)prop-2-en-1-ol (174)[54] 
 
 
 
 
 
To a stirred solution of benzaldehyde 61 (5.44 g, 14.9 mmol, 1 eq.) in THF (71 mL) 
was added vinylmagnesiumbromide (1 M solution in THF, 17.8 mL, 17.8 mmol, 1.2 
eq.) at 0°C. The reaction mixture was stirred for 3 h at 0 °C and upon completion, aq. 
sat. NH4Cl (30 mL) was added. The reaction mixture was extracted with Et2O (3 × 
100 mL) and combined organic extracts were washed with sat. aq. NaCl (20 ml) and 
dried (Na2SO4). The crude product was purified by flash column chromatography 
[Isohexane: EtOAc 30:1) to afford 174 (4.45 g, 76 %) as colorless oil. 
 
Rf: 0.31 (Isohexane: EtOAc 7:1). 
 
1H NMR (400 MHz, CDCl3): δ 6.83 – 6.78 (m, 3H) 6.00 (ddd, J = 17.1, 10.4, 5.8 Hz, 
1H), 5.28 (dt, J = 17.1, 1.4 Hz, 1H), 5.15 (dt, J = 10.4, 1.4 Hz, 1H), 5.06 (dt, J = 3.8, 
1.6 Hz, 1H), 0.97 (s, 9 H), 0.97 (s, 9H), 0.17 (s, 12H) ppm. 
 
13C NMR (100 MHz, CDCl3): δ  147.0, 146.7, 140.5, 136.0, 121.1, 119.6, 119.6, 
114.9, 75.0, 26.2 (2C), 26.1, 18.7, –3.9, –3.9, –3.9 ppm. 
 
IR (ATR): ṽ = 3416 (w), 2929 (m), 2857 (s), 2359 (m), 1506 (s), 1290 (s), 1252 (s), 
1119 (s), 985 (s), 902 (s), 836 (s), 788 (s) cm–1. 
 
HRMS (ESI):  calcd. for C21H37O2Si2+ [M–OH]+:   377.2327, 
found:       377.2329. 
 
 
 
 
TBSO
TBSO
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(E)-((4-(3-(2,4-dimethoxyphenyl)prop-1-en-1-yl)-1,2-phenylene)bis(oxy))bis(tert-
butyldimethylsilane) (175) 
 
 
 
 
 
To a solution of allylic alcohol 174 (883 mg, 2.24 mmol, 1 eq.) and O,O’-
dimethylresorcinol 170 (1.24 g, 8.96 mmol, 4 eq.) in CH2Cl2 (20 mL) was added 
successively molecular sieves 4 Å (1.00 g) and Cu(OTf)2 (80.0 mg, 220 µmol, 10 
mol-%) at 0 °C. The reaction mixture was stirred at this temperature for 30 min and 
upon completion, aq. sat. NH4Cl (30 mL) was added. The reaction mixture was 
extracted with Et2O (3 × 70 mL) and the combined organic extracts were washed with 
sat. aq. NaCl (30 mL) and dried (Na2SO4). The crude product was purified by flash 
column chromatography [Isohexane:EtOAc 40:1] to afford benzylstyrene 175 (725 
mg, 63%) as a colorless oil. 
 
Rf: 0.41 (Isohexane:EtOAc 16:1). 
 
1H NMR (600 MHz, CDCl3): δ  7.07 (d, J = 8.2 Hz, 1H), 6.83 (d, J = 2.2 Hz, 1H), 
6.80 (dd, J = 8.2, 2.2 Hz, 1H), 6.73 (d, J = 8.2 Hz, 1H), 6.47 (d, J = 2.4 Hz, 1H), 6.44 
(dd, J = 8.2, 2.4 Hz, 1H), 6.26 (d, J = 15.7 Hz, 1H) 6.15 (dt, J = 15.7, 6.8 Hz, 1H), 
3.82 (s, 3H), 3.80 (s, 3H), 3.42 (d, J = 6.8 Hz, 2H), 0.99 (s, 9H), 0.97 (s, 9H), 0.19 (s, 
6H), 0.18 (s, 6H) ppm. 
 
13C NMR (150 MHz, CDCl3): δ 159.6, 158.4, 146.9, 146.3, 131.8, 130.2, 130.2, 
127.4, 121.6, 121.2, 119.5, 119.0, 104.2, 98.8, 55.6, 55.6, 32.8, 26.2, 26.2, 18.7, 18.7, 
–3.6, –3.9 ppm. 
 
IR (ATR): ṽ = 3362 (w), 2958 (w), 1610 (m), 1503 (s), 1437 (m), 1279 (s), 1205 (s), 
1151 (s), 1034 (s), 963 (m), 818 (s), 785 (m) cm–1. 
 
TBSO
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HRMS (ESI):  calcd. for C29H45O4Si2+ [M–H]+:  513.2851, 
found:      513.2851. 
 
 
 
 
(E)-4-(3-(2,4-dimethoxyphenyl)prop-1-en-1-yl)benzene-1,2-diol (176) 
 
 
 
 
 
To a stirred solution of styrene 175 (200 mg, 390 µmol, 1 eq.) in THF (4 mL) was 
added TBAF (1 M solution in THF, 860 µL, 860 µmol, 2.2 eq.) at 0 °C. The reaction 
mixture was stirred at 0 °C for 30 min and upon completion, H2O (10 mL) was added. 
The reaction mixture was extracted with Et2O (3 × 25 mL) and the combined organic 
extracts were washed with sat. aq. NaCl (2 mL) and dried (Na2SO4). The crude 
product was purified by flash column chromatography [CH2Cl2:MeOH 98:2 → 95:5] 
to afford benzylstyrene 176 (79.0 mg, 71%) as a pale yellow oil.  
 
Rf: 0.25 (CH2Cl2:MeOH 95:5). 
 
1H NMR (400 MHz, CDCl3): δ  7.06 (d, J = 8.2 Hz, 1H), 6.84 (d, J = 1.0 Hz, 1H), 
6.72 – 6.71 (m, 2H), 6.61 (br, 2H, OH), 6.52 (d, J = 2.4 Hz, 1H), 6.46 (dd, J = 8.2, 2.4 
Hz, 1H), 6.25 (dt, J = 15.9, 1.1 Hz, 1H), 6.16 (dt, J = 15.9, 6.6 Hz, 1H), 3.81 (s, 3H), 
3.76 (s, 3H), 3.36 (d, J = 6.6 Hz, 2H) ppm. 
 
13C NMR (100 MHz, CDCl3): δ 160.7, 159.3, 145.6, 144.9, 131.7, 131.1, 130.9, 
127.8, 122.0, 119.5, 116.3, 113.5, 105.5, 99.5, 56.2, 56.0, 33.3 ppm. 
 
IR (ATR): ṽ = 2952 (m), 2928 (m), 2894 (w), 2856 (m), 1612 (m), 1504 (s), 1470 
(m), 1287 (s), 1251 (s), 1206 (s), 1155 (s), 1121 (s), 900 (s) 833 (s), 777 (s) cm–1. 
HO
HO
OMe
OMe
	  184	  
 
HRMS (ESI):  calcd. for C17H17O4– [M–H]–:   285.1121, 
found:       285.1129. 
 
 
 
 
santarubin B (20) 
 
 
 
 
 
Benzylstyrene 176 (6.00 mg, 20.0 µmol, 1 eq.) and anhydrobase 30 (16.0 mg, 50.0 
µmol, 2.5 eq.) were dissolved in MeCN/MeOH (5:1, 0.6 mL). The reaction vessel was  
sealed and was heated to 80 °C for 10 h. After this time, an orange precipitate formed, 
which was collected, upon cooling the reaction mixture to room temperature, by 
transferring the suspension into an Eppendorf tube and sedimentation with a 
centrifuge. The precipitate was washed with MeOH (2 × 0.3 mL) affording santarubin 
B (20) (9.00 mg, 74%) as a red powder. 
 
Rf: 0.33 (CH2Cl2: MeOH 10:1). 
 
mp (MeOH): 272 °C decomp. 
 
UV (CH2Cl2): λmax = 443, 469, 501 nm. 
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1H NMR (600 MHz, d6-DMSO): δ 9.53 (s, 1H), 9.22 (br, 3H, OH), 7.05 (s, 1H), 6.85 
(d, J = 8.0 Hz, 1H), 6.76 (s, 1H), 6.65 (d, J = 2.1 Hz, 1H), 6.54 – 6.49 (m, 3H), 6.27 
(dd, J = 8.5, 2.4 Hz, 1H), 6.04 (d, J = 1.1 Hz, 1H), 3.98 (d, J = 15.9 Hz, 1H), 3.94 (d, 
J = 16.0 Hz, 1H), 3.91 (s, 3H), 3.81 (s, 3H), 3.66 (s, 3H), 3.64 (s, 3H) ppm. 
 
13C NMR (150 MHz, d6-DMSO): δ 177.1, 158.5, 157.3, 156.1, 152.1, 149.0, 148.3, 
145.1, 145.0, 144.9, 143.6, 141.4, 133.6, 128.7, 128.1, 124.4, 123.9, 121.3, 120.4, 
120.3, 117.2, 116.8, 115.7, 113.0, 105.0, 104.2, 103.9, 101.0, 98.1, 59.5, 55.4, 55.4, 
54.9, 26.6 ppm. 
 
IR (ATR): ṽ = 3118 (m), 2923 (m), 2893 (w), 2471 (w), 1546 (m), 1497 (s), 1468 (s), 
1342 (s), 1295 (s), 1208 (s), 1175 (s), 1151 (s), 1071 (s), 1043 (s) cm–1. 
 
HRMS (ESI):  calcd. for C34H29O10+ [M+H]+:   597.1755, 
found:       597.1762. 
 
Number 1H (synthetic) 13C (Synthetic) 
1  149.0 
2  113.0 
3 9.53 (s, 1H) 133.6 
4 7.05 (s, 1H) 105.0 
5  152.1 
6  177.1 
7 6.04 (d, J = 0.7 
Hz, 1H) 
101.0 
8  156.1 
9  121.3 
10  117.2 
11  143.6 
12  141.4 
13  148.3 
14 6.75 (s, 1H) 103.9 
15  124.4 
16 4.00, 3.95 
(ABq, d, J = 
16.0 Hz, 1H) 
26.2 
17  123.9 
18  144.9 
19  128.7 
20 6.65 (d, J = 2.2 
Hz, 1H) 
116.8 
21  145.1 
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22  145.0 
23 6.85 (d, J = 8.1 
Hz, 1H) 
115.7 
24 6.54 – 6.49  
(m, 3H)* 
120.4 
25  120.3 
26  157.3 
27 6.54 – 6.49  
(m, 3H)* 
98.1 
28  158.5 
29 6.27 (dd, J = 
8.2, 1.5 Hz, 
1H) 
104.2  
30 6.54 – 6.49  
(m, 3H)* 
128.1 
31 3.91 (s, 3H) 55.4 
32 3.64 (s, 3H) 59.5 
33 3.81 (s, 3H) 55.4 
34 3.66 (s, 3H) 54.9 
 
 
 
 
* 3 aromatic H were detected in the range of 6.54–6.49. 
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VI. Appendix I – Table 10 
	  
	  
Table 10 Conditions screened towards the synthesis of santalin Y 
	  
	  
	  
	  
	  
	  
	  
	  
Entry Ratio 
27:30 
Solvent Additive Light 
source 
Filter T 
[° C] 
Observation 
1 1:1 MeOH - RL Q 12 s.m. + 102 
2 1:1 MeCN/MeOH - RL	   Q 12 s.m. + 102 
3 1:1 MeCN/H2O - RL	   Q 12 s.m. + 102 
4 1:1 MeCN/MeOH - RL	   Q 12 s.m. + 102 
5 1:1 MeCN/EtOH - RL	   P 12 s.m. + 102 
6 1:1 EtOH - RL	   P 12 s.m. + 102 
7 1:1 iPrOH - RL	   Q 12 s.m. + 102 
8 1:1 amylOH - RL	   Q 12 s.m. 
9 1:1 CHCl3 - RL	   P 12 s.m. + 102 + 
97 
10 1:1 THF - RL	   Q 80 c.m. + 97 
11 1:1 CHCl3/MeOH - RL	   Q 12 s.m. + 103 + 
102 
12 1:2 aceton/H2O - RL	   P 12 s.m. + 102 
13 1:3 aceton/MeOH - RL	   P 12 s.m. + 102 
14 1:4 CHCl3/aceton - RL	   P 12 s.m. 
15 2:1 MeOH - RL	   Q 12 s.m. + 102 
16 3:1 MeOH - RL	   Q 12 s.m. + 102 
17 1:1 MeOH a RL	   Q 12 s.m. + 102 
18 1:1 MeOH a RL	   P 12 s.m. + 102 
19 1:1 MeCN/MeOH a RL	   Q 12 s.m. + 102 
20 1:1 MeOH LiClO4 RL	   P 12 decomp. 
21 1:1 CHCl3 AlCl3 RL	   P 12 decomp. 
22 1:1 CHCl3 SnCl4 RL	   P 12 c.m. 
23 1:1 CHCl3 AcOH RL	   P 12 s.m. + 97 
24 1:1 CHCl3 pTSA RL	   P 12 s.m. + 97 
HO
HO
OMe
OH
OO
HO
MeO
OH
OMe
O
HO
O
HO
OH
MeO
HO OMe
MeO
OHConditions
27
30
22
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25 1:1 MeOH - Hg150 P rt s.m. + 102 
26 1:1 MeOH - Hg150 P rt s.m. + 102 
27 1:1 aceton/H2O - Hg150 P rt s.m. + 102 
28 1:1 aceton/MeOH - Hg150 P rt s.m. + 102 
29 3:1 MeOH - Hg150 P rt s.m. + 102 
30 1:1 MeOH - Hg150 Q >100 s.m. + 97 
31 3:1 MeCN/H2O - Hg150 Q >100 s.m. + 97 
32 5:1 CHCl3/MeOH - Hg150 Q rt s.m. + 102 
33 1:1 MeOH - SL300W Q 4 s.m. + 102 
34 1:1 MeCN/MeOH - SL300W Q 4 s.m. + 102 
35 1:1 MeOH - SL300W P 4 s.m. + 102 
36 1:1 MeCN/MeOH - SL300W P 4 s.m. + 102 
37 1:1 MeOH a SL500W Q 6 s.m. + 102 
38 1:1 MeCN/MeOH a SL500W Q 6 s.m. + 102 
39 1:1 aceton/H2O - SL500W Q 6 s.m. + 102 
40 1:1 MeOH a SL500W P 6 s.m. + 102 
41 1:1 CHCl3/MeOH - SL500W P 4 s.m. + 102 
42 1:1 MeOH a SL750W Q 4 s.m. + 102 
43 1:1 MeCN/H2O - SL750W Q 4 s.m. + 102 
44 1:1 MeOH/H2O - SL750W Q 4 s.m. + 102 
45 1:1 MeOH - SL750W P 4 s.m. + 102 
46 1:1 aceton/H2O - SL750W P 4 s.m. + 102 
47 1:1 MeOH - SL1000W Q 4 s.m. + 102 
48 1:1 aceton/H2O - SL1000W Q 4 s.m. + 102 
49 1:1 CHCl3 - SL1000W Q 4 s.m. + 102 + 
103 + 97 
50 1:1 MeOH - SL1000W P 4 s.m. + 102 
51 1:1 MeCN/MeOH - SL1000W P 4 s.m. + 102 
52 1:1 MeOH - RN	   P rt s.m. + 102 
53 1:1 MeOH/CHCl3 - RN	   P rt s.m. + 102 
54 1:1 CHCl3 - RN	   P rt s.m. + 102 
55 4:1 Aceton/H2O - RN	   P rt s.m. + 102 
56 1:4 Aceton/H2O - RN	   P rt s.m. + 102 
57 1:1 MeOH - RN	   Q rt s.m. + 102 
58 1:1 MeOH pHb4 RN	   Q rt s.m. + 97  
59 1:1 MeOH pHb7 RN	   Q rt decomp. 
60 1:1 MeOH pHb12 RN	   Q rt decomp. 
61 1:3 CHCl3 - RN Q rt s.m. + 102 
62 1:1 MeOH - Hg450 P rt s.m. + 102 
63 1:1 MeOH pHb4 Hg450 P rt s.m. + 97 
64 1:1 Aceton/H2O - Hg450 P rt s.m. + 102 
65 1:1 MeCN/MeOH - Hg450 P rt s.m. + 102 
66 1:1 CHCl3 - Hg450 P rt s.m. + 102 + 
97 
67 1:1 CH2Cl2 - Hg450 P rt s.m. + 102 + 
97 
68 1:1 MeOH - Hg450 Q rt s.m. + 102 
69 1:1 MeCN/MeCN - Hg450 Q rt s.m. + 102 
70 1:1 aceton/MeOH - Hg450 Q rt s.m. + 102 
71 1:1 THF - Hg450 Q rt decomp. 
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72 1:1 CHCl3 - Hg450 Q rt s.m. + 102 + 
97 
73 2:1 MeOH - Hg450 Q rt s.m. + 102 
74 4:1 MeOH - Hg450 Q rt s.m. + 102 
75 7:1 MeOH - Hg450 Q rt s.m. + 102 
76 10:1 MeOH - Hg450 Q rt  s.m. + 103 + 
102 + 97 
 
RL = reptile sun lamp, 275 W; Hg150 = Mercury medium pressure lamp, 150 W; Hg450 = Mercury 
medium pressure lamp, 450 W; SLXXW = stationary lamp, flexible W (300 W – 1000 W); RN = 
Rayonet, 250 W; a = phenylboronic acid; pHbXX = pH buffer XX (4 – 12); P = pyrex filter; Q = quartz 
filter; s.m. = starting material; c.m. = complex mixture; decomp. = decomposition. 
 
 
 
 
 
Observed side-products: 
 
 
 
 
Formation of 102 in case of protic solvent (R = H, Me, Et, iPr). Isolation of 102 was not possible, but 
was detected by crude NMR. Formation of 103 could be detected by HR-MS and 1H NMR (13C NMR 
showed formation of oxidized product 97).  
	  
OHO
HO
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OH
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OH
HO OMe
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O OR
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VII. Appendix II – Spectral Data 
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VIII. Appendix III – Crystal structures 
	  
	  
	  
	  
	  
	  
	  
	  
 81 
net formula C17H15ClO10 
Mr/g mol−1 414.748 
crystal size/mm 0.30 × 0.21 × 0.16 
T/K 173(2) 
radiation MoKα 
diffractometer 'Oxford XCalibur' 
crystal system monoclinic 
space group P21/n 
a/Å 11.5176(11) 
b/Å 12.5567(9) 
c/Å 12.9588(13) 
α/° 90 
β/° 114.178(12) 
γ/° 90 
V/Å3 1709.7(3) 
Z 4 
calc. density/g cm−3 1.6113(3) 
μ/mm−1 0.283 
absorption correction 'multi-scan' 
transmission factor range 0.60526–1.00000 
refls. measured 5834 
Rint 0.0322 
mean σ(I)/I 0.0510 
θ range 4.20–26.37 
observed refls. 2773 
x, y (weighting scheme) 0.0568, 0.5985 
C12
C13
C14 C15
C10
C2
C1 O1
C9 C8
C7 O3
O2C6C5
C4C3
O6
C17
O5
C11
O4
C16
O8
O7
O10
O9
Cl1
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hydrogen refinement constr 
refls in refinement 3463 
parameters 258 
restraints 0 
R(Fobs) 0.0451 
Rw(F2) 0.1251 
S 1.045 
shift/errormax 0.001 
max electron density/e Å−3 0.271 
min electron density/e Å−3 −0.521 
	  
	  
	  
	  
	  
	  
	  
	  
	  
 
 111 
net formula C14H14N2 
Mr/g mol−1 210.274 
crystal size/mm 0.29 × 0.21 × 0.14 
T/K 153(2) 
radiation MoKα 
diffractometer 'Oxford XCalibur' 
crystal system orthorhombic 
space group Pbca 
a/Å 5.6864(6) 
b/Å 18.4059(14) 
c/Å 21.690(2) 
α/° 90 
β/° 90 
γ/° 90 
V/Å3 2270.1(4) 
Z 8 
C7
C6
C5
C4
C8
C3
C2
N1
N2
C1
C9
C14
C13
C12
C11
C10
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calc. density/g cm−3 1.2305(2) 
μ/mm−1 0.074 
absorption correction 'multi-scan' 
transmission factor range 0.53991–1.00000 
refls. measured 7194 
Rint 0.0377 
mean σ(I)/I 0.0367 
θ range 4.20–26.36 
observed refls. 1876 
x, y (weighting scheme) 0.0484, 0.7336 
hydrogen refinement mixed 
refls in refinement 2314 
parameters 151 
restraints 0 
R(Fobs) 0.0448 
Rw(F2) 0.1137 
S 1.024 
shift/errormax 0.001 
max electron density/e Å−3 0.200 
min electron density/e Å−3 −0.198 
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Addendum 
 
A possible solution in the biomimetic synthesis of santalin Y (22) has been mentioned 
previously in the final chapter IV “Summary, Conclusion and Future Directions” of 
this thesis. It has been proposed that a generic bifunctional catalyst, shown in Scheme 
103, can coordinate to the carbonyl function with simultanious activation of a 
Brønstedt basic site (B). The Brønstedt base enhances deprotonation of the vicinal 
hydroxy-group, thus favoring the attack to the ortho-quinone methide leading to 
santalin Y (22). 
 
 
	  
Scheme 103 – Hypothesis for the biomimetic formation of santalin Y. 
 
Due to the presence of catechol units with metal chelating properties, organocatalytic 
bifunctional catalysts were preferred to bimetallic catalysts developed by the group of 
Shibasaki[42]. A thiourea-based catalyst 119, developed by the group of Takemoto[43], 
with a tertiary amine in close proximity, was chosen (Figure 17). 
 
	  
Figure 17 – Takemotoʼs bifunctional catalyst. 
 
Formation of santalin Y can be observed in moderate yield with unreacted starting 
material still present (Scheme 104). An increase of the catalyst loading to 
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stochiometric amounts or a different Brønstedt-basic subunit, making the amine more 
basic, might favor full conversion.  
	  
	  
	  
Scheme 104 – Biosynthetic assembly of santalin Y (22). 
 
Our proposed mechanism describes a vinylogous attack of the benzylstyrene 27 to the 
anhydrobase 30, which coordinates the catalyst 119 by hydrogen-bonds. Due to the 
Brønstedt-basic site in close proximity to the thiourea unit, deprotonation can only 
take place at the vicinal hydroxy group thus favoring the attack of the chromane 
heterocycle leading to cyclohepten 178. Subsequent keto-enol tautomerization and 
activation of the resulting carbonylfunction by the thiourea catalyst facilitates a 
Friedel-Crafts type attack to result in santalin Y (22) (Scheme 105). 
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Scheme 105 – Proposed mechanism using Takemotoʼs catalyst (119). 
 
 
Santalin Y (22) 
 
 
 
 
 
To a stirred solution of anhydrobase 30 (10 mg, 0.031 mmol, 1 eq.) and 
benzylstyrene 27 (8.7 mg, 0.031 mmol, 1 eq.) in THF (1.3 mL) was added racemic 
thiourea catalyst 119 (2.6 mg, 0.006 mmol, 20 mol-%) at –20°C. The reaction mixture 
was allowed to come to room temperature and was stirred for 2 d. After the set time, 
the reaction mixture was concentrated in vacuo. Sequential purification with a 
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sephadex column (LH-20, MeOH) and preparative TLC (CH2Cl2:MeOH 10:1) 
afforded santalin Y (20) (4 mg, 22%) and benzylstyrene 27 (6.5 mg). 
 
 
Rf = 0.38 (CH2Cl2:MeOH 9:1). 
 
UV (MeCN): λmax = 357 nm. 
 
IR (ATR):  ṽ = 3271 (m), 2925 (s), 2854 (s), 1733 (w), 1666 (m), 1596 (m), 1508 (m), 
1462 (m), 1381 (w), 1278 (s), 1243 (m), 1176 (s), 1131 (s), 1024 (s), 1005 (m) cm–1. 
 
HRMS (ESI):  calcd. for C33H31O10+ [M+H]+:   587.1912, 
found:        587.1918. 
 
 
Number 1H (d6-DMSO, 600 
MHz) Synthetic 
13C (d6-
DMSO, 150 
MHz) 
Synthetic 
1H (d6-DMSO, 600 
MHz) Isolated 
13C (d6-
DMSO, 150 
MHz) 
Isolated 
OH 9.21 (s, 1H)    
OH 8.88 (s, 1H)    
OH 8.78 (s, 1H)    
OH 8.66 (s, 1H)    
OH 5.82 (s, 1H)    
1 4.84 (s, 1H) 80.93 4.85 (s, 1H) 80.9 
2  152.83  152.9 
3 6.36 (s, 1H) 120.79 6.36 (s, 1H) 120.8 
4  154.89  154.9 
5 5.62 (d, J = 0.6 Hz, 
1H) 
119.73 5.62 (s, 1H) 119.8 
6  198.45  198.4 
7  78.02  78.0 
8 2.47, 
2.62 
(ABq, J = 10.7 Hz, 
2H) 
46.31 2.48, 
2.62 
(ABq, J = 10.6 Hz, 
2H) 
46.3 
9  83.23  83.2 
10  121.51  121.5 
11  146.20  146.2 
12  139.51  139.5 
13  149.55  149.6 
14 6.42 (d, J = 8.9 Hz, 106.95 6.43 (d, J = 8.8 Hz, 107.0 
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1H) 1H) 
15 6.07 (d, J = 8.8 Hz) 117.92 6.08 (d, J = 8.8 Hz, 
1H) 
117.9 
16 3.30 (m, 1H) 54.96 3.32 (m, 1H) 54.9 
17 2.46 (m, 1H) 50.61 2.46 (m, 1H) 50.6 
18 2.67 (dd, J = 13.8, 
10.3 Hz, 1H), 
3.00 (dd, J = 13.8, 
4.0 Hz, 1H) 
36.43 2.68 (dd, J = 13.7, 
10.2 Hz, 1H), 
3.00 (dd, J = 13.7, 
3.6 Hz, 1H) 
36.4 
19  118.06  118.0 
20  157.87  157.9 
21 6.27 (d, J = 2.3 Hz, 
1H) 
98.87 6.27 (d, J = 2.2 Hz, 
1H) 
98.9 
22  157.43  157.4 
23 6.18 (dd, J = 8.0, 2.3 
Hz, 1H) 
106.55 6.19 (dd, J = 8.1, 2.2 
Hz, 1H) 
106.6 
24 6.91 (d, J = 8.1 Hz, 
1H) 
130.58 6.91 (d, J = 8.1 Hz, 
1H) 
130.6 
25  124.56  124.5 
26 6.81 (s, 1H) 113.78 6.81 (s, 1H) 113.8 
27  145.48  145.5 
28  143.69  143.7 
29 6.50 (d, J = 0.8 Hz, 
1H) 
112.32 6.51 (s, 1H) 112.3 
30  128.80  128.8 
31 3.56 (s, 3H) 59.80 3.55 (s, 3H) 59.8 
32 3.77 (s, 3H) 55.79 3.77 (s, 3H) 55.8 
33 3.66 (s, 3H) 54.93 3.67 (s, 3H) 55.0 
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